Amedeo Smart

Free Medical Literature Service


 

Amedeo

Hypertension

  Free Subscription

Articles published in
J Hypertens
    May 2018
  1. PERINI W, Agyemang C, Snijder MB, Peters RJG, et al
    Ethnic disparities in treatment rates for hypertension and dyslipidemia: an analysis by different treatment indications: the Healthy Life in an Urban Setting study.
    J Hypertens. 2018 May 15. doi: 10.1097/HJH.0000000000001716.
    >> Share

  2. LIU J, Yasuno S, Oba K, Konda M, et al
    Long-term effects of antihypertensive therapy on cardiovascular events and new-onset diabetes mellitus in high-risk hypertensive patients in Japan.
    J Hypertens. 2018 May 9. doi: 10.1097/HJH.0000000000001780.
    >> Share

  3. KANSUI Y, Matsumura K, Morinaga Y, Inoue M, et al
    Impact of serum uric acid on incident hypertension in a worksite population of Japanese men.
    J Hypertens. 2018 May 8. doi: 10.1097/HJH.0000000000001743.
    >> Share

  4. CHENG XW, Narisawa M, Jin X, Murohara T, et al
    Sirtuin 1 as a potential therapeutic target in pulmonary artery hypertension.
    J Hypertens. 2018;36:1032-1035.
    >> Share

  5. GREMMELS H, Joles JA
    Fibrates in hypertension: where do we stand?
    J Hypertens. 2018;36:1024-1028.
    >> Share

  6. ROSSI GP
    Mineralocorticoid receptor antagonists: time of repositioning them in the treatment of arterial hypertension.
    J Hypertens. 2018;36:1015-1018.
    >> Share

    April 2018
  7. LEFFERTS WK, DeBlois JP, Receno CN, Barreira TV, et al
    Effects of acute aerobic exercise on arterial stiffness and cerebrovascular pulsatility in adults with and without hypertension.
    J Hypertens. 2018 Apr 19. doi: 10.1097/HJH.0000000000001752.
    >> Share

  8. WALLBACH M, Bohning E, Lehnig LY, Schroer C, et al
    Safety profile of baroreflex activation therapy (NEO) in patients with resistant hypertension.
    J Hypertens. 2018 Apr 19. doi: 10.1097/HJH.0000000000001753.
    >> Share

  9. LEHTONEN AO, Langen VL, Porthan K, Kahonen M, et al
    Electrocardiographic predictors of atrial fibrillation in nonhypertensive and hypertensive individuals.
    J Hypertens. 2018 Apr 19. doi: 10.1097/HJH.0000000000001760.
    >> Share

  10. VIAZZI F, Ceriello A, Fioretto P, Giorda C, et al
    Changes in albuminuria and renal outcome in patients with type 2 diabetes and hypertension: a real-life observational study.
    J Hypertens. 2018 Apr 19. doi: 10.1097/HJH.0000000000001749.
    >> Share

  11. PEREZ-HERNANDEZ J, Olivares MD, Solaz E, Martinez F, et al
    Urinary podocyte-associated molecules and albuminuria in hypertension.
    J Hypertens. 2018 Apr 19. doi: 10.1097/HJH.0000000000001747.
    >> Share

  12. EIKELIS N, Marques FZ, Hering D, Marusic P, et al
    A polymorphism in the noradrenaline transporter gene is associated with increased blood pressure in patients with resistant hypertension.
    J Hypertens. 2018 Apr 19. doi: 10.1097/HJH.0000000000001736.
    >> Share

  13. LIU K, Hao Q, Wei J, Li GH, et al
    MicroRNA-19a/b-3p protect the heart from hypertension-induced pathological cardiac hypertrophy through PDE5A.
    J Hypertens. 2018 Apr 16. doi: 10.1097/HJH.0000000000001769.
    >> Share

  14. KOTSIS V, Tsioufis K, Antza C, Seravalle G, et al
    Obesity and cardiovascular risk: a call for action from the European Society of Hypertension Working Group of Obesity, Diabetes and the High-risk Patient and European Association for the Study of Obesity: part B: obesity-induced cardiovascular disease
    J Hypertens. 2018 Apr 12. doi: 10.1097/HJH.0000000000001731.
    >> Share

  15. KOTSIS V, Jordan J, Micic D, Finer N, et al
    Obesity and cardiovascular risk: a call for action from the European Society of Hypertension Working Group of Obesity, Diabetes and the High-risk Patient and European Association for the Study of Obesity: part A: mechanisms of obesity induced hyperten
    J Hypertens. 2018 Apr 9. doi: 10.1097/HJH.0000000000001730.
    >> Share

  16. GASECKI D, Coca A, Cunha P, Hering D, et al
    Blood pressure in acute ischemic stroke: challenges in trial interpretation and clinical management: position of the ESH Working Group on Hypertension and the Brain.
    J Hypertens. 2018 Apr 4. doi: 10.1097/HJH.0000000000001704.
    >> Share

  17. MCDOOM MM, Palta P, Vart P, Juraschek S, et al
    Late life socioeconomic status and hypertension in an aging cohort: the Atherosclerosis Risk in Communities Study.
    J Hypertens. 2018 Apr 4. doi: 10.1097/HJH.0000000000001696.
    >> Share

  18. MEHATA S, Shrestha N, Mehta R, Vaidya A, et al
    Prevalence, awareness, treatment and control of hypertension in Nepal: data from nationally representative population-based cross-sectional study.
    J Hypertens. 2018 Apr 4. doi: 10.1097/HJH.0000000000001745.
    >> Share

  19. DUNN PH, Woo BKP
    Facebook advertising for disseminating hypertension knowledge to older Chinese adults.
    J Hypertens. 2018;36:962.
    >> Share

  20. PONZETTO A, Figura N
    Hypertensive disorders of pregnancy.
    J Hypertens. 2018;36:957.
    >> Share

  21. DELLES C, Currie G
    Sex differences in hypertension and other cardiovascular diseases.
    J Hypertens. 2018;36:768-770.
    >> Share

  22. FOY CG, Lovato LC, Vitolins MZ, Bates JT, et al
    Gender, blood pressure, and cardiovascular and renal outcomes in adults with hypertension from the Systolic Blood Pressure Intervention Trial.
    J Hypertens. 2018;36:904-915.
    >> Share

  23. LI GQ, Wang Z, Zhao T, Dai SX, et al
    Role of cannabinoid receptor type 1 in rostral ventrolateral medulla in high-fat diet-induced hypertension in rats.
    J Hypertens. 2018;36:801-808.
    >> Share

    March 2018
  24. MWASONGWE S, Min YI, Booth JN 3rd, Katz R, et al
    Masked hypertension and kidney function decline: the Jackson Heart Study.
    J Hypertens. 2018 Mar 29. doi: 10.1097/HJH.0000000000001727.
    >> Share

  25. SEKOBA NP, Kruger R, Labuschagne P, Schutte AE, et al
    Left ventricular mass independently associates with masked hypertension in young healthy adults: the African-PREDICT study.
    J Hypertens. 2018 Mar 29. doi: 10.1097/HJH.0000000000001740.
    >> Share

  26. DE LA SIERRA A, Armario P, Oliveras A, Banegas JR, et al
    Antihypertensive drug use in resistant and nonresistant hypertension and in controlled and uncontrolled resistant hypertension.
    J Hypertens. 2018 Mar 29. doi: 10.1097/HJH.0000000000001729.
    >> Share

  27. LORBEER R, Rospleszcz S, Schlett CL, Heber SD, et al
    Correlation of MRI-derived adipose tissue measurements and anthropometric markers with prevalent hypertension in the community.
    J Hypertens. 2018 Mar 29. doi: 10.1097/HJH.0000000000001741.
    >> Share

  28. PALATINI P, Rosei EA, Avolio A, Bilo G, et al
    Isolated systolic hypertension in the young: a position paper endorsed by the European Society of Hypertension.
    J Hypertens. 2018 Mar 22. doi: 10.1097/HJH.0000000000001726.
    >> Share

  29. LEMBO M, Esposito R, Santoro C, Lo Iudice F, et al
    Three-dimensional echocardiographic ventricular mass/end-diastolic volume ratio in native hypertensive patients: relation between stroke volume and geometry.
    J Hypertens. 2018 Mar 22. doi: 10.1097/HJH.0000000000001717.
    >> Share

  30. CERVENKA L, Huskova Z, Kopkan L, Kikerlova S, et al
    Two pharmacological epoxyeicosatrienoic acid-enhancing therapies are effectively antihypertensive and reduce the severity of ischemic arrhythmias in rats with angiotensin II-dependent hypertension.
    J Hypertens. 2018 Mar 22. doi: 10.1097/HJH.0000000000001708.
    >> Share

  31. ZANCHETTI A
    From blood pressure measurement to treatment: the scope of hypertension research.
    J Hypertens. 2018 Mar 14. doi: 10.1097/HJH.0000000000001710.
    >> Share

  32. TANAKA S, Masuda T, Kamada Y, Hamazaki N, et al
    Excessive SBP elevation during moderate exercise discriminates patients at high risk of developing left ventricular hypertrophy from hypertensive patients.
    J Hypertens. 2018 Mar 7. doi: 10.1097/HJH.0000000000001700.
    >> Share

  33. STERGIOU GS, Asmar R, Myers M, Palatini P, et al
    Improving the accuracy of blood pressure measurement: the influence of the European Society of Hypertension International Protocol (ESH-IP) for the validation of blood pressure measuring devices and future perspectives.
    J Hypertens. 2018;36:479-487.
    >> Share

  34. STERGIOU GS, Alpert B, Mieke S, Asmar R, et al
    A universal standard for the validation of blood pressure measuring devices: Association for the Advancement of Medical Instrumentation/European Society of Hypertension/International Organization for Standardization (AAMI/ESH/ISO) Collaboration Statem
    J Hypertens. 2018;36:472-478.
    >> Share

    February 2018
  35. SARAFIDIS PA, Ruilope LM, Loutradis C, Gorostidi M, et al
    Blood pressure variability increases with advancing chronic kidney disease stage: a cross-sectional analysis of 16 546 hypertensive patients.
    J Hypertens. 2018 Feb 20. doi: 10.1097/HJH.0000000000001670.
    >> Share

  36. SALAM A, Rodgers A
    False reassurance about the consequences of withdrawing antihypertensive drug therapy.
    J Hypertens. 2018;36:447-448.
    >> Share

  37. BANEGAS JR, Ruilope LM, Williams B
    White-coat UnControlled Hypertension, Masked UnControlled Hypertension, and True UnControlled Hypertension, phonetic and mnemonic terms for treated hypertension phenotypes.
    J Hypertens. 2018;36:446-447.
    >> Share

  38. GKALIAGKOUSI E, Anyfanti P, Lazaridis A, Douma S, et al
    Plasma renin activity to plasma aldosterone concentration ratio for the assessment of essential hypertensive patients in real-life clinical practice.
    J Hypertens. 2018;36:444.
    >> Share

    January 2018
  39. MIR SA, Li Y, Story JD, Bal S, et al
    Mice overexpressing chromogranin A display hypergranulogenic adrenal glands with attenuated ATP levels contributing to the hypertensive phenotype.
    J Hypertens. 2018 Jan 31. doi: 10.1097/HJH.0000000000001678.
    >> Share

  40. HE WJ, Zhong C, Xu T, Wang D, et al
    Early antihypertensive treatment and clinical outcomes in acute ischemic stroke: subgroup analysis by baseline blood pressure.
    J Hypertens. 2018 Jan 31. doi: 10.1097/HJH.0000000000001690.
    >> Share

  41. ZURLO G, Piquereau J, Moulin M, Pires Da Silva J, et al
    Sirtuin 1 regulates pulmonary artery smooth muscle cell proliferation: role in pulmonary arterial hypertension.
    J Hypertens. 2018 Jan 24. doi: 10.1097/HJH.0000000000001676.
    >> Share

  42. ZANCHETTI A
    Focus on diagnostic and therapeutic aspects of hypertension.
    J Hypertens. 2018 Jan 23. doi: 10.1097/HJH.0000000000001689.
    >> Share

  43. BOTZER A, Grossman E, Moult J, Unger R, et al
    A system view and analysis of essential hypertension.
    J Hypertens. 2018 Jan 23. doi: 10.1097/HJH.0000000000001680.
    >> Share

  44. NIIRANEN TJ, Lin H, Larson MG, Vasan RS, et al
    Familial clustering of hypertensive target organ damage in the community.
    J Hypertens. 2018 Jan 23. doi: 10.1097/HJH.0000000000001679.
    >> Share

  45. BAZOUKIS G, Thomopoulos C, Tsioufis C
    Effect of mineralocorticoid antagonists on blood pressure lowering: overview and meta-analysis of randomized controlled trials in hypertension.
    J Hypertens. 2018 Jan 19. doi: 10.1097/HJH.0000000000001671.
    >> Share

  46. CUSHMAN WC, Bakris GL, White WB, Weber MA, et al
    A randomized titrate-to-target study comparing fixed-dose combinations of azilsartan medoxomil and chlorthalidone with olmesartan and hydrochlorothiazide in stage-2 systolic hypertension.
    J Hypertens. 2018 Jan 13. doi: 10.1097/HJH.0000000000001647.
    >> Share

  47. BUUS NH, Carlsen RK, Khatir DS, Eiskjaer H, et al
    Arterial stiffness and peripheral vascular resistance in offspring of hypertensive parents: influence of sex and other confounders.
    J Hypertens. 2018 Jan 4. doi: 10.1097/HJH.0000000000001645.
    >> Share

  48. LING L, Chen D, Tong Y, Zang YH, et al
    Fibronectin type III domain containing 5 attenuates inflammasome activation and phenotypic transformation of adventitial fibroblasts in hypertension.
    J Hypertens. 2018 Jan 4. doi: 10.1097/HJH.0000000000001654.
    >> Share

  49. DEBORDE T, Amar L, Bobrie G, Postel-Vinay N, et al
    Sex differences in antihypertensive treatment in France among 17 856 patients in a tertiary hypertension unit.
    J Hypertens. 2018 Jan 4. doi: 10.1097/HJH.0000000000001607.
    >> Share

  50. ZANCHETTI A
    Blood pressure measurement, blood vessels and treatment of hypertension.
    J Hypertens. 2018 Jan 2. doi: 10.1097/HJH.0000000000001667.
    >> Share

  51. YANNOUTSOS A, Bahous SA, Safar ME, Blacher J, et al
    Clinical relevance of aortic stiffness in end-stage renal disease and diabetes: implication for hypertension management.
    J Hypertens. 2018 Jan 2. doi: 10.1097/HJH.0000000000001665.
    >> Share

  52. LI Y, Wang L, Feng X, Zhang M, et al
    Geographical variations in hypertension prevalence, awareness, treatment and control in China: findings from a nationwide and provincially representative survey.
    J Hypertens. 2018;36:178-187.
    >> Share

  53. LEMOGOUM D, Van de Borne P, Lele CEB, Damasceno A, et al
    Prevalence, awareness, treatment, and control of hypertension among rural and urban dwellers of the Far North Region of Cameroon.
    J Hypertens. 2018;36:159-168.
    >> Share

  54. MAHFOUD F, Bohm M, Edelman ER
    Catheter-based renal denervation in hypertension: heading for new shores.
    J Hypertens. 2018;36:41-42.
    >> Share

  55. AHMAD A, Oparil S
    What is the most appropriate target SBP in persons with hypertension and diabetes mellitus?
    J Hypertens. 2018;36:37-40.
    >> Share

    December 2017
  56. WITTE J, Lampe J, Koenen A, Urbaneck I, et al
    The role of distal tubule and collecting duct sodium reabsorption in sunitinib-induced hypertension.
    J Hypertens. 2017 Dec 27. doi: 10.1097/HJH.0000000000001650.
    >> Share

  57. CASTIGLIONI L, Pignieri A, Fiasche M, Giudici M, et al
    Fenofibrate attenuates cardiac and renal alterations in young salt-loaded spontaneously hypertensive stroke-prone rats through mitochondrial protection.
    J Hypertens. 2017 Dec 22. doi: 10.1097/HJH.0000000000001651.
    >> Share

  58. CHOWDHURY EK, Wing LMH, Jennings GLR, Beilin LJ, et al
    Visit-to-visit (long-term) and ambulatory (short-term) blood pressure variability to predict mortality in an elderly hypertensive population.
    J Hypertens. 2017 Dec 20. doi: 10.1097/HJH.0000000000001652.
    >> Share

  59. GONCALVES VSS, Andrade KRC, Carvalho KMB, Silva MT, et al
    Accuracy of self-reported hypertension: a systematic review and meta-analysis.
    J Hypertens. 2017 Dec 11. doi: 10.1097/HJH.0000000000001648.
    >> Share

  60. TADIC M, Cuspidi C, Bombelli M, Grassi G, et al
    Hypertensive heart disease beyond left ventricular hypertrophy: are we ready for echocardiographic strain evaluation in everyday clinical practice?
    J Hypertens. 2017 Dec 7. doi: 10.1097/HJH.0000000000001632.
    >> Share

  61. NAGAI M, Ohira T, Takahashi H, Nakano H, et al
    Impact of evacuation onstrends in the prevalence, treatment, and control of hypertension before and after a disaster.
    J Hypertens. 2017 Dec 7. doi: 10.1097/HJH.0000000000001626.
    >> Share

  62. SMART NA, Carlson DJ, Swaine I, McGowan C, et al
    Commentary on aerobic versus isometric handgrip exercise in hypertension: a randomized controlled trial.
    J Hypertens. 2017;35:2554-2556.
    >> Share

  63. CHENG X, Narisawa M, Jin E, Li X, et al
    alpha-Solanine as potential therapeutic target in pulmonary artery hypertension.
    J Hypertens. 2017;35:2377-2379.
    >> Share

  64. MUNTNER P, Shimbo D
    Should sleep blood pressure be used as a criterion to define white-coat hypertension?
    J Hypertens. 2017;35:2372-2373.
    >> Share

  65. SPENCE JD
    Hypertension in US-born vs. foreign-born African-Americans.
    J Hypertens. 2017;35:2369-2371.
    >> Share

  66. CALHOUN DA, Grassi G
    True versus pseudoresistant hypertension.
    J Hypertens. 2017;35:2367-2368.
    >> Share

  67. HALIMI JM, Persu A, Sarafidis PA, Burnier M, et al
    Optimizing hypertension management in renal transplantation: a call to action.
    J Hypertens. 2017;35:2335-2338.
    >> Share

    November 2017
  68. ZANCHETTI A
    Mechanisms, diagnosis and therapy of hypertension.
    J Hypertens. 2017 Nov 30. doi: 10.1097/HJH.0000000000001638.
    >> Share

  69. JESSEN N, Damasceno A, Silva-Matos C, Tuzine E, et al
    Hypertension in Mozambique: trends between 2005 and 2015.
    J Hypertens. 2017 Nov 27. doi: 10.1097/HJH.0000000000001618.
    >> Share

  70. SHI Y, Zhou W, Liu X, Ping Z, et al
    Resting heart rate and the risk of hypertension and heart failure: a dose-response meta-analysis of prospective studies.
    J Hypertens. 2017 Nov 25. doi: 10.1097/HJH.0000000000001627.
    >> Share

  71. ROSSI GP, Seccia TM, Barton M, Danser AHJ, et al
    Endothelial factors in the pathogenesis and treatment of chronic kidney disease Part II: Role in disease conditions: a joint consensus statement from the European Society of Hypertension Working Group on Endothelin and Endothelial Factors and the Japa
    J Hypertens. 2017 Nov 14. doi: 10.1097/HJH.0000000000001600.
    >> Share

  72. FAN M, Yu C, Guo Y, Bian Z, et al
    Effect of total, domain-specific, and intensity-specific physical activity on all-cause and cardiovascular mortality among hypertensive adults in China.
    J Hypertens. 2017 Nov 8. doi: 10.1097/HJH.0000000000001601.
    >> Share

  73. COCA A, Lopez-Jaramillo P, Thomopoulos C, Zanchetti A, et al
    Best antihypertensive strategies to improve blood pressure control in Latin America: position of the Latin American Society of Hypertension.
    J Hypertens. 2017 Nov 8. doi: 10.1097/HJH.0000000000001593.
    >> Share

  74. YANG S, Chen D, Chen F, Zhao X, et al
    Deletion of protein kinase B2 preserves cardiac function by blocking interleukin-6-mediated injury and restores blood pressure during angiotensin II/high-salt-diet-induced hypertension.
    J Hypertens. 2017 Nov 8. doi: 10.1097/HJH.0000000000001613.
    >> Share

  75. ROSSI GP, Seccia TM, Barton M, Danser AHJ, et al
    Endothelial factors in the pathogenesis and treatment of chronic kidney disease Part I: General mechanisms: a joint consensus statement from the European Society of Hypertension Working Group on Endothelin and Endothelial Factors and The Japanese Soci
    J Hypertens. 2017 Nov 7. doi: 10.1097/HJH.0000000000001599.
    >> Share

  76. MOHAMED-NORIEGA J, Scott A, Pinto LA, Rousseau A, et al
    Cautious interpretation of the associations between systemic hypertension, antihypertensive medications and the risk of developing glaucoma.
    J Hypertens. 2017;35:2328-2329.
    >> Share

  77. FAGARD RH
    Predicting risk of fatal cardiovascular disease and sudden death in hypertension.
    J Hypertens. 2017;35:2165-2167.
    >> Share

  78. BOESEN EI
    Consequences of in-utero exposure to antihypertensive medication: the search for definitive answers continues.
    J Hypertens. 2017;35:2161-2164.
    >> Share

    October 2017
  79. XIAO L, Dong JH, Teng X, Jin S, et al
    Hydrogen sulfide improves endothelial dysfunction in hypertension by activating peroxisome proliferator-activated receptor delta/endothelial nitric oxide synthase signaling.
    J Hypertens. 2017 Oct 27. doi: 10.1097/HJH.0000000000001605.
    >> Share

  80. ZANCHETTI A
    Hypertension: prognostic, diagnostic and therapeutic aspects.
    J Hypertens. 2017 Oct 25. doi: 10.1097/HJH.0000000000001611.
    >> Share

  81. ROSENBAEK JB, Hornstrup BG, Jorgensen AN, Mortensen J, et al
    Effects of sodium nitrite on renal function and blood pressure in hypertensive vs. healthy study participants: a randomized, placebo-controlled, crossover study.
    J Hypertens. 2017 Oct 23. doi: 10.1097/HJH.0000000000001598.
    >> Share

  82. MOGOS MF, Salemi JL, Spooner KK, McFarlin BL, et al
    Hypertensive disorders of pregnancy and postpartum readmission in the United States: national surveillance of the revolving door.
    J Hypertens. 2017 Oct 16. doi: 10.1097/HJH.0000000000001594.
    >> Share

  83. OMBONI S, Kario K, Bakris G, Parati G, et al
    Effect of antihypertensive treatment on 24-h blood pressure variability: pooled individual data analysis of ambulatory blood pressure monitoring studies based on olmesartan mono or combination treatment.
    J Hypertens. 2017 Oct 16. doi: 10.1097/HJH.0000000000001608.
    >> Share

  84. YANG Y, Wang Y, Xu J, Gao P, et al
    Association between common carotid artery diameter and target organ damage in essential hypertension.
    J Hypertens. 2017 Oct 13. doi: 10.1097/HJH.0000000000001590.
    >> Share

  85. SCHMIEDER RE, Ott C, Toennes SW, Bramlage P, et al
    Phase II randomized sham-controlled study of renal denervation for individuals with uncontrolled hypertension - WAVE IV.
    J Hypertens. 2017 Oct 13. doi: 10.1097/HJH.0000000000001584.
    >> Share

  86. DOROBANTU M, Tautu OF, Dimulescu D, Sinescu C, et al
    Perspectives on hypertension's prevalence, treatment and control in a high cardiovascular risk East European country: data from the SEPHAR III survey.
    J Hypertens. 2017 Oct 13. doi: 10.1097/HJH.0000000000001572.
    >> Share

  87. SONG L, Shen L, Li H, Liu B, et al
    Age at natural menopause and hypertension among middle-aged and older Chinese women.
    J Hypertens. 2017 Oct 7. doi: 10.1097/HJH.0000000000001585.
    >> Share

  88. KITAMOTO T, Omura M, Suematsu S, Saito J, et al
    KCNJ5 mutation as a predictor for resolution of hypertension after surgical treatment of aldosterone-producing adenoma.
    J Hypertens. 2017 Oct 7. doi: 10.1097/HJH.0000000000001578.
    >> Share

  89. BRUNSTROM M, Carlberg B
    Standardization according to blood pressure lowering in meta-analyses of antihypertensive trials: comparison of three methodological approaches.
    J Hypertens. 2017 Oct 4. doi: 10.1097/HJH.0000000000001574.
    >> Share

  90. DISSE SC, Ostermayer SH, Schmidt D, Kamrath C, et al
    Factitious hypertensive crises unraveled by Doppler ultrasound: potential limitations of oscillometric blood pressure assessment.
    J Hypertens. 2017;35:2116-2118.
    >> Share

  91. ZOCCALI C, Mallamaci F
    Propensity to calcification as a pathway to renal hypoxia in chronic kidney disease and in hypertension.
    J Hypertens. 2017;35:1963-1965.
    >> Share

    September 2017
  92. ZANCHETTI A
    Blood vessels and the kidney in hypertension.
    J Hypertens. 2017 Sep 28. doi: 10.1097/HJH.0000000000001592.
    >> Share

  93. MARC Y, Hmazzou R, Balavoine F, Flahault A, et al
    Central antihypertensive effects of chronic treatment with RB150: an orally active aminopeptidase A inhibitor in deoxycorticosterone acetate-salt rats.
    J Hypertens. 2017 Sep 28. doi: 10.1097/HJH.0000000000001563.
    >> Share

  94. MACQUART DE TERLINE D, Diop BI, Bernard M, Do B, et al
    Substandard drugs among five common antihypertensive generic medications: an analysis from 10 African countries.
    J Hypertens. 2017 Sep 27. doi: 10.1097/HJH.0000000000001560.
    >> Share

  95. HOLMQVIST L, Bostrom KB, Kahan T, Schioler L, et al
    Cardiovascular outcome in treatment-resistant hypertension: results from the Swedish Primary Care Cardiovascular Database (SPCCD).
    J Hypertens. 2017 Sep 27. doi: 10.1097/HJH.0000000000001561.
    >> Share

  96. LIU K, Qin F, Sun X, Zhang Y, et al
    Analysis of the genes involved in Mendelian forms of low-renin hypertension in Chinese early-onset hypertensive patients.
    J Hypertens. 2017 Sep 14. doi: 10.1097/HJH.0000000000001556.
    >> Share

  97. DOLMATOVA EV, Moazzami K, Bansilal S
    Dietary sodium intake among US adults with hypertension, 1999-2012.
    J Hypertens. 2017 Sep 14. doi: 10.1097/HJH.0000000000001558.
    >> Share

  98. CERVANTES-PEREZ LG, Castaneda-Bueno M, Jimenez JV, Vazquez N, et al
    Disruption of the with no lysine kinase-STE20-proline alanine-rich kinase pathway reduces the hypertension induced by angiotensin II.
    J Hypertens. 2017 Sep 4. doi: 10.1097/HJH.0000000000001554.
    >> Share

  99. JENNINGS GLR
    Antihypertensive therapy: strategic withdrawal or a mandatory life sentence?
    J Hypertens. 2017;35:1778-1779.
    >> Share

  100. PERRONE-FILARDI P, Coca A, Galderisi M, Paolillo S, et al
    Noninvasive cardiovascular imaging for evaluating subclinical target organ damage in hypertensive patients: a consensus article from the European Association of Cardiovascular Imaging, the European Society of Cardiology Council on Hypertension and the
    J Hypertens. 2017;35:1727-1741.
    >> Share

    August 2017
  101. THOMOPOULOS C, Parati G, Zanchetti A
    Effects of blood-pressure-lowering treatment on outcome incidence in hypertension. 11. Effects of total cardiovascular risk and achieved blood pressure: overview and meta-analyses of randomized trials.
    J Hypertens. 2017 Aug 30. doi: 10.1097/HJH.0000000000001548.
    >> Share

  102. CATENA C, Colussi G, Martinis F, Novello M, et al
    Microalbuminuria and plasma aldosterone levels in nondiabetic treatment-naive patients with hypertension.
    J Hypertens. 2017 Aug 30. doi: 10.1097/HJH.0000000000001476.
    >> Share

  103. MARTINEZ-MARTINEZ E, Ibarrola J, Fernandez-Celis A, Calvier L, et al
    Galectin-3 pharmacological inhibition attenuates early renal damage in spontaneously hypertensive rats.
    J Hypertens. 2017 Aug 30. doi: 10.1097/HJH.0000000000001545.
    >> Share

  104. AGYEMANG C, Nyaaba G, Beune E, Meeks K, et al
    Variations in hypertension awareness, treatment, and control among Ghanaian migrants living in Amsterdam, Berlin, London, and nonmigrant Ghanaians living in rural and urban Ghana - the RODAM study.
    J Hypertens. 2017 Aug 29. doi: 10.1097/HJH.0000000000001520.
    >> Share

  105. AZEGAMI T, Yuki Y, Hayashi K, Hishikawa A, et al
    Intranasal vaccination against angiotensin II type 1 receptor and pneumococcal surface protein A attenuates hypertension and pneumococcal infection in rodents.
    J Hypertens. 2017 Aug 21. doi: 10.1097/HJH.0000000000001519.
    >> Share

  106. TADIC M, Cuspidi C, Celic V, Pencic-Popovic B, et al
    Nocturnal hypertension and right heart remodeling.
    J Hypertens. 2017 Aug 16. doi: 10.1097/HJH.0000000000001506.
    >> Share

  107. TSIOUFIS C, Andrikou I, Pruijm M, Ponte B, et al
    Should renal color Doppler ultrasonography be a routine test in newly diagnosed hypertensive patient?
    J Hypertens. 2017 Aug 16. doi: 10.1097/HJH.0000000000001508.
    >> Share

  108. ZANCHETTI A
    From lifestyle changes to outcomes in hypertension.
    J Hypertens. 2017 Aug 12. doi: 10.1097/HJH.0000000000001542.
    >> Share

  109. FU W, Wang C, Zou L, Liu Q, et al
    Association between exposure to noise and risk of hypertension: a meta-analysis of observational epidemiological studies.
    J Hypertens. 2017 Aug 12. doi: 10.1097/HJH.0000000000001504.
    >> Share

  110. RAMAN MR, Tosakulwong N, Zuk SM, Senjem ML, et al
    Influence of preeclampsia and late-life hypertension on MRI measures of cortical atrophy.
    J Hypertens. 2017 Aug 10. doi: 10.1097/HJH.0000000000001492.
    >> Share

  111. GILARDINI L, Lombardi C, Redaelli G, Mattaliano P, et al
    Effect of continuous positive airway pressure in hypertensive patients with obstructive sleep apnea and high urinary metanephrines.
    J Hypertens. 2017 Aug 10. doi: 10.1097/HJH.0000000000001507.
    >> Share

  112. ZANCHETTI A
    Epidemiological, pathophysiological and therapeutic aspects of hypertension.
    J Hypertens. 2017 Aug 5. doi: 10.1097/HJH.0000000000001503.
    >> Share

  113. ZANCHETTI A
    Epidemiological, pathophysiological and therapeutic aspects of hypertension.
    J Hypertens. 2017 Aug 5. doi: 10.1097/HJH.0000000000001503.
    >> Share

  114. IWASHIMA Y, Fukuda T, Horio T, Hayashi SI, et al
    Association between renal function and outcomes after percutaneous transluminal renal angioplasty in hypertensive patients with renal artery stenosis.
    J Hypertens. 2017 Aug 3. doi: 10.1097/HJH.0000000000001499.
    >> Share

  115. BROWN AGM, Houser RF, Mattei J, Mozaffarian D, et al
    Hypertension among US-born and foreign-born non-Hispanic Blacks: National Health and Nutrition Examination Survey 2003-2014 data.
    J Hypertens. 2017 Aug 3. doi: 10.1097/HJH.0000000000001489.
    >> Share

  116. ALTUNDAG K
    Antihypertensive medication use and breast cancer risk.
    J Hypertens. 2017;35:1722.
    >> Share

  117. HOUBEN AJHM, Berendschot TTJM, Grassi G
    Retinal microvascular diameters: normative data and their use in clinical hypertension.
    J Hypertens. 2017;35:1573-1574.
    >> Share

  118. DURAND H, Hayes P, Morrissey EC, Newell J, et al
    Medication adherence among patients with apparent treatment-resistant hypertension: systematic review and meta-analysis.
    J Hypertens. 2017 Aug 1. doi: 10.1097/HJH.0000000000001502.
    >> Share

  119. WU VC, Chueh SJ, Chen L, Chang CH, et al
    Risk of new-onset diabetes mellitus in primary aldosteronism: a population study over 5 years.
    J Hypertens. 2017;35:1698-1708.
    >> Share

  120. MESSERLI FH, Hofstetter L, Agabiti-Rosei E, Burnier M, et al
    Expertise: no longer a sine qua non for guideline authors?
    J Hypertens. 2017;35:1564-1566.
    >> Share

  121. ROSSI E, Perazzoli F, Negro A, Magnani A, et al
    Diagnostic rate of primary aldosteronism in Emilia-Romagna, Northern Italy, during 16 years (2000-2015).
    J Hypertens. 2017;35:1691-1697.
    >> Share

  122. CURRIE KD, Sless RT, Notarius CF, Thomas SG, et al
    Absence of resting cardiovascular dysfunction in middle-aged endurance-trained athletes with exaggerated exercise blood pressure responses.
    J Hypertens. 2017;35:1586-1593.
    >> Share

    July 2017
  123. VAN DER SANDE NGC, de Beus E, Bots ML, Voskuil M, et al
    Apparent resistant hypertension and the risk of vascular events and mortality in patients with manifest vascular disease.
    J Hypertens. 2017 Jul 29. doi: 10.1097/HJH.0000000000001494.
    >> Share

  124. SHI Z, Nicholls SJ, Taylor AW, Magliano DJ, et al
    Early life exposure to Chinese famine modifies the association between hypertension and cardiovascular disease.
    J Hypertens. 2017 Jul 20. doi: 10.1097/HJH.0000000000001496.
    >> Share

  125. DE LA SIERRA A, Vinyoles E, Banegas JR, Segura J, et al
    Prevalence and clinical characteristics of white-coat hypertension based on different definition criteria in untreated and treated patients.
    J Hypertens. 2017 Jul 18. doi: 10.1097/HJH.0000000000001493.
    >> Share

  126. OOSTERHUIS NR, Fernandes R, Maicas N, Bae SE, et al
    Extravascular renal denervation ameliorates juvenile hypertension and renal damage resulting from experimental hyperleptinemia in rats.
    J Hypertens. 2017 Jul 12. doi: 10.1097/HJH.0000000000001472.
    >> Share

  127. NIE X, Dai Y, Tan J, Chen Y, et al
    alpha-Solanine reverses pulmonary vascular remodeling and vascular angiogenesis in experimental pulmonary artery hypertension.
    J Hypertens. 2017 Jul 12. doi: 10.1097/HJH.0000000000001475.
    >> Share

  128. WINKLER L, Lhuissier FJ, Richalet JP
    Systemic blood pressure at exercise in hypoxia in hypertensive and normotensive patients.
    J Hypertens. 2017 Jul 12. doi: 10.1097/HJH.0000000000001479.
    >> Share

  129. WANG A, Liu X, Su Z, Chen S, et al
    Two-year changes in proteinuria and risk for myocardial infarction in patients with hypertension: a prospective cohort study.
    J Hypertens. 2017 Jul 3. doi: 10.1097/HJH.0000000000001462.
    >> Share

  130. TANEMOTO M
    Renal resistive index for resistant hypertension.
    J Hypertens. 2017;35:1525-1526.
    >> Share

  131. CLEMENT DL
    Poor blood pressure control: what can we do?
    J Hypertens. 2017;35:1368-1370.
    >> Share

  132. JOAS E, Guo X, Kern S, Ostling S, et al
    Sex differences in time trends of blood pressure among Swedish septuagenarians examined three decades apart: a longitudinal population study.
    J Hypertens. 2017;35:1424-1431.
    >> Share

  133. YANG Y, Lynch BM, Hodge AM, Liew D, et al
    Blood pressure and risk of breast cancer, overall and by subtypes: a prospective cohort study.
    J Hypertens. 2017;35:1371-1380.
    >> Share

  134. ASHOR AW, Lara J, Siervo M
    Medium-term effects of dietary nitrate supplementation on systolic and diastolic blood pressure in adults: a systematic review and meta-analysis.
    J Hypertens. 2017;35:1353-1359.
    >> Share

  135. HEINIGER S, Viswanathan B, Gedeon J, Paccaud F, et al
    Trends in prevalence, awareness, treatment and control of high blood pressure in the Seychelles between 1989 and 2013.
    J Hypertens. 2017;35:1465-1473.
    >> Share

  136. TEIXEIRA R, Monteiro R, Baptista R, Pereira T, et al
    Aortic arch mechanics measured with two-dimensional speckle tracking echocardiography.
    J Hypertens. 2017;35:1402-1410.
    >> Share

  137. BEIGE J, Jentzsch T, Wendt R, Hennig G, et al
    Blood pressure after blinded, randomized withdrawal, and resumption of baroreceptor-activating therapy.
    J Hypertens. 2017;35:1496-1501.
    >> Share

  138. SYLVESTRE MP, Ka K, Dugas EN, Zappitelli M, et al
    Sex-specific trajectories of systolic and diastolic blood pressure in youth.
    J Hypertens. 2017;35:1416-1423.
    >> Share

  139. NANDAKUMAR P, Lee D, Richard MA, Tekola-Ayele F, et al
    Rare coding variants associated with blood pressure variation in 15 914 individuals of African ancestry.
    J Hypertens. 2017;35:1381-1389.
    >> Share

  140. HIDAYAT K, Du X, Zou SY, Shi BM, et al
    Blood pressure and kidney cancer risk: meta-analysis of prospective studies.
    J Hypertens. 2017;35:1333-1344.
    >> Share

    June 2017
  141. FITTON CA, Steiner MFC, Aucott L, Pell JP, et al
    In-utero exposure to antihypertensive medication and neonatal and child health outcomes: a systematic review.
    J Hypertens. 2017 Jun 28. doi: 10.1097/HJH.0000000000001456.
    >> Share

  142. LE HH, Subtil F, Cerou M, Marchant I, et al
    A sudden death risk score specifically for hypertension: based on 25 648 individual patient data from six randomized controlled trials.
    J Hypertens. 2017 Jun 24. doi: 10.1097/HJH.0000000000001451.
    >> Share

  143. WANG Y, Chen L, Wang Y, Qain Y, et al
    Morning hypertension is more common in elderly hypertensive patients with controlled documented office blood pressure in primary care clinics: the Minhang study.
    J Hypertens. 2017 Jun 24. doi: 10.1097/HJH.0000000000001449.
    >> Share

  144. MANOHAR S, Thongprayoon C, Cheungpasitporn W, Mao MA, et al
    Associations of rotational shift work and night shift status with hypertension: a systematic review and meta-analysis.
    J Hypertens. 2017 Jun 24. doi: 10.1097/HJH.0000000000001442.
    >> Share

  145. ZANCHETTI A
    Diagnostic and therapeutic approaches to hypertension.
    J Hypertens. 2017 Jun 24. doi: 10.1097/HJH.0000000000001465.
    >> Share

  146. KWON LH, Wats K, Rosendorff C
    The effect of vasodilator beta-blockers on renal function in hypertensive patients.
    J Hypertens. 2017 Jun 24. doi: 10.1097/HJH.0000000000001447.
    >> Share

  147. PAGONAS N, Vlatsas S, Bauer F, Seibert FS, et al
    Aerobic versus isometric handgrip exercise in hypertension: a randomized controlled trial.
    J Hypertens. 2017 Jun 15. doi: 10.1097/HJH.0000000000001445.
    >> Share

  148. SHANTSILA A, Shantsila E, Beevers DG, Lip GYH, et al
    Predictors of 5-year outcomes in malignant phase hypertension: the West Birmingham Malignant Hypertension Registry.
    J Hypertens. 2017 Jun 14. doi: 10.1097/HJH.0000000000001446.
    >> Share

  149. SPANNELLA F, Giulietti F, Balietti P, Borioni E, et al
    Plasma renin activity to plasma aldosterone concentration ratio correlates with night-time and pulse pressures in essential hypertensive patients treated with angiotensin-converting enzyme inhibitors/AT1 blockers.
    J Hypertens. 2017 Jun 13. doi: 10.1097/HJH.0000000000001438.
    >> Share

  150. ALGHARABLY EAH, Bolbrinker J, Lezius S, Reibis R, et al
    Uromodulin associates with cardiorenal function in patients with hypertension and cardiovascular disease.
    J Hypertens. 2017 Jun 8. doi: 10.1097/HJH.0000000000001432.
    >> Share

  151. DE LA SIERRA A, Pareja J, Fernandez-Llama P, Armario P, et al
    Twenty-four-hour central blood pressure is not better associated with hypertensive target organ damage than 24-h peripheral blood pressure.
    J Hypertens. 2017 Jun 7. doi: 10.1097/HJH.0000000000001431.
    >> Share

  152. SARAFIDIS PA, Bikos A, Loutradis C, Tzikas S, et al
    Diagnosis of tuberous sclerosis complex in a patient referred for uncontrolled hypertension and renal dysfunction: a case highlighting the importance of proper diagnostic work-up of hypertensive patients.
    J Hypertens. 2017 Jun 7. doi: 10.1097/HJH.0000000000001423.
    >> Share

  153. HOLMQUIST C, Hasselstrom J, Bengtsson Bostrom K, Manhem K, et al
    Improved treatment and control of hypertension in Swedish primary care: results from the Swedish primary care cardiovascular database.
    J Hypertens. 2017 Jun 2. doi: 10.1097/HJH.0000000000001429.
    >> Share

  154. FENGLER K, Hollriegel R, Okon T, Stiermaier T, et al
    Ultrasound-based renal sympathetic denervation for the treatment of therapy-resistant hypertension: a single-center experience.
    J Hypertens. 2017;35:1310-1317.
    >> Share

  155. LI Y, Qin X, Luo L, Wang B, et al
    Folic acid therapy reduces the risk of mortality associated with heavy proteinuria among hypertensive patients.
    J Hypertens. 2017;35:1302-1309.
    >> Share

  156. JARDIM TV, Reiger S, Abrahams-Gessel S, Gomez-Olive FX, et al
    Hypertension management in a population of older adults in rural South Africa.
    J Hypertens. 2017;35:1283-1289.
    >> Share

  157. KAWADA T
    Blood pressure control in hypertensive patients with chronic kidney disease.
    J Hypertens. 2017;35:1327-1328.
    >> Share

  158. KAHAN T, Spaak J
    Potential of folate supplementation to reduce mortality in hypertensive patients.
    J Hypertens. 2017;35:1168-1169.
    >> Share

  159. KJELDSEN SE, Os I
    Interventions to improve adherence of antihypertensive medication in African-Americans.
    J Hypertens. 2017;35:1164-1165.
    >> Share

  160. LIU W, Zhou J, Chen J, Meng M, et al
    Ambulatory arterial stiffness index and its role in assessing arterial stiffness in dialysis patients.
    J Hypertens. 2017;35:1297-1301.
    >> Share

  161. RAVINDRARAJAH R, Dregan A, Hazra NC, Hamada S, et al
    Declining blood pressure and intensification of blood pressure management among people over 80 years: cohort study using electronic health records.
    J Hypertens. 2017;35:1276-1282.
    >> Share

  162. BERGE E
    Should elevated blood pressure be lowered in the acute phase of ischaemic stroke?
    J Hypertens. 2017;35:1166-1167.
    >> Share

    May 2017
  163. PRUIJM M, Lu Y, Megdiche F, Piskunowicz M, et al
    Serum calcification propensity is associated with renal tissue oxygenation and resistive index in patients with arterial hypertension or chronic kidney disease.
    J Hypertens. 2017 May 29. doi: 10.1097/HJH.0000000000001406.
    >> Share


  164. Guidelines on the management of arterial hypertension and related comorbidities in Latin America.
    J Hypertens. 2017 May 17. doi: 10.1097/HJH.0000000000001418.
    >> Share

  165. GILES TD, Cockcroft JR, Pitt B, Jakate A, et al
    Rationale for nebivolol/valsartan combination for hypertension: review of preclinical and clinical data.
    J Hypertens. 2017 May 15. doi: 10.1097/HJH.0000000000001412.
    >> Share

  166. VAN MIDDELAAR T, van Vught LA, van Charante EPM, Eurelings LSM, et al
    Lower dementia risk with different classes of antihypertensive medication in older patients.
    J Hypertens. 2017 May 13. doi: 10.1097/HJH.0000000000001411.
    >> Share

  167. WANG L, Zhu Q, Lu A, Liu X, et al
    Sodium butyrate suppresses angiotensin II-induced hypertension by inhibition of renal (pro)renin receptor and intrarenal renin-angiotensin system.
    J Hypertens. 2017 May 13. doi: 10.1097/HJH.0000000000001378.
    >> Share

  168. ZHANG P, Wang H, Sun L, Zhang J, et al
    Telmisartan and hydrochlorothiazide antihypertensive treatment in high sodium intake population: a randomized double-blind trial.
    J Hypertens. 2017 May 13. doi: 10.1097/HJH.0000000000001407.
    >> Share

  169. HAMDIDOUCHE I, Jullien V, Boutouyrie P, Billaud E, et al
    Routine urinary detection of antihypertensive drugs for systematic evaluation of adherence to treatment in hypertensive patients.
    J Hypertens. 2017 May 12. doi: 10.1097/HJH.0000000000001402.
    >> Share

  170. PONTO KA, Werner DJ, Wiedemer L, Laubert-Reh D, et al
    Retinal vessel metrics: normative data and their use in systemic hypertension: results from the Gutenberg Health Study.
    J Hypertens. 2017 May 12. doi: 10.1097/HJH.0000000000001380.
    >> Share

  171. VAN DER WARDT V, Harrison JK, Welsh T, Conroy S, et al
    Withdrawal of antihypertensive medication: a systematic review.
    J Hypertens. 2017 May 9. doi: 10.1097/HJH.0000000000001405.
    >> Share

  172. YUSUFALI AM, Khatib R, Islam S, Alhabib KF, et al
    Prevalence, awareness, treatment and control of hypertension in four Middle East countries.
    J Hypertens. 2017 May 8. doi: 10.1097/HJH.0000000000001326.
    >> Share


  173. Effect of estrogen on the change of GABA function in the vasopressin neurons of salt-dependent hypertension model rats: Retraction.
    J Hypertens. 2017;35:1129.
    >> Share

  174. HAMDIDOUCHE I, Boutouyrie P
    Is renal denervation an alternative or a complement to aldosterone antagonists in treatment of resistant hypertension?
    J Hypertens. 2017;35:955-957.
    >> Share

  175. DOUMAS M, Stavropoulos K, Imprialos K
    Obstructive sleep apnea, hypertension, and fibrin clot properties: a novel pathogenetic link with cardiovascular disease?
    J Hypertens. 2017;35:950-952.
    >> Share

  176. HEAGERTY AM
    Changes in small artery structure in hypertension: ready for prognostic translation?
    J Hypertens. 2017;35:945-946.
    >> Share

  177. LEE CJ, Hwang J, Oh J, Lee SH, et al
    Treatment of uncomplicated hypertension is associated with a reduction in cardiovascular mortality: a Korean national cohort study.
    J Hypertens. 2017;35 Suppl 1:S41-S49.
    >> Share

  178. TIMASHEVA Y, Nasibullin T, Imaeva E, Erdman V, et al
    Genetic determinants of essential hypertension in the population of Tatars from Russia.
    J Hypertens. 2017;35 Suppl 1:S16-S23.
    >> Share

  179. ZANCHETTI A
    Therapeutic approaches, age and ethnicity in hypertension.
    J Hypertens. 2017 May 1. doi: 10.1097/HJH.0000000000001404.
    >> Share

  180. CHIA YC, Ching SM, Lim HM
    Visit-to-visit SBP variability and cardiovascular disease in a multiethnic primary care setting: 10-year retrospective cohort study.
    J Hypertens. 2017;35 Suppl 1:S50-S56.
    >> Share

  181. MURATA M, Kitamura T, Tamada D, Mukai K, et al
    Plasma aldosterone level within the normal range is less associated with cardiovascular and cerebrovascular risk in primary aldosteronism.
    J Hypertens. 2017;35:1079-1085.
    >> Share

  182. TSIOUFIS C, Dimitriadis K, Kasiakogias A, Kalos T, et al
    Effects of multielectrode renal denervation on elevated sympathetic nerve activity and insulin resistance in metabolic syndrome.
    J Hypertens. 2017;35:1100-1108.
    >> Share

  183. SCHEEPERS LE, Boonen A, Pijnenburg W, Bierau J, et al
    Associations of plasma uric acid and purine metabolites with blood pressure in children: the KOALA Birth Cohort Study.
    J Hypertens. 2017;35:982-993.
    >> Share

  184. AGABITI-ROSEI E, Rizzoni D
    Microvascular structure as a prognostically relevant endpoint.
    J Hypertens. 2017;35:914-921.
    >> Share

  185. SHERWOOD A, Hill LK, Blumenthal JA, Johnson KS, et al
    Race and sex differences in cardiovascular alpha-adrenergic and beta-adrenergic receptor responsiveness in men and women with high blood pressure.
    J Hypertens. 2017;35:975-981.
    >> Share

  186. MOKWATSI GG, Schutte AE, Kruger R
    Ethnic differences regarding arterial stiffness of 6-8-year-old black and white boys.
    J Hypertens. 2017;35:960-967.
    >> Share

  187. CALO LA, Maiolino G, Alessi M
    Magnesium, cardiovascular-renal disease and the Gitelman's syndrome paradox.
    J Hypertens. 2017;35:1122-1124.
    >> Share

    April 2017
  188. COCA A, Agabiti-Rosei E, Cifkova R, Manolis AJ, et al
    The polypill in cardiovascular prevention: evidence, limitations and perspective - position paper of the European Society of Hypertension.
    J Hypertens. 2017 Apr 26. doi: 10.1097/HJH.0000000000001390.
    >> Share

  189. VOGIATZAKIS N, Tsioufis C, Georgiopoulos G, Thomopoulos C, et al
    Effect of renal sympathetic denervation on short-term blood pressure variability in resistant hypertension: a meta-analysis.
    J Hypertens. 2017 Apr 25. doi: 10.1097/HJH.0000000000001391.
    >> Share

  190. KURDI AI, Chen LC, Elliott RA
    Exploring factors associated with patients' adherence to antihypertensive drugs among people with primary hypertension in the United Kingdom.
    J Hypertens. 2017 Apr 22. doi: 10.1097/HJH.0000000000001382.
    >> Share

  191. MENDEZ-LOPEZ I, Bomfim GH, Musial DC, Arranz-Tagarro JA, et al
    Altered mitochondrial function, capacitative calcium entry and contractions in the aorta of hypertensive rats.
    J Hypertens. 2017 Apr 11. doi: 10.1097/HJH.0000000000001360.
    >> Share

  192. RUBATTU S, Cotugno M, Bianchi F, Sironi L, et al
    A differential expression of uncoupling protein-2 associates with renal damage in stroke-resistant spontaneously hypertensive rat/stroke-prone spontaneously hypertensive rat-derived stroke congenic lines.
    J Hypertens. 2017 Apr 10. doi: 10.1097/HJH.0000000000001374.
    >> Share

  193. LEONE D, Tosello F, Faletti R, Schivazappa G, et al
    Accuracy of transthoracic echocardiography in the assessment of proximal aortic diameter in hypertensive patients: comparison with cardiac magnetic resonance.
    J Hypertens. 2017 Apr 10. doi: 10.1097/HJH.0000000000001381.
    >> Share

  194. PENG H, Yeh F, de Simone G, Best LG, et al
    Relationship between plasma plasminogen activator inhibitor-1 and hypertension in American Indians: findings from the Strong Heart Study.
    J Hypertens. 2017 Apr 4. doi: 10.1097/HJH.0000000000001375.
    >> Share

  195. WANG JG, Kario K, Park JB, Chen CH, et al
    Morning blood pressure monitoring in the management of hypertension.
    J Hypertens. 2017 Apr 4. doi: 10.1097/HJH.0000000000001379.
    >> Share

  196. RAVASSA S, Lopez B, Querejeta R, Echegaray K, et al
    Phenotyping of myocardial fibrosis in hypertensive patients with heart failure. Influence on clinical outcome.
    J Hypertens. 2017;35:853-861.
    >> Share

  197. FERNANDEZ-MENDOZA J, He F, Vgontzas AN, Liao D, et al
    Objective short sleep duration modifies the relationship between hypertension and all-cause mortality.
    J Hypertens. 2017;35:830-836.
    >> Share

  198. VELOUDI P, Blizzard CL, Srikanth VK, Breslin M, et al
    Age-dependent changes in blood pressure over consecutive office measurements: impact on hypertension diagnosis and implications for international guidelines.
    J Hypertens. 2017;35:753-760.
    >> Share

  199. RIM TH, Lee SY, Kim SH, Kim SS, et al
    Increased incidence of open-angle glaucoma among hypertensive patients: an 11-year nationwide retrospective cohort study.
    J Hypertens. 2017;35:729-736.
    >> Share

  200. HUANG Y, Huang W, Mai W, Cai X, et al
    White-coat hypertension is a risk factor for cardiovascular diseases and total mortality.
    J Hypertens. 2017;35:677-688.
    >> Share

  201. ZANCHETTI A
    Predisposing factors, accompanying diseases and complications of hypertension.
    J Hypertens. 2017;35:655-656.
    >> Share

  202. BURNIER M
    Is there a place for a dual angiotensin receptor-neprilysin inhibitor in the treatment of hypertension?
    J Hypertens. 2017;35:726-728.
    >> Share

  203. KOLLIAS A, Protogerou AD, Stergiou GS
    Antihypertensive treatment-induced changes in arterial stiffness: Which artery? Which method?
    J Hypertens. 2017;35:721-725.
    >> Share

  204. PERSEGHIN G, Manzoni G, Grassi G
    Hypertension and hepatic triglycerides content: a two (multi)-faceted clinical challenge?
    J Hypertens. 2017;35:715-717.
    >> Share

  205. MANCIA G
    White-coat hypertension: growing evidence in favour of its adverse prognostic significance.
    J Hypertens. 2017;35:710-712.
    >> Share

  206. VAN TWIST DJ, Houben AJ, de Haan MW, de Leeuw PW, et al
    Pathophysiological differences between multifocal fibromuscular dysplasia and atherosclerotic renal artery stenosis.
    J Hypertens. 2017;35:845-852.
    >> Share

  207. RICCI F, Manzoli L, Sutton R, Melander O, et al
    Hospital admissions for orthostatic hypotension and syncope in later life: insights from the Malmo Preventive Project.
    J Hypertens. 2017;35:776-783.
    >> Share

  208. LORBEER R, Bayerl C, Auweter S, Rospleszcz S, et al
    Association between MRI-derived hepatic fat fraction and blood pressure in participants without history of cardiovascular disease.
    J Hypertens. 2017;35:737-744.
    >> Share

    March 2017
  209. ZANCHETTI A
    Treatment adherence and hypertension in the elderly.
    J Hypertens. 2017 Mar 17. doi: 10.1097/HJH.0000000000001351.
    >> Share

  210. BAHADORAN Z, Mirmiran P, Momenan AA, Azizi F, et al
    Allium vegetable intakes and the incidence of cardiovascular disease, hypertension, chronic kidney disease, and type 2 diabetes in adults: a longitudinal follow-up study.
    J Hypertens. 2017 Mar 17. doi: 10.1097/HJH.0000000000001356.
    >> Share

  211. CORRAO G, Rea F, Monzio Compagnoni M, Merlino L, et al
    Protective effects of antihypertensive treatment in patients aged 85 years or older.
    J Hypertens. 2017 Mar 17. doi: 10.1097/HJH.0000000000001323.
    >> Share

  212. YAO QP, Xie ZW, Wang KX, Zhang P, et al
    Profiles of long noncoding RNAs in hypertensive rats: long noncoding RNA XR007793 regulates cyclic strain-induced proliferation and migration of vascular smooth muscle cells.
    J Hypertens. 2017 Mar 17. doi: 10.1097/HJH.0000000000001304.
    >> Share

  213. POULTER NR, Schutte AE, Tomaszewski M, Lackland DT, et al
    May Measurement Month: a new joint global initiative by the International Society of Hypertension and the World Hypertension League to raise awareness of raised blood pressure.
    J Hypertens. 2017 Mar 16. doi: 10.1097/HJH.0000000000001346.
    >> Share

  214. MOURAD JJ, Amodeo C, de Champvallins M, Brzozowska-Villatte R, et al
    Blood pressure-lowering efficacy and safety of perindopril/indapamide/amlodipine single-pill combination in patients with uncontrolled essential hypertension: a multicenter, randomized, double-blind, controlled trial.
    J Hypertens. 2017 Mar 16. doi: 10.1097/HJH.0000000000001359.
    >> Share

  215. MUIESAN ML, Salvetti M, Paini A, Riviera M, et al
    Ocular fundus photography with a smartphone device in acute hypertension.
    J Hypertens. 2017 Mar 16. doi: 10.1097/HJH.0000000000001354.
    >> Share

  216. HAMDIDOUCHE I, Jullien V, Boutouyrie P, Billaud E, et al
    Drug adherence in hypertension: from methodological issues to cardiovascular outcomes.
    J Hypertens. 2017 Mar 16. doi: 10.1097/HJH.0000000000001299.
    >> Share

  217. KAZE AD, Schutte AE, Erqou S, Kengne AP, et al
    Prevalence of hypertension in older people in Africa: a systematic review and meta-analysis.
    J Hypertens. 2017 Mar 6. doi: 10.1097/HJH.0000000000001345.
    >> Share

  218. KAWADA T
    Thiazide diuretics and fracture in patients with hypertension.
    J Hypertens. 2017;35:645-646.
    >> Share

  219. HERING D, Grassi G
    Prognostic significance of masked tachycardia in hypertension: evidence from a prospective international registry.
    J Hypertens. 2017;35:468-470.
    >> Share

  220. KOCH SE, Mann A, Jones S, Robbins N, et al
    Transient receptor potential vanilloid 2 function regulates cardiac hypertrophy via stretch-induced activation.
    J Hypertens. 2017;35:602-611.
    >> Share

  221. TZOURIO C, Hanon O, Godin O, Soumare A, et al
    Impact of home blood pressure monitoring on blood pressure control in older individuals: a French randomized study.
    J Hypertens. 2017;35:612-620.
    >> Share

  222. CHA RH, Lee H, Lee JP, Kang E, et al
    Changes of blood pressure patterns and target organ damage in patients with chronic kidney disease: results of the APrODiTe-2 study.
    J Hypertens. 2017;35:593-601.
    >> Share

  223. KALLIOINEN N, Hill A, Horswill MS, Ward HE, et al
    Sources of inaccuracy in the measurement of adult patients' resting blood pressure in clinical settings: a systematic review.
    J Hypertens. 2017;35:421-441.
    >> Share

  224. KOLLIAS A, Ntineri A, Stergiou GS
    Association of night-time home blood pressure with night-time ambulatory blood pressure and target-organ damage: a systematic review and meta-analysis.
    J Hypertens. 2017;35:442-452.
    >> Share

  225. POLONIA J, Lobo MF, Martins L, Pinto F, et al
    Estimation of populational 24-h urinary sodium and potassium excretion from spot urine samples: evaluation of four formulas in a large national representative population.
    J Hypertens. 2017;35:477-486.
    >> Share

  226. BOARDMAN H, Lewandowski AJ, Lazdam M, Kenworthy Y, et al
    Aortic stiffness and blood pressure variability in young people: a multimodality investigation of central and peripheral vasculature.
    J Hypertens. 2017;35:513-522.
    >> Share

  227. DE BUYZERE M, Rietzschel E
    From one-man bands to harmoniously playing chamber and full orchestras.
    J Hypertens. 2017;35:473-476.
    >> Share

  228. MANCIA G, Kjeldsen SE
    Adopting Systolic Pressure Intervention Trial (SPRINT)-like office blood pressure measurements in clinical practice.
    J Hypertens. 2017;35:471-472.
    >> Share

  229. HEAD GA
    The importance and prognostic value of nocturnal blood pressure assessments using inexpensive domestic devices.
    J Hypertens. 2017;35:463-465.
    >> Share

    February 2017
  230. ZANCHETTI A
    Problems of antihypertensive management: diabetes mellitus, ethnic differences, organ damage and resistance to treatment.
    J Hypertens. 2017 Feb 27. doi: 10.1097/HJH.0000000000001334.
    >> Share

  231. PARK SK, Kim WJ, Lee DY, Lee SY, et al
    Comparing the clinical efficacy of resting and antihypertensive medication in patients of hypertensive urgency: a randomized, control trial.
    J Hypertens. 2017 Feb 27. doi: 10.1097/HJH.0000000000001340.
    >> Share

  232. ZHANG Z, Li Z, Cao K, Fang D, et al
    Adjunctive therapy with statins reduces residual albuminuria/proteinuria and provides further renoprotection by downregulating the angiotensin II-AT1 pathway in hypertensive nephropathy.
    J Hypertens. 2017 Feb 27. doi: 10.1097/HJH.0000000000001325.
    >> Share

  233. JIN L, Lin MQ, Piao ZH, Cho JY, et al
    Gallic acid attenuates hypertension, cardiac remodeling, and fibrosis in mice with NG-nitro-L-arginine methyl ester-induced hypertension via regulation of histone deacetylase 1 or histone deacetylase 2.
    J Hypertens. 2017 Feb 22. doi: 10.1097/HJH.0000000000001327.
    >> Share

  234. FRITH E, Loprinzi PD
    Physical activity and cognitive function among older adults with hypertension.
    J Hypertens. 2017 Feb 17. doi: 10.1097/HJH.0000000000001311.
    >> Share

  235. UITERWIJK R, Staals J, Huijts M, de Leeuw PW, et al
    MRI progression of cerebral small vessel disease and cognitive decline in patients with hypertension.
    J Hypertens. 2017 Feb 6. doi: 10.1097/HJH.0000000000001294.
    >> Share

  236. NAUMCZYK P, Sabisz A, Witkowska M, Graff B, et al
    Compensatory functional reorganization may precede hypertension-related brain damage and cognitive decline: a functional magnetic resonance imaging study.
    J Hypertens. 2017 Feb 6. doi: 10.1097/HJH.0000000000001293.
    >> Share

  237. XU T, Zhang Y, Bu X, Wang D, et al
    Blood pressure reduction in acute ischemic stroke according to time to treatment: a subgroup analysis of the China Antihypertensive Trial in Acute Ischemic Stroke trial.
    J Hypertens. 2017 Feb 6. doi: 10.1097/HJH.0000000000001288.
    >> Share

  238. ATKINS ER, Hirakawa Y, Salam A, Woodward M, et al
    Side effects and tolerability of combination blood pressure lowering according to blood pressure levels: an analysis of the perindopril protection against recurrent stroke study and action in diabetes and vascular disease: preterax and diamicron-MR co
    J Hypertens. 2017 Feb 6. doi: 10.1097/HJH.0000000000001287.
    >> Share

  239. SARAFIDIS PA, Persu A, Agarwal R, Burnier M, et al
    Hypertension in dialysis patients: a consensus document by the European Renal and Cardiovascular Medicine (EURECA-m) working group of the European Renal Association - European Dialysis and Transplant Association (ERA-EDTA) and the Hypertension and the
    J Hypertens. 2017 Feb 2. doi: 10.1097/HJH.0000000000001283.
    >> Share

  240. DE SOCIO GV, Ricci E, Maggi P, Parruti G, et al
    Time trend in hypertension prevalence, awareness, treatment, and control in a contemporary cohort of HIV-infected patients: the HIV and Hypertension Study.
    J Hypertens. 2017;35:409-416.
    >> Share

  241. SATOH A, Arima H, Ohkubo T, Nishi N, et al
    Associations of socioeconomic status with prevalence, awareness, treatment, and control of hypertension in a general Japanese population: NIPPON DATA2010.
    J Hypertens. 2017;35:401-408.
    >> Share

  242. PEKARSKIY SE, Baev AE, Mordovin VF, Semke GV, et al
    Denervation of the distal renal arterial branches vs. conventional main renal artery treatment: a randomized controlled trial for treatment of resistant hypertension.
    J Hypertens. 2017;35:369-375.
    >> Share

  243. GARCIA ML, Pontes RB, Nishi EE, Ibuki FK, et al
    The antioxidant effects of green tea reduces blood pressure and sympathoexcitation in an experimental model of hypertension.
    J Hypertens. 2017;35:348-354.
    >> Share

  244. MONNIER A, Garnier P, Quirie A, Pernet N, et al
    Effect of short-term exercise training on brain-derived neurotrophic factor signaling in spontaneously hypertensive rats.
    J Hypertens. 2017;35:279-290.
    >> Share

  245. PUCCI G, Battista F, Anastasio F, Schillaci G, et al
    Morning pressor surge, blood pressure variability, and arterial stiffness in essential hypertension.
    J Hypertens. 2017;35:272-278.
    >> Share

  246. XU SL, Trevathan E, Qian Z, Vivian E, et al
    Prenatal and postnatal exposure to pet ownership, blood pressure, and hypertension in children: the Seven Northeastern Cities study.
    J Hypertens. 2017;35:259-265.
    >> Share

  247. O'ROURKE MF, Adji A
    Managing hypertension in children and adolescents.
    J Hypertens. 2017;35:417.
    >> Share

  248. LEYVRAZ M, Santschi V, Chiolero A
    What systematic reviews bring to the field of hypertension.
    J Hypertens. 2017;35:240-242.
    >> Share

  249. AKBARI M, Moosazadeh M, Ghahramani S, Tabrizi R, et al
    High prevalence of hypertension among Iranian children and adolescents: a systematic review and meta-analysis.
    J Hypertens. 2017 Feb 1. doi: 10.1097/HJH.0000000000001261.
    >> Share

  250. TADE G, Norton GR, Booysen HL, Sibiya MJ, et al
    Time to the peak of the aortic forward wave determines the impact of aortic backward wave and pulse pressure on left ventricular mass.
    J Hypertens. 2017;35:300-309.
    >> Share

  251. PIZZOLO F, Chiecchi L, Morandini F, Castagna A, et al
    Increased urinary excretion of the epithelial Na channel activator prostasin in patients with primary aldosteronism.
    J Hypertens. 2017;35:355-361.
    >> Share

  252. KOH-TAN HH, Dashti M, Wang T, Beattie W, et al
    Dissecting the genetic components of a quantitative trait locus for blood pressure and renal pathology on rat chromosome 3.
    J Hypertens. 2017;35:319-329.
    >> Share

  253. SIVEN SS, Niiranen TJ, Langen VL, Puukka PJ, et al
    Home versus office blood pressure: longitudinal relations with left ventricular hypertrophy: the Finn-Home study.
    J Hypertens. 2017;35:266-271.
    >> Share

    January 2017
  254. THOMOPOULOS C, Parati G, Zanchetti A
    Effects of blood-pressure-lowering treatment on outcome incidence in hypertension: 10 - Should blood pressure management differ in hypertensive patients with and without diabetes mellitus? Overview and meta-analyses of randomized trials.
    J Hypertens. 2017 Jan 30. doi: 10.1097/HJH.0000000000001276.
    >> Share

  255. JOZWIK-PLEBANEK K, Prejbisz A, Wypasek E, Pregowska-Chwala B, et al
    Altered plasma fibrin clot properties in hypertensive patients with obstructive sleep apnoea are improved by continuous positive airway pressure treatment.
    J Hypertens. 2017 Jan 30. doi: 10.1097/HJH.0000000000001269.
    >> Share

  256. DASGUPTA K, Rosenberg E, Joseph L, Trudeau L, et al
    Carotid femoral pulse wave velocity in type 2 diabetes and hypertension: capturing arterial health effects of step counts.
    J Hypertens. 2017 Jan 27. doi: 10.1097/HJH.0000000000001277.
    >> Share

  257. LEE CJ, Oh J, Lee SH, Kang SM, et al
    Efficacy of aspirin and statins in primary prevention of cardiovascular mortality in uncomplicated hypertensive participants: a Korean national cohort study.
    J Hypertens. 2017 Jan 27. doi: 10.1097/HJH.0000000000001279.
    >> Share

  258. WEIR MR, Mayo MR, Garza D, Arthur SA, et al
    Effectiveness of patiromer in the treatment of hyperkalemia in chronic kidney disease patients with hypertension on diuretics.
    J Hypertens. 2017 Jan 27. doi: 10.1097/HJH.0000000000001278.
    >> Share

  259. DE SOUZA F, Muxfeldt ES, Margallo V, Cortez AF, et al
    Effects of continuous positive airway pressure treatment on aldosterone excretion in patients with obstructive sleep apnoea and resistant hypertension: a randomized controlled trial.
    J Hypertens. 2017 Jan 27. doi: 10.1097/HJH.0000000000001254.
    >> Share

  260. SALADINI F, Mos L, Fania C, Garavelli G, et al
    Regular physical activity prevents development of hypertension in young people with hyperuricemia.
    J Hypertens. 2017 Jan 23. doi: 10.1097/HJH.0000000000001271.
    >> Share

  261. ROSA J, Widimsky P, Waldauf P, Zelinka T, et al
    Renal denervation in comparison with intensified pharmacotherapy in true resistant hypertension: 2-year outcomes of randomized PRAGUE-15 study.
    J Hypertens. 2017 Jan 23. doi: 10.1097/HJH.0000000000001257.
    >> Share

  262. SCHNEIDER A, Schwab J, Karg MV, Kalizki T, et al
    Low-dose eplerenone decreases left ventricular mass in treatment-resistant hypertension.
    J Hypertens. 2017 Jan 23. doi: 10.1097/HJH.0000000000001264.
    >> Share

  263. LI X, Wang W, Wang A, Li P, et al
    Vulnerability of the frontal and parietal regions in hypertensive patients during working memory task.
    J Hypertens. 2017 Jan 23. doi: 10.1097/HJH.0000000000001250.
    >> Share

  264. VINYOLES E, de la Sierra A, Roso-Llorach A, Banegas JR, et al
    24-h pulse pressure cutoff point definition by office pulse pressure in a population of Spanish older hypertensive patients.
    J Hypertens. 2017 Jan 23. doi: 10.1097/HJH.0000000000001268.
    >> Share

  265. RUPPAR TM, Dunbar-Jacob JM, Mehr DR, Lewis L, et al
    Medication adherence interventions among hypertensive black adults: a systematic review and meta-analysis.
    J Hypertens. 2017 Jan 18. doi: 10.1097/HJH.0000000000001260.
    >> Share

  266. TEDLA YG, Gepner AD, Vaidya D, Colangelo L, et al
    Association between long-term blood pressure control and ten-year progression in carotid arterial stiffness among hypertensive individuals: the multiethnic study of atherosclerosis.
    J Hypertens. 2017 Jan 13. doi: 10.1097/HJH.0000000000001199.
    >> Share

  267. MYERS MG
    Statistical analysis as a cause of white-coat hypertension.
    J Hypertens. 2017 Jan 12. doi: 10.1097/HJH.0000000000001232.
    >> Share

  268. CHU C, Dai Y, Mu J, Yang R, et al
    Associations of risk factors in childhood with arterial stiffness 26 years later: the Hanzhong adolescent hypertension cohort.
    J Hypertens. 2017 Jan 5. doi: 10.1097/HJH.0000000000001242.
    >> Share

  269. HAMET P, Haloui M, Harvey F, Marois-Blanchet FC, et al
    PROX1 gene CC genotype as a major determinant of early onset of type 2 diabetes in slavic study participants from Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation study.
    J Hypertens. 2017 Jan 5. doi: 10.1097/HJH.0000000000001241.
    >> Share

  270. CHUANG YW, Yu MC, Huang ST, Yang CK, et al
    Spironolactone and the risk of urinary tract cancer in patients with hypertension: a nationwide population-based retrospective case-control study.
    J Hypertens. 2017;35:170-177.
    >> Share

  271. MALOBERTI A, Meani P, Vallerio P, Varrenti M, et al
    Annexin A5 in treated hypertensive patients and its association with target organ damage.
    J Hypertens. 2017;35:154-161.
    >> Share

  272. LINZ D, Mancia G, Mahfoud F, Narkiewicz K, et al
    Renal artery denervation for treatment of patients with self-reported obstructive sleep apnea and resistant hypertension: results from the Global SYMPLICITY Registry.
    J Hypertens. 2017;35:148-153.
    >> Share

  273. OH JY, Allison MA, Barrett-Connor E
    Different impacts of hypertension and diabetes mellitus on all-cause and cardiovascular mortality in community-dwelling older adults: the Rancho Bernardo Study.
    J Hypertens. 2017;35:55-62.
    >> Share

  274. ZANCHETTI A
    Factors and consequences of hypertension.
    J Hypertens. 2017;35:1-2.
    >> Share

  275. TANEMOTO M
    Blood pressure reduction after renal denervation in obese hypertensive swine model.
    J Hypertens. 2017;35:199.
    >> Share

  276. TEO KK
    Does spironolactone reduce the risk of urinary tract cancers in hypertensive patients?
    J Hypertens. 2017;35:36-38.
    >> Share

  277. BANEGAS JR
    Mass starvation in early life and adult hypertension in China.
    J Hypertens. 2017;35:29-32.
    >> Share

  278. ALVIM RO, Horimoto AR, Oliveira CM, Bortolotto LA, et al
    Heritability of arterial stiffness in a Brazilian population: Baependi Heart Study.
    J Hypertens. 2017;35:105-110.
    >> Share

  279. BOKRANTZ T, Ljungman C, Kahan T, Bostrom KB, et al
    Thiazide diuretics and the risk of osteoporotic fractures in hypertensive patients. Results from the Swedish Primary Care Cardiovascular Database.
    J Hypertens. 2017;35:188-197.
    >> Share

  280. SILVA RC, Silva DA, Bastos JL, Peres KG, et al
    Anthropometric measures change and incidence of high blood pressure levels among adults: a population-based prospective study in Southern Brazil.
    J Hypertens. 2017;35:39-46.
    >> Share

  281. TANEMOTO M
    High-sensitive C-reactive protein in primary aldosteronism.
    J Hypertens. 2017;35:200-201.
    >> Share

  282. SEGERS P
    A lesson in vigilance: pressure dependency of a presumed pressure-independent index of arterial stiffness.
    J Hypertens. 2017;35:33-35.
    >> Share

    December 2016
  283. BORGHI C, Paolillo S, Cicero AF, Gargiulo P, et al
    New oral anticoagulants and prevention of thromboembolic events in patients with hypertension and atrial fibrillation: an appraisal.
    J Hypertens. 2016 Dec 28. doi: 10.1097/HJH.0000000000001228.
    >> Share

  284. BAI YP, Xiao S, Tang YB, Tan Z, et al
    Shear stress-mediated upregulation of GTP cyclohydrolase/tetrahydrobiopterin pathway ameliorates hypertension-related decline in reendothelialization capacity of endothelial progenitor cells.
    J Hypertens. 2016 Dec 28. doi: 10.1097/HJH.0000000000001216.
    >> Share

  285. WANG JG, Yukisada K, Sibulo A Jr, Hafeez K, et al
    Efficacy and safety of sacubitril/valsartan (LCZ696) add-on to amlodipine in Asian patients with systolic hypertension uncontrolled with amlodipine monotherapy.
    J Hypertens. 2016 Dec 24. doi: 10.1097/HJH.0000000000001219.
    >> Share

  286. KOTON S, Tanne D, Grossman E
    Prestroke treatment with beta-blockers for hypertension is not associated with severity and poor outcome in patients with ischemic stroke: data from a national stroke registry.
    J Hypertens. 2016 Dec 24. doi: 10.1097/HJH.0000000000001218.
    >> Share

  287. CHOWDHURY EK, Nelson MR, Jennings GL, Wing LM, et al
    Pet ownership and survival in the elderly hypertensive population.
    J Hypertens. 2016 Dec 22. doi: 10.1097/HJH.0000000000001214.
    >> Share

  288. STEVENSON ER, Johns EM, Marques FZ, Jackson KL, et al
    Positive allosteric modulation of GABAA receptors attenuates high blood pressure in Schlager hypertensive mice.
    J Hypertens. 2016 Dec 22. doi: 10.1097/HJH.0000000000001210.
    >> Share

  289. CHEN CW, Kuo TB, Chen CY, Yang CC, et al
    Reduced capacity of autonomic and baroreflex control associated with sleep pattern in spontaneously hypertensive rats with a nondipping profile.
    J Hypertens. 2016 Dec 21. doi: 10.1097/HJH.0000000000001205.
    >> Share

  290. LIU X, Gu W, Li Z, Lei H, et al
    Hypertension prevalence, awareness, treatment, control, and associated factors in Southwest China: an update.
    J Hypertens. 2016.
    >> Share

  291. KINTIS K, Tsioufis C, Kasiakogias A, Dimitriadis K, et al
    Noninvasive assessment of haemodynamics in resistant hypertension: the role of the renal resistive index.
    J Hypertens. 2016.
    >> Share

  292. BONNET F, Gastaldelli A, Pihan-Le Bars F, Natali A, et al
    Gamma-glutamyltransferase, fatty liver index and hepatic insulin resistance are associated with incident hypertension in two longitudinal studies.
    J Hypertens. 2016.
    >> Share

  293. WANG Z, Chen Z, Wang X, Hao G, et al
    Cost-effectiveness of nitrendipine and hydrochlorothiazide or metoprolol to treat hypertension in rural community health centers in China.
    J Hypertens. 2016.
    >> Share

  294. PALATINI P, Reboldi G, Beilin LJ, Casiglia E, et al
    Masked tachycardia. A predictor of adverse outcome in hypertension.
    J Hypertens. 2016.
    >> Share

  295. CUSPIDI C, Facchetti R, Bombelli M, Sala C, et al
    Is night-time hypertension worse than daytime hypertension? A study on cardiac damage in a general population: the PAMELA study.
    J Hypertens. 2016.
    >> Share

  296. FODOR JG, Baker P, Chen L, Leenen FH, et al
    On-treatment blood pressures of older hypertensive patients in Canada: implications for systolic blood pressure intervention trial.
    J Hypertens. 2016.
    >> Share

  297. ZANCHETTI A
    From inflammation to renal denervation in hypertension research.
    J Hypertens. 2016;34:2301-2302.
    >> Share

  298. TOMLINSON B, Sritara P, Lopez E, Dalal J, et al
    Hypertension and elevated heart rate: focus on the Asia Pacific region.
    J Hypertens. 2016;34:2330-2332.
    >> Share

    November 2016
  299. MANCIA G, Rea F, Cuspidi C, Grassi G, et al
    Blood pressure control in hypertension. Pros and cons of available treatment strategies.
    J Hypertens. 2016.
    >> Share

  300. BRUNSTROM M, Eliasson M, Nilsson PM, Carlberg B, et al
    Blood pressure treatment levels and choice of antihypertensive agent in people with diabetes mellitus: an overview of systematic reviews.
    J Hypertens. 2016.
    >> Share

  301. ASH GI, Taylor BA, Thompson PD, MacDonald HV, et al
    The antihypertensive effects of aerobic versus isometric handgrip resistance exercise.
    J Hypertens. 2016.
    >> Share

  302. WANG T, Li GQ, Zhang HP, Zhang Y, et al
    Overactivation of cannabinoid receptor type 1 in rostral ventrolateral medulla promotes cardiovascular responses in spontaneously hypertensive rats.
    J Hypertens. 2016.
    >> Share

  303. YU EY, Wan EY, Wong CK, Chan AK, et al
    Effects of risk assessment and management programme for hypertension on clinical outcomes and cardiovascular disease risks after 12 months: a population-based matched cohort study.
    J Hypertens. 2016.
    >> Share

  304. DIEDERICHS C, Neuhauser H
    The incidence of hypertension and its risk factors in the German adult population: results from the German National Health Interview and Examination Survey 1998 and the German Health Interview and Examination Survey for Adults 2008-2011.
    J Hypertens. 2016.
    >> Share

  305. RAYNER BL, Spence JD
    Hypertension in blacks: insights from Africa.
    J Hypertens. 2016.
    >> Share

  306. BRUNO RM, Cartoni G, Stea F, Armenia S, et al
    Carotid and aortic stiffness in essential hypertension and their relation with target organ damage: the CATOD study.
    J Hypertens. 2016.
    >> Share

  307. GORDON RD
    The importance of not overlooking curable hypertension: primary aldosteronism rarely screened for reflecting poor uptake of Endocrine Society Guidelines.
    J Hypertens. 2016;34:2143-4.
    >> Share

  308. SCHMITZ B, Brand SM
    Uric acid and essential hypertension: the endothelial connection.
    J Hypertens. 2016;34:2138-9.
    >> Share

    October 2016
  309. SECCIA TM, Caroccia B, Calo LA
    Hypertensive nephropathy. Moving from classic to emerging pathogenetic mechanisms.
    J Hypertens. 2016.
    >> Share

  310. CUNHA AR, D'El-Rei J, Medeiros F, Umbelino B, et al
    Oral magnesium supplementation improves endothelial function and attenuates subclinical atherosclerosis in thiazide-treated hypertensive women.
    J Hypertens. 2016.
    >> Share

  311. MOSS JG, Belli AM, Coca A, Lee M, et al
    Executive summary of the joint position paper on renal denervation of the Cardiovascular and Interventional Radiological Society of Europe and the European Society of Hypertension.
    J Hypertens. 2016.
    >> Share

  312. THOMSEN LC, Mccarthy NS, Melton PE, Cadby G, et al
    The antihypertensive MTHFR gene polymorphism rs17367504-G is a possible novel protective locus for preeclampsia.
    J Hypertens. 2016.
    >> Share

  313. ROUSH GC, Amante B, Singh T, Ayele H, et al
    Quality of meta-analyses for randomized trials in the field of hypertension: a systematic review.
    J Hypertens. 2016.
    >> Share

  314. BOHM M, Ukena C, Ewen S, Linz D, et al
    Renal denervation reduces office and ambulatory heart rate in patients with uncontrolled hypertension: 12-month outcomes from the global SYMPLICITY registry.
    J Hypertens. 2016.
    >> Share

  315. MENDES M, Dubourg J, Blanchard A, Bergerot D, et al
    Copeptin is increased in resistant hypertension.
    J Hypertens. 2016.
    >> Share

  316. JACKSON CA, Pathirana T, Gardiner PA
    Depression, anxiety and risk of hypertension in mid-aged women: a prospective longitudinal study.
    J Hypertens. 2016;34:1959-1966.
    >> Share

    September 2016
  317. KULCHAITANAROAJ P, Brooks JM, Chaiyakunapruk N, Goedken AM, et al
    Cost-utility analysis of physician-pharmacist collaborative intervention for treating hypertension compared with usual care.
    J Hypertens. 2016.
    >> Share

  318. CAMACHO PA, Gomez-Arbelaez D, Molina DI, Sanchez G, et al
    Social disparities explain differences in hypertension prevalence, detection and control in Colombia.
    J Hypertens. 2016.
    >> Share

  319. NAPOLI C, Omboni S, Borghi C
    Fixed-dose combination of zofenopril plus hydrochlorothiazide vs. irbesartan plus hydrochlorothiazide in hypertensive patients with established metabolic syndrome uncontrolled by previous monotherapy. The ZAMES study (Zofenopril in Advanced MEtabolic
    J Hypertens. 2016.
    >> Share

  320. CARRARA D, Bruno RM, Bacca A, Taddei S, et al
    Cholecalciferol treatment downregulates renin-angiotensin system and improves endothelial function in essential hypertensive patients with hypovitaminosid D.
    J Hypertens. 2016.
    >> Share

  321. YU C, Wang J, Li Y, Han X, et al
    Exposure to the Chinese famine in early life and hypertension prevalence risk in adults.
    J Hypertens. 2016.
    >> Share

  322. SCHEEPERS LE, Wei FF, Stolarz-Skrzypek K, Malyutina S, et al
    Xanthine oxidase gene variants and their association with blood pressure and incident hypertension: a population study.
    J Hypertens. 2016.
    >> Share

  323. SVEDMYR S, Zou D, Sommermeyer D, Ficker JH, et al
    Vascular stiffness determined from a nocturnal digital pulse wave signal: association with sleep, sleep-disordered breathing, and hypertension.
    J Hypertens. 2016.
    >> Share

  324. ZAMAMI R, Kohagura K, Miyagi T, Kinjyo T, et al
    Modification of the impact of hypertension on proteinuria by renal arteriolar hyalinosis in nonnephrotic chronic kidney disease.
    J Hypertens. 2016.
    >> Share

  325. OTT C, Mahfoud F, Schmid A, Ewen S, et al
    The effect of renal denervation in moderate treatment-resistant hypertension with confirmed medication adherence.
    J Hypertens. 2016.
    >> Share

  326. MAIDA KD, Vieira S, Gastaldi AC, Bezerra VB, et al
    Amlodipine and enalapril promote distinct effects on cardiovascular autonomic control in spontaneously hypertensive rats: the role of aerobic physical training.
    J Hypertens. 2016.
    >> Share

  327. YAN W, Li X, Zhang Y, Niu D, et al
    Reevaluate secular trends of body size measurements and prevalence of hypertension among Chinese children and adolescents in past two decades.
    J Hypertens. 2016.
    >> Share

  328. MARTINEZ-AGUAYO A, Campino C, Baudrand R, Carvajal CA, et al
    Cortisol/cortisone ratio and matrix metalloproteinase-9 activity are associated with pediatric primary hypertension.
    J Hypertens. 2016;34:1808-14.
    >> Share

  329. CALHOUN DA
    Spironolactone versus renal nerve denervation for treatment of uncontrolled resistant hypertension.
    J Hypertens. 2016;34:1701-3.
    >> Share

  330. CUSPIDI C, Sala C, Grassi G
    ECG left atrial abnormality: a marker of stroke prediction in hypertension.
    J Hypertens. 2016;34:1698-700.
    >> Share

  331. JORDAN J, Toplak H, Grassi G, Yumuk V, et al
    Joint statement of the European Association for the Study of Obesity and the European Society of Hypertension: obesity and heart failure.
    J Hypertens. 2016;34:1678-88.
    >> Share

  332. ZANCHETTI A
    Consensus documents and challenges in hypertension research.
    J Hypertens. 2016;34:1663-4.
    >> Share

  333. PARREIRA LB, Jardim PC, Sousa AL, Jardim TS, et al
    [OP.8A.06] CARDIAC REHABILITATION IN HYPERTENSIVE PATIENTS: COMPARISON BETWEEN TWO PROTOCOLS.
    J Hypertens. 2016;34 Suppl 2:e99.
    >> Share

  334. MOS L, Fania C, Saladini F, Mazzer A, et al
    [OP.8A.05] REGULAR PHYSICAL ACTIVITY ATTENUATES THE ASSOCIATION BETWEEN COFFEE CONSUMPTION AND CARDIOVASCULAR EVENTS IN HYPERTENSION. THE HARVEST.
    J Hypertens. 2016;34 Suppl 2:e99.
    >> Share

  335. MILLEN A, Woodiwiss A, Norton GR
    [OP.8A.02] POST-EXERCISE EFFECTS ON AORTIC WAVE REFLECTION DERIVED FROM WAVE SEPARATION ANALYSIS IN PRE-HYPERTENSIVES AND HYPERTENSIVES: COMPARISON WITH CHANGES IN AUGMENTATION INDEXES.
    J Hypertens. 2016;34 Suppl 2:e98.
    >> Share

  336. MENDES P, Martinho R, Leite S, Leite-Moreira A, et al
    [OP.8A.01] EXERCISE-INDUCED HYPERTENSION AND CARDIAC HYPERTROPHY IN EPINEPHRINE-DEFICIENT MICE.
    J Hypertens. 2016;34 Suppl 2:e98.
    >> Share

  337. EIKELIS N, Hering D, Marusic P, Walton A, et al
    [OP.7D.10] THE EFFECT OF RENAL DENERVATION ON ADIPOKINES IN PATIENTS WITH RESISTANT HYPERTENSION.
    J Hypertens. 2016;34 Suppl 2:e97.
    >> Share

  338. ROSA J, Widimsky P, Waldauf P, Lambert L, et al
    [OP.7D.09] THE ROLE OF ADDING SPIRONOLACTONE AND RENAL DENERVATION IN TRUE RESISTANT HYPERTENSION. ONE-YEAR OUTCOMES OF RANDOMIZED PRAGUE-15 STUDY.
    J Hypertens. 2016;34 Suppl 2:e96-7.
    >> Share

  339. KASIAKOGIAS A, Tsioufis C, Kordalis A, Dimitriadis K, et al
    [OP.7D.08] SEVERE RESISTANT HYPERTENSION EXHIBITS THE GREATEST CARDIOVASCULAR RISK AMONG TREATED UNCONTROLLED HYPERTENSIVES: A 4-YEAR FOLLOW-UP STUDY.
    J Hypertens. 2016;34 Suppl 2:e96.
    >> Share

  340. MEGDICHE F, Vakilzadeh N, Maillard M, Grouzmann E, et al
    [OP.7D.04] CHANGES IN RENAL HEMODYNAMIC AND TUBULAR SODIUM HANDLING ONE YEAR AFTER TRANSCATHETER RENAL DENERVATION IN RESISTANT HYPERTENSION.
    J Hypertens. 2016;34 Suppl 2:e95.
    >> Share

  341. SANDERS M, de Jager R, Bots M, Lobo M, et al
    [OP.7D.03] RENAL DENERVATION IN HYPERTENSIVE PATIENTS NOT ON BLOOD PRESSURE LOWERING DRUGS.
    J Hypertens. 2016;34 Suppl 2:e94-5.
    >> Share

  342. DUBOURG J, Mendes M, Blanchard A, Frank M, et al
    [OP.7D.02] INCREASE IN PLASMA COPEPTIN CONCENTRATION IN PATIENTS WITH CONFIRMED RESISTANT ESSENTIAL HYPERTENSION.
    J Hypertens. 2016;34 Suppl 2:e94.
    >> Share

  343. RIMPELA J, Hiltunen TP, Fyhrquist F, Kontula KK, et al
    [OP.7C.10] IDENTIFICATION OF GENE VARIANTS ASSOCIATED WITH ANTIHYPERTENSIVE RESPONSES TO BETA BLOCKERS AND LOSARTAN.
    J Hypertens. 2016;34 Suppl 2:e92-3.
    >> Share

  344. SIEDLINSKI M, Szczepaniak P, Nosalski R, Ludwig-Galezowska A, et al
    [OP.7C.06] VASCULAR TRANSCRIPTOME PROFILING IDENTIFIES SPHINGOSINE KINASE 1 AS A KEY MODULATOR OF ANGIOTENSIN II-INDUCED HYPERTENSION.
    J Hypertens. 2016;34 Suppl 2:e91.
    >> Share

  345. TENTORI S, Lanzani C, Citterio L, Brioni E, et al
    [OP.7C.03] KLOTHO GENE POLYMORPHISM INTERACTS WITH ADDUCIN-ENDOGENOUS OUABAIN-NA+-K+ ATPASE SYSTEM IN SALT SENSITIVE HYPERTENSION.
    J Hypertens. 2016;34 Suppl 2:e90-1.
    >> Share

  346. MULE G, Castiglia A, Schillaci MK, Luna C, et al
    [OP.7B.08] INFLUENCE OF GENDER ON THE RELATIONSHIPS BETWEEN NEW INDICES OF ADIPOSITY AND LEFT VENTRICULAR MASS AND HYPERTROPHY IN HYPERTENSIVE PATIENTS.
    J Hypertens. 2016;34 Suppl 2:e88.
    >> Share

  347. BORDICCHIA M, Ceresiani M, Pavani M, Sarzani R, et al
    [OP.7B.04] UP-REGULATION OF THE NATRIURETIC PEPTIDE CLEARANCE RECEPTOR AND INHIBITION OF LIPOLYSIS BY INSULIN: FILLING THE GAP BETWEEN METABOLIC SYNDROME AND HYPERTENSION.
    J Hypertens. 2016;34 Suppl 2:e86-7.
    >> Share

  348. DIMITRIADIS K, Tsioufis C, Andrikou E, Kasiakogias A, et al
    [OP.7B.02] METABOLIC SYNDROME IS ASSOCIATED WITH INCREASED SYMPATHETIC NERVOUS SYSTEM ACTIVITY AND ARTERIAL STIFFNESS IN RESISTANT HYPERTENSIVE PATIENTS.
    J Hypertens. 2016;34 Suppl 2:e86.
    >> Share

  349. LIM K, Barzel B, Burke S, Head G, et al
    [OP.7B.01] NEUROGENIC HYPERTENSION AND THE SYMPATHO-EXCITATION IN DIET INDUCED OBESITY.
    J Hypertens. 2016;34 Suppl 2:e86.
    >> Share

  350. DARABONT R, Tautu O, Ardeleanu M, Dorobantu M, et al
    [OP.7A.10] COMMON AND EMERGENT FACTORS ASSOCIATED WITH HYPERTENSION CONTROL IN ROMANIA.
    J Hypertens. 2016;34 Suppl 2:e84-5.
    >> Share

  351. VAISSE B, Pannier B, Hanon O, Mourad JJ, et al
    [OP.7A.09] A NATIONWIDE EVALUATION OF BLOOD PRESSURE CONTROL IN FRANCE USING HOME BLOOD PRESSURE MONITORING: THE FRENCH LEAGUE AGAINST HYPERTENSION SURVEY (FLAHS 2015).
    J Hypertens. 2016;34 Suppl 2:e84.
    >> Share

  352. STERGIOU GS, Margetaki A, Boubouchairopoulou N, Haidich B, et al
    [OP.7A.08] AWARENESS, TREATMENT AND CONTROL OF HYPERTENSION IN GREECE: INTERIM ANALYSIS OF THE EMENO NATIONAL EPIDEMIOLOGICAL STUDY.
    J Hypertens. 2016;34 Suppl 2:e84.
    >> Share

  353. CARRERE P, Halbert N, Helene-Pelage J, Lang T, et al
    [OP.7A.07] TRENDS IN HYPERTENSION AMONG POOR FRENCH CARIBBEAN, 2003 TO 2014: BETTER BUT STILL NOT GOOD ENOUGH.
    J Hypertens. 2016;34 Suppl 2:e83-4.
    >> Share

  354. GABBA M, Salinaro F, Mussinelli R, Boldrini M, et al
    [OP.7A.06] TREATING HYPERTENSIVE CRISES BETWEEN GUIDELINES AND REAL-WORLD: AN ANTI-HYPERTENSIVE ROLE OF ANTI-ANXIETY DRUGS?
    J Hypertens. 2016;34 Suppl 2:e83.
    >> Share

  355. VRDOLJAK A, Ivkovic V, Karanovic S, Dika Z, et al
    [OP.7A.05] TRENDS IN PREVALENCE, TREATMENT AND CONTROL OF HYPERTENSION IN CROATIAN CONTINENTAL RURAL POPULATION - ENAH STUDY.
    J Hypertens. 2016;34 Suppl 2:e83.
    >> Share

  356. BOKRANTZ T, Schioler L, Ljungman C, Kahan T, et al
    [OP.7A.04] ANTIHYPERTENSIVE DRUGS AND THE RISK OF FEMUR FRACTURE IN HYPERTENSIVE PATIENTS IN SWEDISH PRIMARY HEALTH CARE. RESULTS FROM THE SWEDISH PRIMARY CARE CARDIOVASCULAR DATABASE (SPCCD).
    J Hypertens. 2016;34 Suppl 2:e83.
    >> Share

  357. SAMJI S, Small HY, Coley S, Mischak H, et al
    [OP.LB.02: 06] INVESTIGATION OF URINARY PEPTIDOME OVER PREGNANCY IN RODENT MODEL OF HYPERTENSION.
    J Hypertens. 2016;34 Suppl 2:e80.
    >> Share

  358. MARAIS L, Boutouyrie P, Khettab H, Boulanger C, et al
    [OP.1C.04] STRUCTURAL AND FUNCTIONAL ARTERIAL ABNORMALITIES IN FIBROMUSCULAR DYSPLASIA ARE IN THE CONTINUUM OF HYPERTENSION: AN IMAGING AND BIOMECHANICAL STUDY.
    J Hypertens. 2016;34 Suppl 2:e8-9.
    >> Share

  359. MITCHELL A, Nokay B, Guberina H, Behlen-Wilm U, et al
    [OP.LB.02.05] A PATIENT WITH MALIGNANT HYPERTENSION SUCCESSFULLY TREATED WITH ECULIZUMAB AND BOSENTAN - SUGGESTIONS OF SIGNIFICANT INTERACTIONS OF COMPLEMENT AND THE ENDOTHELIN SYSTEM IN BLOOD PRESSURE CONTROL.
    J Hypertens. 2016;34 Suppl 2:e79-80.
    >> Share

  360. LOBO M, Saxena M, Sobotka PA, Ott C, et al
    [OP.LB.02.04] CENTRAL ILIAC ARTERIOVENOUS ANASTOMOSIS FOR UNCONTROLLED HYPERTENSION: 12 MONTH FOLLOW UP RESULTS OF THE ROX CONTROL HTN RANDOMISED CONTROLLED TRIAL.
    J Hypertens. 2016;34 Suppl 2:e78-9.
    >> Share

  361. NECHUTOVA H, Soucek M, Brabencova K, Stepanova R, et al
    [OP.LB.02.02] NEUROMODULATION IN HYPERTENSION.
    J Hypertens. 2016;34 Suppl 2:e78.
    >> Share

  362. HMAZZOU R, Flahault A, Marc Y, Llorens-Cortes C, et al
    [OP.6D.03] MODE OF ACTION OF RB150, AN AMINOPEPTIDASE A INHIBITOR PRODRUG AS A CENTRALLY-ACTING ANTIHYPERTENSIVE AGENT IN DOCA-SALT HYPERTENSIVE RATS.
    J Hypertens. 2016;34 Suppl 2:e75.
    >> Share

  363. BUESS D, Giezendanner S, Henny-Fullin K, Handschin A, et al
    [OP.6C.07] COMPLIANCE WITH ESH/ESC GUIDELINES FOR ARTERIAL HYPERTENSION IN SWISS PRIMARY CARE: PHARMACOLOGICAL THERAPY.
    J Hypertens. 2016;34 Suppl 2:e73-4.
    >> Share

  364. NEBIERIDZE D, Saricheva A
    [OP.6C.05] THE POSSIBILITY OF IMPROVING THE COMPLIANCE TO THE TREATMENT BY USING OF ELECTRONIC VERSION OF SCORE IN HYPERTENSIVE PATIENTS.
    J Hypertens. 2016;34 Suppl 2:e73.
    >> Share

  365. KARAKAYA G, Van Tielen R, Umbach I
    [OP.6C.02] RISK FACTORS ASSOCIATED WITH MEDICATION NON-COMPLIANCE IN ARTERIAL HYPERTENSION.
    J Hypertens. 2016;34 Suppl 2:e72.
    >> Share

  366. KASIAKOGIAS A, Tsioufis C, Athanasakis K, Andrikou E, et al
    [OP.6C.01] REAL-WORLD MEDICATION COMPLIANCE IN A SAMPLE OF PATIENTS RECEIVING ANTIHYPERTENSIVE TREATMENT IN GREECE.
    J Hypertens. 2016;34 Suppl 2:e72.
    >> Share

  367. BASTOS J, Pires J, Pinto J, Araujo A, et al
    [OP.6B.09] AMONG ALL DATA FROM 24-H BLOOD PRESSURE, NIGHTTIME SYSTOLIC BLOOD PRESSURE HAS THE HIGHEST PREDICTIVE VALUE OF CV EVENTS, STOKE AND HEART ATTACKS IN A PORTUGUESE SAMPLE OF TREATED HYPERTENSIVES PATIENTS FOLLOWED FOR 11,8 +/- 5,1 YEARS.
    J Hypertens. 2016;34 Suppl 2:e71.
    >> Share

  368. PIETRI P, Vlachopoulos C, Vyssoulis G, Ioakeimidis N, et al
    [OP.1B.08] ASSOCIATION OF APOB/APOA 1 RATIO WITH TARGET ORGAN DAMAGE IN HYPERTENSIVE PATIENTS.
    J Hypertens. 2016;34 Suppl 2:e7.
    >> Share

  369. MALDONADO J, Pereira T
    [OP.6A.03] PREVALENCE AND DETERMINANTS OF HYPERTENSION IN A COHORT OF 15.049 PORTUGUESE CHILDREN AND ADOLESCENTS. THE AVELEIRA REGISTRY.
    J Hypertens. 2016;34 Suppl 2:e66-7.
    >> Share

  370. BARRIENTOS G, Uceda A, Sgariglia A, Giardina G, et al
    [OP.5D.06] HYPERTENSION AS A PATERNAL FACTOR INFLUENCES MATERNAL ADAPTATION TO PREGNANCY AND IS ASSOCIATED WITH PLACENTAL INSUFFICIENCY AND FETAL GROWTH RESTRICTION.
    J Hypertens. 2016;34 Suppl 2:e64-5.
    >> Share

  371. SAMUELSSON A, Pombo JM, Coen CW, Mallard C, et al
    [OP.5D.03] CHRONIC INFLAMMATION DURING PREGNANCY INFLUENCE THE PROGRESSION OF EARLY SYMPATHETIC-MEDIATED HYPERTENSION IN OFFSPRING ARISING FROM MATERNAL OBESITY.
    J Hypertens. 2016;34 Suppl 2:e63.
    >> Share

  372. MORGAN H, Small HY, Beattie E, McBride MW, et al
    [OP.5D.02] TRANSCRIPTOMIC CHANGES IN EARLY PREGNANCY-ASSOCIATED UTERINE ARTERY REMODELLING IN STROKE PRONE SPONTANEOUSLY HYPERTENSIVE RAT.
    J Hypertens. 2016;34 Suppl 2:e63.
    >> Share

  373. SMALL H, Nosalski R, Morgan H, Beattie E, et al
    [OP.5D.01] INHIBITON OF TNF-ALPHA SIGNALLING USING ETANERCEPT IMPROVES DEFICIENT UTERINE ARTERY REMODELLING AND PREGNANCY OUTCOME IN THE STROKE PRONE SPONTANEOUSLY HYPERTENSIVE RAT.
    J Hypertens. 2016;34 Suppl 2:e63.
    >> Share

  374. ZVARTAU N, Krikunov A, Semakova A, Bolgova E, et al
    [OP.5C.08] FIVE-YEARS TRENDS IN DEMOGRAPHIC CHCRACTERISTICS OF HYPERTENSIVE PATIENTS REFERRED TO SPECIALIZED CARDIOLOGICAL CENTRE: AGE AND GENDER.
    J Hypertens. 2016;34 Suppl 2:e62.
    >> Share

  375. PALATINI P, Reboldi P, Pierdomenico S, Eguchi K, et al
    [OP.5C.06] MASKED TACHYCARDIA PREDICTS ADVERSE OUTCOME IN HYPERTENSION. THE ABP-INTERNATIONAL STUDY.
    J Hypertens. 2016;34 Suppl 2:e61.
    >> Share

  376. CLEMENTI A, Buiatti M, Mussinelli R, Salinaro F, et al
    [OP.5C.03] HIGHER PREVALENCE OF HYPERTENSION IN MIGRANTS IN ITALY: A SNAPSHOT OF THE 2012 AND 2013C WORLD KIDNEY DAY.
    J Hypertens. 2016;34 Suppl 2:e60-1.
    >> Share

  377. MORISCO C, Meccariello A, Buono F, Orefice G, et al
    [OP.5C.02] MICROALBUMINURIA PREDICTS THE RECURRENCE OF CARDIOVASCULAR EVENTS IN PATIENTS WITH ESSENTIAL HYPERTENSION.
    J Hypertens. 2016;34 Suppl 2:e60.
    >> Share

  378. CREMER A, Boulestreau R, Gosse P
    [OP.1B.05] OVER-24H CENTRAL PULSE PRESSURE IS SUPERIOR TO PERIPHERAL PULSE PRESSURE FOR CARDIOVASCULAR EVENTS PREDICTION. RESULTS FROM THE BORDEAUX HYPERTENSIVE COHORT.
    J Hypertens. 2016;34 Suppl 2:e6.
    >> Share

  379. DI PILLA M, Bruno RM, Ghiadoni L, Stea F, et al
    [OP.5B.08] IMPACT OF SEASONALITY AND AIR POLLUTANTS ON CAROTID-FEMORAL PULSE WAVE VELOCITY IN HYPERTENSIVE PATIENTS.
    J Hypertens. 2016;34 Suppl 2:e59.
    >> Share

  380. TERENTES-PRINTZIOS D, Vlachopoulos C, Vyssoulis G, Pietri P, et al
    [OP.5B.06] TOTAL ARTERIAL COMPLIANCE AND TARGET ORGAN DAMAGE IN HYPERTENSIVES.
    J Hypertens. 2016;34 Suppl 2:e58.
    >> Share

  381. GALLO A, Rosenbaum D, Mattina A, Koch E, et al
    [OP.5A.02] SHORT AND LONG-TERM EFFECTS OF ANTIHYPERTENSIVE TREATMENT ON HUMAN RETINAL ARTERIOLE REMODELING EVALUATED WITH ADAPTIVE OPTICS CAMERA.
    J Hypertens. 2016;34 Suppl 2:e54.
    >> Share

  382. MALLAMACI F, Tripepi R, Versace MC, Provenzano F, et al
    [OP.4D.08] DISORDERED SLEEP BREATHING (SDB) IS THE MAJOR DETERMINANT OF NON-DIPPING AND NOCTURNAL HYPERTENSION IN KIDNEY TRANSPLANT PATIENTS.
    J Hypertens. 2016;34 Suppl 2:e53.
    >> Share

  383. RUAN C, Li Y, Ma Y, Kong LR, et al
    [OP.4D.02] ADIPONECTIN-MEDIATED EPITHILIAL AUTOPHAGY ATTENUATES HYPERTENSIVE RENAL FIBROSIS.
    J Hypertens. 2016;34 Suppl 2:e51.
    >> Share

  384. DEROSA G, Romano D, D'Angelo A, Maffioli P, et al
    [OP.4C.09] COMPARISON BETWEEN CANRENONE OR HYDROCHLOROTHIAZIDE IN ADDITION TO SARTANS IN HYPERTENSIVE DIABETIC PATIENTS.
    J Hypertens. 2016;34 Suppl 2:e49.
    >> Share

  385. MAZZA A, Lenti S, Schiavon L, Ramazzina E, et al
    [OP.4C.08] ROLE OF THE FIXED-DOSE TRIPLE COMBINATION THERAPY IN THE MANAGEMENT OF UNCONTROLLED HYPERTENSION: FROM THE RANDOMIZED CLINICAL TRIALS TO CLINICAL PRACTICE.
    J Hypertens. 2016;34 Suppl 2:e49.
    >> Share

  386. KJELDSEN SE, Okin PM, Devereux RB
    [OP.4C.05] IMPACT OF ACHIEVED SYSTOLIC BLOOD PRESSURE ON RENAL FUNCTION IN HYPERTENSIVE PATIENTS: THE LIFE STUDY.
    J Hypertens. 2016;34 Suppl 2:e48.
    >> Share

  387. LOBO MD, Montarello J, Saxena M, Jain A, et al
    [OP.4C.04] SAFETY AND PERFORMANCE OF THE ENLIGHTN RENAL DENERVATION SYSTEM IN PATIENTS WITH DRUG-RESISTANT HYPERTENSION: POOLED ANALYSES FROM THE ENLIGHTN 1, 2 AND 3 TRIALS.
    J Hypertens. 2016;34 Suppl 2:e48.
    >> Share

  388. OLIVERAS A, Armario P, Sans L, Clara A, et al
    [OP.4C.02] CHANGES IN SUBCLINICAL ORGAN DAMAGE IN PATIENTS WITH RESISTANT HYPERTENSION RANDOMIZED TO RECEIVE RENAL DENERVATION OR SPIRONOLACTONE AS ADD-ON THERAPY. THE DENERVHTA STUDY RESULTS.
    J Hypertens. 2016;34 Suppl 2:e47.
    >> Share

  389. SERAVALLE GL, Brambilla G, Dell'Oro R, Trevano FQ, et al
    [OP.4C.01] ANTIHYPERTENSIVE DRUG TREATMENT FAILS TO NORMALIZE SYMPATHETIC ACTIVITY: MICRONEUROGRAPHIC EVIDENCE AND CLINICAL IMPLICATIONS.
    J Hypertens. 2016;34 Suppl 2:e47.
    >> Share

  390. SALVETTI M, Paini A, Rosei CA, Bertacchini F, et al
    [OP.4B.09] CARDIAC ORGAN DAMAGE IN HYPERTENSIVE PATIENTS ACCORDING TO ON-TREATMENT BLOOD PRESSURE VALUES.
    J Hypertens. 2016;34 Suppl 2:e46.
    >> Share

  391. BOMBELLI M, Seravalle G, Maloberti A, Macchiarulo M, et al
    [OP.4B.08] PROGNOSTIC RELEVANCE OF ELECTROCARDIOGRAPHIC TP-TE INTERVAL IN THE GENERAL AND IN THE HYPERTENSIVE POPULATION: DATA FROM THE PAMELA STUDY.
    J Hypertens. 2016;34 Suppl 2:e46.
    >> Share

  392. DIPLA K, Triantafyllou A, Koletsos N, Sachpekidis V, et al
    [OP.4B.07] EXAGGERATED BLOOD PRESSURE RESPONSE DURING HANDGRIP EXERCISE IN MASKED HYPERTENSIVE: CAN IT BE USED AS AN ADDITIONAL SCREENING TOOL?
    J Hypertens. 2016;34 Suppl 2:e45-6.
    >> Share

  393. TADIC M, Cuspidi C, Vukomanovic V, Kocijancic V, et al
    [OP.4B.06] THE IMPACT OF UPDATED LEFT VENTRICULAR GEOMETRY CLASSIFICATION ON RIGHT VENTRICULAR REMODELLING IN A HYPERTENSIVE POPULATION.
    J Hypertens. 2016;34 Suppl 2:e45.
    >> Share

  394. CATENA C, Colussi GL, Novello M, Nait F, et al
    [OP.4B.05] RELATIONSHIPS BETWEEN ALCOHOL INTAKE AND LEFT VENTRICULAR DIASTOLIC FUNCTION IN HYPERTENSION: A TISSUE-DOPPLER STUDY.
    J Hypertens. 2016;34 Suppl 2:e45.
    >> Share

  395. MULE' G, Nardi E, Guarino L, Morreale M, et al
    [OP.4B.03] CIRCULATING ALDOSTERONE LEVELS ARE ASSOCIATED WITH CONCENTRIC LEFT VENTRICULAR GEOMETRY IN ESSENTIAL HYPERTENSIVE PATIENTS.
    J Hypertens. 2016;34 Suppl 2:e44.
    >> Share

  396. BONNET B, Jourdan F, Cailar Gd, Fesler P, et al
    [OP.4B.02] NON INVASIVE EVALUATION OF END SYSTOLIC LEFT VENTRICULAR ELASTANCE ACCORDING TO PRESSURE-VOLUME CURVE MODELING DURING EJECTION IN ARTERIAL HYPERTENSION.
    J Hypertens. 2016;34 Suppl 2:e44.
    >> Share

  397. TADIC M, Cuspidi C, Vukomanovic V, Pencic B, et al
    [OP.4B.01] LEFT VENTRICULAR MECHANICS IN PATIENTS WITH MASKED HYPERTENSION.
    J Hypertens. 2016;34 Suppl 2:e44.
    >> Share

  398. DE LA SIERRA A, Pareja J, Armario P, Barrera A, et al
    [OP.4A.10] RENAL DENERVATION VERSUS SPIRONOLACTONE IN RESISTANT HYPERTENSION. EFFECTS ON CIRCADIAN PATTERNS AND BLOOD PRESSURE VARIABILITY.
    J Hypertens. 2016;34 Suppl 2:e43.
    >> Share

  399. SKULTETYOVA D, Filipova S
    [OP.4A.06] RELATIONSHIP BETWEEN CIRCADIAN PATTERNS OF BLOOD PRESSURE AND CAROTID ARTERY STIFFNESS AND WAVE INTENSITY IN PATIENTS WITH ARTERIAL HYPERTENSION.
    J Hypertens. 2016;34 Suppl 2:e41-2.
    >> Share

  400. CHI C, Zhang Y, Yu S, Argyris A, et al
    [OP.4A.04] ASSOCIATION OF CARDIAC STRUCTURE AND FUNCTION WITH CENTRAL AND BRACHIAL BLOOD PRESSURE VARIABILITY IN HYPERTENSIVE PATIENTS: THE SAFAR STUDY.
    J Hypertens. 2016;34 Suppl 2:e41.
    >> Share

  401. SALADINI F, Mos L, Fania C, Benetti E, et al
    [OP.4A.02] SHORT TERM BLOOD PRESSURE VARIABILTY AS PREDICTOR OF FUTURE EVENTS IN YOUNG STAGE I HYPERTENSIVES.
    J Hypertens. 2016;34 Suppl 2:e40.
    >> Share

  402. RAFAEL C, Khalek WA, Kouranti I, Clauser E, et al
    [OP.LB01.10] THE SKIPPING OF EXON 9 IN CULLIN-3 CAUSES A SEVERE FORM OF FAMILIAL HYPERKALEMIC HYPERTENSION IN MICE.
    J Hypertens. 2016;34 Suppl 2:e38-9.
    >> Share

  403. POULTER NR, Anjum A, Cross M, Falaschetti E, et al
    [OP.LB01.07] A COMPARISON OF THE IMPACT OF MORNING OR NIGHT DELIVERY OF ANTIHYPERTENSIVE AGENTS ON 24 HOUR AMBULATORY BLOOD PRESSURE MONITORING (ABPM) LEVELS: A RANDOMISED CROSS-OVER TRIAL.
    J Hypertens. 2016;34 Suppl 2:e37-8.
    >> Share

  404. MALEK F, Vondrakova D, Dvorak J, Sedlackova L, et al
    [OP.3D.07] CORRELATION OF CERULOPLASMIN WITH BIOMARKERS OF CARDIAC REMODELLING AND MYOFIBROSIS: NT-PROBNP, SST2, GALECTIN-3 IN PATIENTS WITH CHRONIC HEART FAILURE AND ARTERIAL HYPERTENSION.
    J Hypertens. 2016;34 Suppl 2:e34-5.
    >> Share

  405. CANIFFI C, Gomez M, Alcober L, Prentky E, et al
    [OP.3D.05] HYPERTENSION AND VASCULAR INJURY: CHRONIC TREATMENT WITH C-TYPE NATRIURETIC PEPTIDE SHOWS BENEFICIAL EFFECTS ON THE LEVEL OF OXIDATIVE STRESS AND PRO-INFLAMMATORY CYTOKINES.
    J Hypertens. 2016;34 Suppl 2:e34.
    >> Share

  406. KASZUBA A, Konior A, Mikolajczyk T, Prejbisz A, et al
    [OP.3D.04] ACTIVATED CD4+ AND CD8+ T-CELL SUBPOPULATIONS IN PATIENTS WITH PRIMARY HYPERALDOSTERONISM AND TRUE RESISTANT HYPERTENSION.
    J Hypertens. 2016;34 Suppl 2:e33-4.
    >> Share

  407. NOSALSKI R, Siedlinski M, Cat AN, Skiba D, et al
    [OP.3D.02] MICRORNA-214 IS INVOLVED IN THE REGULATION OF PERIVASCULAR FIBROSIS IN HYPERTENSION.
    J Hypertens. 2016;34 Suppl 2:e33.
    >> Share

  408. MUELA HC, Costa-Hong V, Machado MF, Yassuda MS, et al
    [OP.3C.03] ARTERIAL STIFFNESS IS ASSOCIATED WITH LOWER PERFORMANCE ON THE COGNITIVE TESTS AT DIFFERENT DOMAINS IN HYPERTENSIVE PATIENTS.
    J Hypertens. 2016;34 Suppl 2:e31.
    >> Share

  409. FOULQUIER S, Namsolleck P, Recarti C, Van Hagen BT, et al
    [OP.3C.01] MICROGLIAL ACTIVATION IN HYPERTENSION-MEDIATED COGNITIVE IMPAIRMENT.
    J Hypertens. 2016;34 Suppl 2:e31.
    >> Share

  410. JARDIM T, Jardim L, Sousa A, Barroso W, et al
    [OP.3B.07] MULTIDISCIPLINARY TREATMENT FOR THE VERY ELDERLY HYPERTENSIVE PATIENT.
    J Hypertens. 2016;34 Suppl 2:e30.
    >> Share

  411. SILVA AP, Matos A, Ribeiro R, Gil A, et al
    [OP.3B.06] WILL BE CENTENARIANS, HYPERTENSIVE INDIVIDUALS? HOW IS THE BLOOD PRESSURE CONTROL OF CENTENARIANS IN PORTUGAL?
    J Hypertens. 2016;34 Suppl 2:e30.
    >> Share

  412. ANDREEVA G, Gorbunov V, Beloliperskaya V, Kukushkin S, et al
    [OP.1A.09] THE RELATIONSHIP BETWEEN THE AGGRESSION LEVEL OF PATIENTS WITH ARTERIAL HYPERTENSION AND THE ANTIHYPERTENSIVE DRUG EFFECTIVENESS.
    J Hypertens. 2016;34 Suppl 2:e3.
    >> Share

  413. GAZZOLA K, Cammenga M, Van Der Hoeven N, Van Montfrans G, et al
    [OP.1A.07] INCREMENTAL DIFFERENCES BETWEEN HOME AND AMBULATORY BLOOD PRESSURE AND THEIR RELATION TO ANXIETY AND HYPERTENSIVE ORGAN DAMAGE: EVIDENCE FOR AN 'AUTO-CUFF' RESPONSE?
    J Hypertens. 2016;34 Suppl 2:e3.
    >> Share

  414. ZHAO X, Yu J
    [OP.3A.07] DROSPIRENONE WITH ESTRADIOL FOR POSTMENOPAUSAL WOMEN WITH HYPERTENSION: A SYSTEMIC REVIEW AND META-ANALYSIS.
    J Hypertens. 2016;34 Suppl 2:e28.
    >> Share

  415. JEKELL A, Kalani M, Kahan T
    [OP.2D.07] THE EFFECTS OF ALPHA 1-ADRENOCEPTOR-BLOCKADE BY DOXAZOSIN OR ACE-INHIBITION BY RAMIPRIL ON ENDOTHELIAL FUNCTION IN PRIMARY HYPERTENSION: THE DORA STUDY.
    J Hypertens. 2016;34 Suppl 2:e25.
    >> Share

  416. TRIANTAFYLLIDI H, Benas D, Vlachos S, Schoinas A, et al
    [OP.2D.06] DIFFERENCES IN ENDOTHELIAL GLYCOCALYX IN RECENTLY DIAGNOSED AND UNTREATED MIDDLE-AGED HYPERTENSIVE PATIENTS REGARDING INCREASED CARDIOVASCULAR RISK.
    J Hypertens. 2016;34 Suppl 2:e25.
    >> Share

  417. COTTONE S, Nardi E, Guarneri M, Guarino L, et al
    [OP.2D.05] RELATIONSHIP OF OXIDATIVE STRESS WITH CARDIAC HYPERTROPHY IN HYPERTENSIVE PATIENTS.
    J Hypertens. 2016;34 Suppl 2:e25.
    >> Share

  418. IONIN V, Zaslavskaya EL, Belyaeva OD, Soboleva AV, et al
    [OP.2C.06] NEW RISK FACTORS FOR ATRIAL FIBRILLATION IN PATIENTS WITH HYPERTENSION AND OBESITY.
    J Hypertens. 2016;34 Suppl 2:e23.
    >> Share

  419. VARGA A, Tatar CM, Mitre A, Podoleanu C, et al
    [OP.2C: 05] ATRIAL FIBRILLATION IN HYPERTENSIVE PATIENTS. A SINGLE PILOT ANTICOAGULATION RISK MANAGEMENT CENTER.
    J Hypertens. 2016;34 Suppl 2:e23.
    >> Share

  420. WANG Q, Chang P, Xu H, Bai F, et al
    [OP.2C.01] TETRAHYDROBIOPTERIN REVERSE LEFT VENTRICULAR HYPERTROPHY AND DIASTOLIC DYSFUNCTION THROUGH THE PI3K/P-AKT PATHWAY IN SPONTANEOUSLY HYPERTENSIVE RATS.
    J Hypertens. 2016;34 Suppl 2:e22.
    >> Share

  421. CHI C, Yu S, Bai B, Wang K, et al
    [OP.1A.06] HYPERTENSIVE TARGET ORGAN DAMAGES ARE BETTER ASSOCIATED WITH CENTRAL THAN BRACHIAL BLOOD PRESSURE: THE NORTHERN SHANGHAI STUDY.
    J Hypertens. 2016;34 Suppl 2:e2.
    >> Share

  422. VRDOLJAK A, Ivkovic V, Karanovic S, Dika Z, et al
    [OP.2B.03] GLOMERULAR HYPERFILTRATION AS A RISK FACTOR FOR RENAL IMPAIRMENT AND HYPERTENSION IN APPARENTLY HEALTHY SUBJECTS.
    J Hypertens. 2016;34 Suppl 2:e19.
    >> Share

  423. MARKETOU M, Parthenakis F, Kontaraki J, Maragoudakis F, et al
    [OP.2B.02] COMPARATIVE MICRORNA PROFILING IN RELATION TO URINARY ALBUMIN EXCRETION IN NEWLY DIAGNOSED HYPERTENSIVE PATIENTS.
    J Hypertens. 2016;34 Suppl 2:e19.
    >> Share

  424. THOMAS-JEAN F, Pannier B, Hanon O, Czernichow S, et al
    [OP.2A.09] SYSTOLIC BLOOD PRESSURE VARIATION DURING 6 YEARS AND MORTALITY: THE AGE AMPLIFIES THE IMPACT OF A SPONTANEOUS INCREASE OR REDUCTION OF PRESSURE AMONG HYPERTENSIVE: IPC COHORT.
    J Hypertens. 2016;34 Suppl 2:e18.
    >> Share

  425. STERGIOU GS, Margetaki A, Boubouchairopoulou N, Mastrokostas A, et al
    [OP.2A.08] HYPERTENSION AND CARDIOVASCULAR DISEASE IN GREECE: INTERIM ANALYSIS OF THE EMENO NATIONAL EPIDEMIOLOGICAL STUDY.
    J Hypertens. 2016;34 Suppl 2:e17-8.
    >> Share

  426. DEBORDE T, Amar L, Bobrie G, Burgun A, et al
    [OP.2A.07] TRENDS IN PATIENTS ATTENDING A TERTIARY HYPERTENSION UNIT: PATIENTS' CHARACTERISTICS AND TREATMENT STRATEGIES STRONGLY EVOLVED OVER THE LAST 15 YEARS.
    J Hypertens. 2016;34 Suppl 2:e17.
    >> Share

  427. WALLENTIN F, Wettermark B, Kahan T
    [OP.2A.06] CURRENT DRUG TREATMENT OF HYPERTENSION IN SWEDEN IN RELATION TO GENDER, AGE, AND COMORBIDITY.
    J Hypertens. 2016;34 Suppl 2:e17.
    >> Share

  428. JUMAR A, Ott C, Kistner I, Friedrich S, et al
    [OP.1D.07] EARLY SIGNS OF END-ORGAN DAMAGE IN RETINAL ARTERIOLES IN TYPE 2 DIABETIC IN COMPARISON WITH HYPERTENSIVE PATIENTS.
    J Hypertens. 2016;34 Suppl 2:e13.
    >> Share

  429. KARPANOU E, Vyssoulis G, Demerouti E, Grassos H, et al
    [OP.1D.06] SALT CONSUMPTION AND GLUCOSE METABOLISM IN ESSENTIAL HYPERTENSION.
    J Hypertens. 2016;34 Suppl 2:e13.
    >> Share

  430. POLONIA J, Ferreira C, Castro P, Penas S, et al
    [OP.1D.03] NIGHTTIME BLOOD PRESSURE IS THE MAJOR DETERMINANT FACTOR OF BOTH MACROVASCULAR AND MICROVASCULAR LESIONS IN A COOHORT OF TYPE 2 DIABETIC AND NON-DIABETIC HYPERTENSIVE PATIENTS.
    J Hypertens. 2016;34 Suppl 2:e12.
    >> Share

  431. NIBOUCHE N, Lanasri N, Chibane A, Zeraoulia F, et al
    [OP.1D.02] ORTHOSTATIC HYPERTENSION IN NORMOTENSIVE PATIENTS PREDICTS PERMANENT ARTERIAL HYPERTENSION IN TYPE 2 DIABETES MELLITUS.
    J Hypertens. 2016;34 Suppl 2:e12.
    >> Share

  432. WIJKMAN M, Lanne T, Ostgren CJ, Nystrom FH, et al
    [OP.1D.01] DIASTOLIC ORTHOSTATIC HYPERTENSION PREDICTS A FAVORABLE CARDIOVASCULAR PROGNOSIS IN TYPE 2 DIABETES.
    J Hypertens. 2016;34 Suppl 2:e12.
    >> Share

  433. TSIOUFIS C, Kasiakogias A, Dimitriadis K, Kalos T, et al
    [OP.LB03.07] EFFECTS OF LERCANIDIPINE/ENALAPRIL COMPARED WITH AMLODIPINE/ENALAPRIL AND HYDROCHLOROTHIAZIDE/ENALAPRIL ON TARGET ORGAN DAMAGE AND SYMPATHETIC ACTIVITY IN HYPERTENSION.
    J Hypertens. 2016;34 Suppl 2:e113.
    >> Share

  434. AGNOLETTI D, Lieber A, Valbusa F, Arcaro G, et al
    [OP.LB03.03] THE RELATIONSHIP BETWEEN DIASTOLIC FUNCTION AND CENTRAL HEMODYNAMICS IN DIABETIC HYPERTENSIVE PATIENTS.
    J Hypertens. 2016;34 Suppl 2:e111-2.
    >> Share

  435. BOUTOUYRIE P, Elmula F, Rebora P, Talvik A, et al
    [OP.LB03.02] NON-INVASIVE HEMODYNAMIC MONITORING IN UNCONTROLLED HYPERTENSIVE PATIENTS: EFFECT ON ARTERIAL STIFFNESS AND CENTRAL BLOOD PRESSURE: THE BEAUTY STUDY.
    J Hypertens. 2016;34 Suppl 2:e111.
    >> Share

  436. BURNIER M, Chappuis A, Glatz N, Bochud M, et al
    [OP.8E.08] REGIONAL VARIATIONS IN THE ASSOCIATIONS OF DIETARY PATTERNS WITH BLOOD PRESSURE AND HYPERTENSION IN SWITZERLAND.
    J Hypertens. 2016;34 Suppl 2:e110.
    >> Share

  437. LESIUK C, Courand PY, Milon H, Defforges-Ranc A, et al
    [OP.8E.06] A SUFFICIENT PROTEIN INTAKE SHOULD BE ENCOURAGED IN HYPERTENSIVE PATIENTS WITHOUT CHRONIC KIDNEY DISEASE: A LONG-TERM OUTCOMES STUDY.
    J Hypertens. 2016;34 Suppl 2:e109.
    >> Share

  438. MUIESAN ML, Riviera M, Pintossi C, Bertacchini F, et al
    [OP.8D.06] OCULAR FUNDUS PHOTOGRAPHY WITH A SMARTPHONE DEVICE IN ACUTE HYPERTENSION.
    J Hypertens. 2016;34 Suppl 2:e106-7.
    >> Share

  439. XU T, Sun JP, Lee AP, Yang Y, et al
    [OP.8D.05] LAYER-SPECIFIC QUANTIFICATION OF MYOCARDIAL DEFORMATION MAY DISCLOSE THE SUBCLINICAL SYSTOLIC DYSFUNCTION AND THE MECHANISM OF RESERVED EJECTION FRACTION IN HYPERTENSIVE PATIENTS.
    J Hypertens. 2016;34 Suppl 2:e106.
    >> Share

  440. MARAIS L, Pernot M, Khettab H, Tanter M, et al
    [OP.8D.03] MEASUREMENT OF ARTERIAL STIFFNESS BY ULTRAFAST ECHO: COMPARISON WITH ECHOTRACKING IN NORMOTENSIVE SUBJECTS AND HYPERTENSIVE PATIENTS.
    J Hypertens. 2016;34 Suppl 2:e105-6.
    >> Share

  441. MARC Y, Hmazzou R, Flahault A, Llorens-Cortes C, et al
    [OP.8C.06] CENTRAL ANTIHYPERTENSIVE EFFECTS OF CHRONIC TREATMENT WITH RB150/QGC001, AN ORALLY ACTIVE AMINOPEPTIDASE A INHIBITOR PRODRUG IN DOCA-SALT HYPERTENSIVE RATS.
    J Hypertens. 2016;34 Suppl 2:e103.
    >> Share

  442. KONG L, Ruan C, Ma Y, Gao P, et al
    [OP.8C.05] A2A RECEPTOR-MEDIATED ACTIVATION OF REGULATORY T CELLS ATTENUATES HYPERTENSION-INDUCED CARDIORENAL CONSEQUENCE.
    J Hypertens. 2016;34 Suppl 2:e103.
    >> Share

  443. ASHLEY Z, Leader C, Sammut I, McDonald F, et al
    [OP.8C.04] THE FLOW DETECTION ROLE OF THE VASCULAR EPITHELIAL SODIUM CHANNEL (ENAC) IN AN EXPERIMENTAL MODEL OF HYPERTENSION: THE NOVEL TARGET FOR SPIRONOLACTONE THERAPY?
    J Hypertens. 2016;34 Suppl 2:e103.
    >> Share

  444. GRABOWSKI K, Herlan L, Eisenreich A, Schulz A, et al
    [OP.8C.01] A NOVEL CANDIDATE GENE IDENTIFIED IN STROKE-PRONE SPONTANEOUSLY HYPERTENSIVE RATS HAS A MAJOR IMPACT ON ADVERSE LEFT VENTRICULAR REMODELING IN SALT-INDUCED HYPERTENSION.
    J Hypertens. 2016;34 Suppl 2:e102.
    >> Share

  445. NOWAK MM, Komand A, Ostrowka D, Jancewicz M, et al
    [OP.8B.07] UTILITY OF SLEEP-POLYGRAPHIC STUDIES IN TERTIARY-CARE HYPERTENSION OUT-PATIENT CLINIC.
    J Hypertens. 2016;34 Suppl 2:e101.
    >> Share

  446. BUGAEV T, Ageeva NV, Dobrovolskiy AB, Litvin AY, et al
    [OP.8B.05] COAGULATION SYSTEM ACTIVITY IN PATIENTS WITH OBSTRUCTIVE SLEEP APNOEA SYNDROME AND ARTERIAL HYPERTENSION.
    J Hypertens. 2016;34 Suppl 2:e101.
    >> Share

  447. BRUNO R, Ghiadoni L, Cervia S, Biancheri R, et al
    [OP.8B.04] GENDER DIFFERENCES IN THE IMPACT OF DYSFUNCTIONAL COPING IN A HYPERTENSIVE POPULATION.
    J Hypertens. 2016;34 Suppl 2:e101.
    >> Share

  448. LOMBARDI C, Parati G, Soranna D, Zambon A, et al
    [OP.8B.01] PERIODIC LIMB MOVEMENT DURING SLEEP, SLEEP RELATED BREATHING DISORDERS AND HYPERTENSION IN THE ESADA COHORT.
    J Hypertens. 2016;34 Suppl 2:e100.
    >> Share

  449. YANNOUTSOS A, Ahouah M, Dreyfuss Tubiana C, Topouchian J, et al
    [OP.1C.08] HEMODYNAMIC PARAMETERS IN HYPERTENSIVE DIABETIC PATIENTS.
    J Hypertens. 2016;34 Suppl 2:e10.
    >> Share

  450. RAYNER B
    SSA 05-4 DIFFERENCES IN MANAGEMENT OF HYPERTENSION BETWEEN ETHNIC GROUPS.
    J Hypertens. 2016;34 Suppl 1:e9.
    >> Share

  451. SCHUTTE A
    SSA 05-3 THE PROGRESSION OF HYPERTENSION IN AFRICA.
    J Hypertens. 2016;34 Suppl 1:e9.
    >> Share

  452. KADIRI S
    SSA 05-2 HYPERTENSION AND KIDNEY COMPLICATION IN AFRICA.
    J Hypertens. 2016;34 Suppl 1:e9.
    >> Share

  453. DAMASCENO A
    SSA 05-1 HYPERTENSION, STEADY BUT CONTINUING CHANGES IN DEVELOPING COUNTRIES.
    J Hypertens. 2016;34 Suppl 1:e9.
    >> Share

  454. WANG W, Ma L, Sui H, Liu L, et al
    OS 12-05 THE EFFECT OF INTENSIVE LIFESTYLE INTERVENTION ON BLOOD PRESSURE IN PATIENTS WITH HYPERTENSION, SUB-ANALYSIS FROM CHIEF.
    J Hypertens. 2016;34 Suppl 1:e77.
    >> Share

  455. KARIO K, Hoshide S
    OS 12-01 ARB AND CCB LONGEST COMBINATION TREATMENT ON AMBULATORY AND HOME BP IN HYPERTENSION WITH ATRIAL FIBRILLATION - MULTICENTER STUDY ON TIME OF DOSING (ACROBAT).
    J Hypertens. 2016;34 Suppl 1:e76.
    >> Share

  456. SOKOLOVIC S, Mehmedagic S
    OS 11-06 The effect of vagus nerve stimulation on arterial hypertension using active implantable device.
    J Hypertens. 2016;34 Suppl 1:e75.
    >> Share

  457. WALAS D, Von Roloff E, Paton J
    OS 11-05 Superior cervical ganglionectomy (SCGx) reduces sympathetic innervation of vertebrobasilar arteries but does not affect cerebrovascular remodelling in the adult spontaneously hypertensive rat (SHR).
    J Hypertens. 2016;34 Suppl 1:e75.
    >> Share

  458. NISHIYAMA A, Hitomi H, Nakano D, Fujisawa Y, et al
    OS 11-03 Role of renal nervous activity in the development of renovascular hypertension in rats.
    J Hypertens. 2016;34 Suppl 1:e74-5.
    >> Share

  459. KIM MN, Kim YB, Park SM, Kim YI, et al
    OS 11-02 Effect of estrogen on the change of GABA function in the vasopressin neurons of salt-dependent hypertension model rats.
    J Hypertens. 2016;34 Suppl 1:e74.
    >> Share

  460. WAINFORD R, Carmichael C, Walsh K
    OS 11-01 Afferent renal nerve modulation of sodium homeostasis and blood pressure: A sodium sensitive PVN Galphai2 protein dependent mechanism countering the development of salt-sensitive hypertension?
    J Hypertens. 2016;34 Suppl 1:e74.
    >> Share

  461. PAULETTO P, Puato M, Rattazzi M, Buso R, et al
    OS 10-06 THE IMPACT OF WELL CONTROLLED BLOOD PRESSURE LEVELS ON ARTERIAL PROPERTIES IN ESSENTIAL HYPERTENSIVES.
    J Hypertens. 2016;34 Suppl 1:e73.
    >> Share

  462. LIU Z, Zhao Y, Dong Y, Lu B, et al
    OS 10-02 EFFECTS OF HELICOBACTER PYLORI INFECTION ON ATHEROSCLEROSIS WITH HYPERTENSION AND TYPE 2 DIABETES MELLITUS IN AGED POPULATION.
    J Hypertens. 2016;34 Suppl 1:e72.
    >> Share

  463. BURSZTYN M, Ben-Dov IZ
    OS 09-03 EXTREME DIPPING IS NOT ASSOCIATED WITH INCREASED MORTALITY IN BOTH TREATED AND UNTREATED HYPERTENSIVES.
    J Hypertens. 2016;34 Suppl 1:e70.
    >> Share

  464. GUO QH, Kang YY, Song J, Chen Q, et al
    OS 09-02 PREVALENCE AND DETERMINANTS OF EXAGGERATED MORNING SURGE AND MORNING HYPERTENSION IN CHINESE: THE CHINA AMBULATORY AND HOME BLOOD PRESSURE REGISTRY (ABPR).
    J Hypertens. 2016;34 Suppl 1:e70.
    >> Share

  465. FAN H, Yan Y, Dong H, Mi J, et al
    OS 09-01 PREVALENCE OF HYPERTENSION AFTER THREE SEPARATE OCCASIONS AMONG CHINESE CHILDREN: A NATIONAL REPRESENTATIVE CROSS-SECTION SURVEY.
    J Hypertens. 2016;34 Suppl 1:e70.
    >> Share

  466. QUINTANA FS
    SSA 04-4 CURRENT STATUS IN MANAGEMENT OF HYPERTENSION IN LATIN AMERICA.
    J Hypertens. 2016;34 Suppl 1:e7-8.
    >> Share

  467. HUANG F, Huang Q, Lin F, Zhu P, et al
    OS 08-02 APELIN AND APLN SINGLE NUCLEOTIDE POLYMORPHISMS AND COMBINED HYPERTENSION AND CENTRAL RETINAL ARTERY STENOSIS IN A CHINESE POPULATION.
    J Hypertens. 2016;34 Suppl 1:e68.
    >> Share

  468. RAZA ST, Abbas S, Mahdi F
    OS 08-01 ASSOCIATION OF ACE, FABP2, PPARG2, GST, FTO AND CYP46A1 GENES POLYMORPHISM WITH ESSENTIAL HYPERTENSION AMONG NORTH INDIAN POPULATION.
    J Hypertens. 2016;34 Suppl 1:e68.
    >> Share

  469. YI JE, Pyun WB, Lee Y, Park J, et al
    OS 07-05 DETERMINANTS OF MORNING BLOOD PRESSURE SURGE IN NORMOTENSIVE SUBJECTS AND UNTREATED HYPERTENSIVE PATIENTS: THE KOREAN AMBULATORY BLOOD PRESSURE MULTICENTER OBSERVATIONAL STUDY.
    J Hypertens. 2016;34 Suppl 1:e66.
    >> Share

  470. MA R, Wang Q, Li N, Zhao Y, et al
    OS 07-04 HOME BLOOD PRESSURE MONITORING IMPROVED SAFETY IN PATIENTS WITH SEVERE HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e66.
    >> Share

  471. KARIO K, Bhatt D, Brar S, Bakris G, et al
    OS 07-02 DIFFERENCES IN CIRCADIAN BLOOD PRESSURE VARIABILITY PATTERNS BETWEEN JAPANESE AND AMERICAN TREATMENT-RESISTANT HYPERTENSIVE POPULATIONS.
    J Hypertens. 2016;34 Suppl 1:e65.
    >> Share

  472. ZHANG DY, Cheng YB, Guo QH, Xu TY, et al
    OS 07-01 SUBTYPES OF MASKED HYPERTENSION AND THEIR ASSOCIATIONS WITH TARGET ORGAN DAMAGE IN UNTREATED CHINESE PATIENTS.
    J Hypertens. 2016;34 Suppl 1:e65.
    >> Share

  473. VAN BALLEGOOIJEN A, Van Schoor N, Brouwer I, Visser M, et al
    OS 06-09 THE SYNERGISTIC ASSOCIATION BETWEEN VITAMIN D AND VITAMIN K WITH INCIDENT HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e64.
    >> Share

  474. BURSZTYN M, Hammerman-Rozenberg A, Jacobs J, Stessman J, et al
    OS 06-06 PREVALENCE AND CONSEQUENCE OF ORTHOSTATIC HYPERTENSION IN COMMUNITY DWELLING 85, AND 90 YEAR OLDS.
    J Hypertens. 2016;34 Suppl 1:e63.
    >> Share

  475. MORE A, Kadam R, Mohite K, Mittal C, et al
    OS 06-05 HEALTHCARE STRUCTURE IN RURAL INDIA AND ITS IMPLICATIONS ON DIAGNOSIS AND MANAGEMENT OF HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e63.
    >> Share

  476. LIU L, Dow J, Simon B, Eisen H, et al
    OS 06-02 MULTIPLE ANTIHYPERTENSIVE MEDICATION USE, RESISTANT HYPERTENSION AND OUTCOMES IN THE UNITED STATES: FINDINGS FROM NHANES 1988 TO 2012.
    J Hypertens. 2016;34 Suppl 1:e62.
    >> Share

  477. MAMUN A
    OS 06-01 DEVELOPMENTAL STAGES OF HYPERTENSION BETWEEN MALES AND FEMALES- ARE THERE DIFFERENT MECHANISMS?
    J Hypertens. 2016;34 Suppl 1:e62.
    >> Share

  478. KIM S, Wang G, Lobaton G, Li E, et al
    OS 05-10 THE MICROBIAL METABOLITE, BUTYRATE ATTENUATES ANGIOTENSIN II-INDUCED HYPERTENSION AND DYSBIOSIS.
    J Hypertens. 2016;34 Suppl 1:e60-1.
    >> Share

  479. MAYOROV D, Kasparov S, Paton J
    OS 05-09 REDUCED VASODILATOR EFFICIENCY OF ADENOSINE IN THE BRAINSTEM OF YOUNG SPONTANEOUSLY HYPERTENSIVE RATS.
    J Hypertens. 2016;34 Suppl 1:e60.
    >> Share

  480. NEZU M, Souma T, Yu L, Sekine H, et al
    OS 05-05 Nrf2 DEFICIENCY ALLEVIATES PERINATAL COMPLICATIONS IN PREGNANCY-ASSOCIATED HYPERTENSION MICE VIA ENHANCING PLACENTAL ANGIOGENESIS.
    J Hypertens. 2016;34 Suppl 1:e59.
    >> Share

  481. ABASSI Z, Leor J, Landa N, Younis F, et al
    OS 05-04 EMPAGLIFLOZIN EXERTS CARDIO- AND NEPHRO-PROTECTIVE EFFECTS IN COHEN-ROSENTHAL DIABETIC HYPERTENSIVE RATS.
    J Hypertens. 2016;34 Suppl 1:e58-9.
    >> Share

  482. ZICHA J, Behuliak M, Vaneckova I
    OS 05-03 DECREASED RHO-KINASE-BASED CALCIUM SENSITIZATION IN HYPERTENSIVE REN-2 TRANSGENIC RATS (TGR).
    J Hypertens. 2016;34 Suppl 1:e58.
    >> Share

  483. ZHU W, Li J, Sun X, Hua Q, et al
    OS 05-02 ASSOCIATION OF G-PROTEIN BETA3 SUBUNIT GENE C825T POLYMORPHISM WITH CARDIAC AND CEREBROVASCULAR EVENTS IN CHINESE HYPERTENSIVE PATIENTS.
    J Hypertens. 2016;34 Suppl 1:e58.
    >> Share

  484. KOKKINOS P, Puneet N, Apostolos T, Michael D, et al
    OS 04-09 CARDIORESPIRATORY FITNESS AND RISK FOR DEVELOPING HEART FAILURE IN HYPERTENSIVES.
    J Hypertens. 2016;34 Suppl 1:e57.
    >> Share

  485. SINNOTT SJ, Root A, Mathur R, Mansfield K, et al
    OS 04-07 THE COMPARATIVE EFFECTIVENESS OF 4TH LINE ANTI-HYPERTENSIVE AGENTS IN PATIENTS WITH RESISTANT HYPERTENSION: A META-ANALYSIS.
    J Hypertens. 2016;34 Suppl 1:e56-7.
    >> Share

  486. MEENA J, Raghav P, Rustagi N
    LBOS 03-06 ANTI HYPERTENSIVE TREATMENT COMPLIANCE AND ADVERSE EFFECT PROFILE AMONG HYPERTENSION CLINIC ATTENDEES IN JODHPUR, INDIA.
    J Hypertens. 2016;34 Suppl 1:e552.
    >> Share

  487. KOHLI C, Gupta K
    LBOS 03-03 ECONOMIC IMPACT OF HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e551-2.
    >> Share

  488. KARAMAT F, Diemer F, Baldew S, Oehlers G, et al
    LBOS 03-02 PREHYPERTENSION AND HYPERTENSION IN URBAN SURINAME: THE HELISUR STUDY.
    J Hypertens. 2016;34 Suppl 1:e551.
    >> Share

  489. YUSUFALI A, Khatib R, Islam S, AlHabib K, et al
    LBOS 03-01 PREVALENCE, AWARENESS, TREATMENT, AND CONTROL OF HYPERTENSION IN THE MIDDLE EAST: RESULTS FROM THE PROSPECTIVE URBAN RURAL EPIDEMIOLOGY (PURE) STUDY.
    J Hypertens. 2016;34 Suppl 1:e551.
    >> Share

  490. DEY SK, Prabhakar P, Saini M, Joseph T, et al
    LBOS 02-05 INHIBITORS OF DOPAMINE-beta-HYDROXYLASE OBTAINED BY STRUCTURE BASED METHODS EXHIBITED ANTI-HYPERTENSIVE EFFECT IN L-NAME INDUCED HYPERTENSIVE RATS.
    J Hypertens. 2016;34 Suppl 1:e550.
    >> Share

  491. CRIPPA G, Zabzuni D, Bravi E, Rossi F, et al
    OS 04-04 ANTIHYPERTENSIVE EFFECT OF MILK-DERIVATIVE TRIPEPTIDES. RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY ON THE EFFECTS OF GRANA PADANO CHEESE DOP IN HYPERTENSIVE PATIENTS.
    J Hypertens. 2016;34 Suppl 1:e55-6.
    >> Share

  492. LIU D
    LBOS 02-02 TELMISARTAN REDUCING MONOCYTE MITOCHONDRIA RESPIRATORY FUNCTION IS ASSOCIATED WITH INHIBITION OF TRANSIENT RECEPTOR POTENTIAL CHANNEL CANONICAL TYPE 3 CHANNELS IN HYPERTENSIVE RATS.
    J Hypertens. 2016;34 Suppl 1:e549.
    >> Share

  493. TAO J
    LBOS 02-01 HYPERTENSION, ALDOSTERONE AND EPC-MEDIATED ENDOTHALIAL INJURY REPAIR.
    J Hypertens. 2016;34 Suppl 1:e549.
    >> Share

  494. VILLEVALDE S, Kobalava Z
    LBOS 01-06 INTEGRATED APPROACH IMPROVED BLOOD PRESSURE CONTROL IN NON ADHERENT MOTIVATED HYPERTENSIVE PATIENTS: PRISMA STUDY.
    J Hypertens. 2016;34 Suppl 1:e548.
    >> Share

  495. CHO EJ, Lee HY, Sung KC, Park S, et al
    LBOS 01-05 24-HOUR CENTRAL BLOOD PRESSURE REDUCTION EFFICACY OF CALCIUM CHANNEL BLOCKER COMBINATION IS SUPERIOR TO DIURETICS COMBINATION WITH ANGIOTENSIN II RECEPTOR BLOCKER ESPECIALLY IN MALE HYPERTENSIVE PATIENTS.
    J Hypertens. 2016;34 Suppl 1:e548.
    >> Share

  496. SEVER P, Gupta A, Thompson D, Whitehouse A, et al
    LBOS 01-04 THE TRUE INCIDENCE OF STATIN -RELATED ADVERSE EVENTS IN HYPERTENSIVE PATIENTS REVEALED BY COMPARISON OF BLINDED AND UN-BLINDED USE OF STATIN IN THE ANGLO-SCANDINAVIAN CARDIAC OUTCOMES TRIAL (ASCOT).
    J Hypertens. 2016;34 Suppl 1:e547-8.
    >> Share

  497. VILLEVALDE S, Kovbalava Z
    LBOS 01-03 MICROALBUMINURIA IS THE MOST INTEGRATED SIGN OF SUBCLINICAL ORGAN DAMAGE IN UNCOMPLICATED HYPERTENSIVE PATIENTS.
    J Hypertens. 2016;34 Suppl 1:e547.
    >> Share

  498. MARCUS Y, Haran A, Shefer G, Stern N, et al
    LBOS 01-02 CLUSTERING OF SILENT HYPOTENSIVE EPISODES IN THE MORNING/LATE-MORNING HOURS IN SUBJECTS TREATED FOR HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e547.
    >> Share

  499. POULTER N, Anjum A, Cross M, Falaschetti E, et al
    LBOS 01-01A COMPARISON OF THE IMPACT OF MORNING OR NIGHT DELIVERY OF ANTIHYPERTENSIVE AGENTS ON 24 HOUR ABPM LEVELS: A RANDOMISED CROSS-OVER TRIAL (HARMONY).
    J Hypertens. 2016;34 Suppl 1:e547.
    >> Share

  500. MUTHUSAMY VV
    BR 08-3 MANAGEMENT OF DYSLIPIDEMIA IN HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e545.
    >> Share

  501. PARK J
    BR 08-2 CARDIOVASCULAR RISK ASSESSMENT IN HYPERTENSIVES WITH CKD.
    J Hypertens. 2016;34 Suppl 1:e544-5.
    >> Share

  502. ZHU Z
    BR 08-1 HIGH SODIUM INTAKE REDUCTION IN DIABETES WITH HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e544.
    >> Share

  503. PARK JB
    ME 04-2 AORTIC PWV FOR RISK STRATIFICATION IN HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e541.
    >> Share

  504. ZHANG P, Sun N, Wang H, Sun L, et al
    OS 03-08 EFFICACY OF TELMISARTAN 40 MG (T40) AND HYDROCHLOROTHIAZIDE 25 MG (H25) MONOTHERAPY IN HIGH SODIUM INTAKE PATIENTS WITH MILD TO MODERATE HYPERTENSION (THAT STUDY): A MULTICENTER RANDOMIZED DOUBLE-BLINDED PARALLEL CONTROLLED TRIAL.
    J Hypertens. 2016;34 Suppl 1:e54.
    >> Share

  505. KIM SH
    HW 03-2 EFFECT OF CPAP ON THE TREATMENT OF RESISTANT HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e538.
    >> Share

  506. KIM BK
    HW 03-1 RENAL SYMPATHETIC DENERVATION FOR RESISTANT HYPERTENSION UNDER OPTIMAL DRUG THERAPY.
    J Hypertens. 2016;34 Suppl 1:e538.
    >> Share

  507. RAIZADA M
    SY 17-4 NEURO-IMMUNE COMMUNICATION IN HYPERTENSION: A NEW THERAPEUTIC ANGLE?
    J Hypertens. 2016;34 Suppl 1:e535.
    >> Share

  508. HARRISON D
    SY 17-2 INFLAMMATION, IMMUNITY AND HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e535.
    >> Share

  509. VAN BALLEGOOIJEN A
    SY 16-4 VITAMIN D WITH OR WITHOUT CALCIUM SUPPLEMENTATION IN RELATION TO HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e534.
    >> Share

  510. TURANA Y
    SSA 03-4 THE BRAIN SCREENING IN PATIENTS WITH HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e5.
    >> Share

  511. OH VM
    SSA 03-3 DIETARY SALT INTAKE AND HYPERTENSION IN SINGAPORE.
    J Hypertens. 2016;34 Suppl 1:e5.
    >> Share

  512. WANG Q, Euy-Myoung J, Liu H, Gu L, et al
    OS 02-04 ASTRAGALOSIDE IV IMPROVES LEFT VENTRICULAR DIASTOLIC DYSFUNCTION IN HYPERTENSIVE MICE BY INCREASING THE PHOSPHORYLATION OF ENDOTHELIAL NITRIC OXIDE SYNTHASE.
    J Hypertens. 2016;34 Suppl 1:e48-9.
    >> Share

  513. HARVEY AP, Montezano A, Wong KC, Hood KY, et al
    OS 02-01 ROLE OF ALDOSTERONE AND NADPH OXIDASE 1 IN HYPERTENSION-ASSOCIATED VASCULAR AGING.
    J Hypertens. 2016;34 Suppl 1:e48.
    >> Share

  514. PARK SH, Park CG, Na JO, Choi CU, et al
    OS 01-08 IMPACT OF HYPERTENSION TREATMENT ON IMMUNOSENESCENCE PARAMETERS.
    J Hypertens. 2016;34 Suppl 1:e46.
    >> Share

  515. SUNG KC
    OS 01-06 LOW GRADE ALBUMINURIA IS A PREDICTOR OF INCIDENT HYPERTENSION AND CARDIOVASCULAR MORTALITY BUT IS NOT A PREDICTOR OF INCIDENT TYPE 2 DIABETES.
    J Hypertens. 2016;34 Suppl 1:e45-6.
    >> Share

  516. KWON A, Chung WB, Kim TH, Suh SM, et al
    OS 01-05 HIGH ALDOSTERONE-RENIN RATIO (ARR) IS ASSOCIATED WITH THE DEVELOPMENT OF ESSENTIAL HYPERTENSION FROM WHITE COAT HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e45.
    >> Share

  517. SONG SK, Lee SR, Jung LY, Kim YS, et al
    OS 01-04 WHOLE BLOOD VISCOSITY WAS ELEVATED IN PATIENTS WITH BOTH HYPERTENSION AND ACUTE CORONARY SYNDROME.
    J Hypertens. 2016;34 Suppl 1:e45.
    >> Share

  518. KIM DO Y, Choi SW, Han SW, Youn JC, et al
    OS 01-03 NEUTROPHIL TO LYMPHOCYTE RATIO IS CLOSELY RELATED WITH BLOOD PRESSURE LEVEL IN HYPERTENSIVE INDIVIDUALS WITHOUT CARDIOVASCULAR DISEASES; DATA FROM THE KOREAN REGISTRY OF TARGET ORGAN DAMAGES IN HYPERTENSION (KorHR).
    J Hypertens. 2016;34 Suppl 1:e44-5.
    >> Share

  519. MALYSZKO J, Musialowska D, Zbroch E, Koc-Zorawska E, et al
    OS 01-02 ENDOCAN LEVEL IN ESSENTIAL HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e44.
    >> Share

  520. WANG Y, Zhang J, Qian Y, Tang X, et al
    OS 01-01 ASSOCIATION OF Lp-PLA2 MASS AND AYSMPTOMATIC INTRACRANIAL AND EXTRACRANIAL ARTERIAL STENOSIS IN HYPERTENSION PATIENTS.
    J Hypertens. 2016;34 Suppl 1:e44.
    >> Share

  521. WALAS D, Nowicki-Osuch K, Alibhai D, Paton J, et al
    ISH NIA OS-06 PUTATIVE MECHANISMS FOR CEREBROVASCULAR REMODELLING IN THE SPONTANEOUSLY HYPERTENSIVE RAT (SHR) USING TRANSCRIPTOMICS.
    J Hypertens. 2016;34 Suppl 1:e43.
    >> Share

  522. PIJACKA W, McBryde F, Ford AP, Paton JF, et al
    ISH NIA OS-04 P2X3 RECEPTOR ACTIVITY IN THE CAROTID BODY (CB) OF SPONTANEOUSLY HYPERTENSIVE (SH) RATS CONTRIBUTES TO INCREASED CHEMOREFLEX HYPERSENSITIVITY AND HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e42-3.
    >> Share

  523. TIMASHEVA Y, Nasibullin T, Imaeva E, Mirsaeva G, et al
    ISH NIA OS-03 GENETIC DETERMINANTS OF ESSENTIAL HYPERTENSION IN THE POPULATION OF TATARS FROM RUSSIA.
    J Hypertens. 2016;34 Suppl 1:e42.
    >> Share

  524. AZEGAMI T, Yuki Y, Hayashi K, Nakamura M, et al
    ISH NIA OS-02 ATTENUATION OF HYPERTENSION BY LESS-INVASIVE INTRANASAL VACCINATION AGAINST ANGIOTENSIN II TYPE 1 RECEPTOR IN SPONTANEOUSLY HYPERTENSIVE RATS.
    J Hypertens. 2016;34 Suppl 1:e42.
    >> Share

  525. XU T, Sun J, Lee AP, Yang Y, et al
    OS 37-09 LAYER-SPECIFIC QUANTIFICATION OF MYOCARDIAL DEFORMATION MAY DISCLOSE THE SUBCLINICAL SYSTOLIC DYSFUNCTION AND THE MECHANISM OF RESERVED EJECTION FRACTION IN PATIENTS WITH HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e407.
    >> Share

  526. KIM D, Shim CY, Hong GR, Cho IJ, et al
    OS 37-08 ASSOCIATION OF CENTRAL HEMODYNAMICS AND NEUROHORMONAL FACTORS TO MECHANICAL ADAPTATION OF LEFT VENTRICLE IN HYPERTENSION: A STUDY WITH TWO DIMENSIONAL LAYER SPECIFIC SPECKLE TRACKING STRAIN IMAGING.
    J Hypertens. 2016;34 Suppl 1:e407.
    >> Share

  527. LIM HM, Chia YC, Ching SM
    OS 37-05 LONG-TERM VISIT-TO-VISIT VARIABILITY OF SYSTOLIC BLOOD PRESSURE AND DECLINE IN RENAL FUNCTION IN HYPERTENSIVE PATIENTS OVER 15 YEARS.
    J Hypertens. 2016;34 Suppl 1:e406.
    >> Share

  528. CHO KI, Cho EA, Heo JH, Kim HS, et al
    OS 37-04 EFFECTS OF WHITE COAT HYPERTENSION ON HEART RATE RECOVERY AND BLOOD PRESSURE RESPONSE DURING EXERCISE TESTING.
    J Hypertens. 2016;34 Suppl 1:e406.
    >> Share

  529. LEE JY, Sung KC
    OS 37-03 IMPACT OF CHANGE IN EXERCISE DOSE ON RISK OF NEWLY DEVELOPED HYPERTENSION AND DIABETES MELLITUS IN KOREAN MEN.
    J Hypertens. 2016;34 Suppl 1:e405-6.
    >> Share

  530. AMUSA G, Awokola B, Isiguzo G, Onuh J, et al
    OS 37-02 HYPERTENSION IN HIV-INFECTED ADULTS IN NORTH-CENTRAL NIGERIA: PREVALENCE, ASSOCIATED RISK FACTORS AND ASSESSMENT OF RISK USING THE FRAMINGHAM RISK SCORE.
    J Hypertens. 2016;34 Suppl 1:e405.
    >> Share

  531. KONG L, Ruan C, Gao P
    OS 36-08 A2A RECEPTOR-MEDIATED ACTIVATION OF REGULATORY T CELLS ATTENUATES HYPERTENSION-INDUCED CARDIOVASCULAR INJURY.
    J Hypertens. 2016;34 Suppl 1:e404.
    >> Share

  532. ZHONG JC, Zhang ZZ, Xu R, Chen LJ, et al
    OS 36-07 TREATMENT WITH APELIN-13 PREVENTS PRESSURE OVERLOAD-INDUCED AORTIC ADVENTITIAL REMODELING AND FIBROSIS IN HYPERTENSIVE RATS WITH TAC.
    J Hypertens. 2016;34 Suppl 1:e403-4.
    >> Share

  533. ZUO C
    OS 36-06 OSTEOGLYCIN INHIBITS HYPERTENSIVE CARDIAC FIBROSIS THOUGH SUPPRESSION OF EGFR SIGNALING.
    J Hypertens. 2016;34 Suppl 1:e403.
    >> Share

  534. WANG Q, Chang P, Xu H, Bai F, et al
    OS 36-05 TETRAHYDROBIOPTERIN REVERSE LEFT VENTRICULAR HYPERTROPHY AND DIASTOLIC DYSFUNCTION THROUGH THE PI3K/p-Akt PATHWAY IN SPONTANEOUSLY HYPERTENSIVE RATS.
    J Hypertens. 2016;34 Suppl 1:e403.
    >> Share

  535. WANG Q, Xie A, Xu H, Yu J, et al
    OS 36-02 ASTRAGALOSIDE IV AMELIORATED MITOCHONDRIAL OXIDATIVE STRESS IN HYPERTENSIVE MICE WITH CARDIOMYOPATHY BY REGULATING MITOCHONDRIAL Ca2+ FLUX.
    J Hypertens. 2016;34 Suppl 1:e402.
    >> Share

  536. MAIOLINO G, Flego A, Rossi GP
    OS 35-09 LONG-TERM OUTCOME OF SURGICALLY- AND MEDICALLY-TREATED PATIENTS OF THE PRIMARY ALDOSTERONISM PREVALENCE IN HYPERTENSIVES (PAPY) STUDY.
    J Hypertens. 2016;34 Suppl 1:e401.
    >> Share

  537. XU J, Ge Q, Zhang J, Zhu L, et al
    OS 35-06 COMPARISON OF N-TERMINAL PRO-B-TYPE NATRIURETIC PEPTIDE LEVEL IN PRIMARY ALDOSTERONISM AND ESSENTIAL HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e401.
    >> Share

  538. POGLITSCH M, Ahmed AH, Resl M, Stoller A, et al
    OS 35-04 THE AA2-RATIO: TOWARDS IMPROVED SCREENING FOR PRIMARY ALDOSTERONISM IN HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e400.
    >> Share

  539. RIPP T, Mordobin V, Ripp E, Semke G, et al
    ISH ADA-05 THE NEW TECHNOLOGY AND CLASSIFICATION FOR THE ARTERIES REACTIVITY IN PATIENTS WITH HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e40.
    >> Share

  540. CHIA YC
    SSA 03-2 PREVALENCE AND PREDICTORS OF RESISTANT HYPERTENSION IN SOUTHEAST ASIA.
    J Hypertens. 2016;34 Suppl 1:e4-5.
    >> Share

  541. CASTILLO R
    SSA 03-1 PREVALENCE AND MANAGEMENT OF HYPERTENSION IN SOUTHEAST ASIA.
    J Hypertens. 2016;34 Suppl 1:e4.
    >> Share

  542. RYUNO H, Kamide K, Gondo Y, Kabayama M, et al
    OS 34-01 ASSOCIATION OF COMBINATION OF HYPERTENSION AND DIABETES WITH COGNITIVE FUNCTION AMONG THE 70-YEARS-OLD JAPANESE GENERAL POPULATION FROM LONGITUDINAL OBSERVATION IN THE SONIC STUDY.
    J Hypertens. 2016;34 Suppl 1:e396.
    >> Share

  543. WANG H, Chen H
    OS 33-09 ASSOCIATION OF CLOCK GENE POLYMORPHISM WITH INSULIN RESISTANCE IN HYPERTENSION: A CASE-CONTROL STUDY.
    J Hypertens. 2016;34 Suppl 1:e395.
    >> Share

  544. CAI A, Wang L, Zhou Y, Chen J, et al
    OS 33-08 OBSTRUCTIVE SLEEP APNEA PROMOTES CARDIOVASCULAR RISK IN HYPERTENSIVE POPULATIONS: A CROSS-SECTIONAL STUDY.
    J Hypertens. 2016;34 Suppl 1:e395.
    >> Share

  545. TANAKA M, Nishimura T, Sekioka R, Kawai T, et al
    OS 33-07 LOW SERUM ALBUMIN CONCENTRATION IN HYPERTENSIVE PATIENTS COMPLICATED BY TYPE 2 DIABETES IS ASSOCIATED WITH MICROVASCULAR COMPLICATIONS.
    J Hypertens. 2016;34 Suppl 1:e394-5.
    >> Share

  546. OGOLA E
    OS 33-05 HIGH PREVALENCE AND POOR CONTROL OF HYPERTENSION AND ASSOCIATED CARDIOVASCULAR RISK FACORS IN DIABETIC PATIENTS IN A RURAL HOSPITAL IN KENYA.
    J Hypertens. 2016;34 Suppl 1:e394.
    >> Share

  547. OPARIL S, Calhoun DA, Ghazi L, Dudenbostel T, et al
    OS 33-02 IN PATIENTS WITH RESISTANT HYPERTENSION INCREASED 24-H URINARY CORTISOL LEVEL PREDICT INCREASED BODY MASS INDEX.
    J Hypertens. 2016;34 Suppl 1:e393.
    >> Share

  548. PENG L, Xia K, Zhao Z, Li D, et al
    OS 32-09 THE BENEFICIAL EFFECT OF LOSARTAN ON PLATELET AGGREGATION RESULTS FROM THE REDUCTION OF ENDOGENOUS ASYMMETRIC DIMETHYL ARGININE IN SPONTANEOUSLY HYPERTENSIVE RATS.
    J Hypertens. 2016;34 Suppl 1:e391-2.
    >> Share

  549. YANG Z, Ruixin M, Jing Y
    OS 32-02 EFFECTS OF RENIN-ANGIOTENSIN SYSTEM INHIBITORS ON VAGINA AND CARDIAC EXPRESSION OF RAAS COMPONENTS IN FEMALE SPONTANEOUSLY HYPERTENSIVE RATS.
    J Hypertens. 2016;34 Suppl 1:e390.
    >> Share

  550. JHEE JH, Yoo TH, Jung SY, Kee YK, et al
    ISH ADA-03 ADEQUATELY CONTROLLED SYSTOLIC BLOOD PRESSURE IS SIGNIFICANTLY ASSOCIATED WITH BETTER SURVIVAL RATE, IRRESPECTIVE OF NUMBER OF ANTIHYPERTENSIVE AGENTS IN PREVALENT DIALYSIS PATIENTS.
    J Hypertens. 2016;34 Suppl 1:e39-40.
    >> Share

  551. CHEN X, Wang S, Li J, Zhou X, et al
    OS 31-06 COMPARISON BETWEEN THE EFFECTS OF HYDROCHLOROTHIAZIDE AND INDAPAMIDE ON THE KIDNEY IN HYPERTENSIVE PATIENTS INADEQUATELY CONTROLLED WITH LOSARTAN.
    J Hypertens. 2016;34 Suppl 1:e389.
    >> Share

  552. SEUNG-WOON R, Geol CB, Hu L, Oh NJ, et al
    OS 31-04 COMPARISON OF CALCIUM CHANNEL BLOCKERS VERSUS CALCIUM CHANNEL BLOCKERS WITH RENIN ANGIOTENSIN SYSTEM BLOCKERS ON THE DEVELOPMENT OF NEW-ONSET DIABETES MELLITUS IN HYPERTENSIVE PATIENTS.
    J Hypertens. 2016;34 Suppl 1:e388-9.
    >> Share

  553. GIULIETTI F, Spannella F, Borioni E, Lombardi FE, et al
    OS 31-03 CLINICAL EFFECTIVENESS OF ANTI-HYPERTENSIVE THERAPY WITH ACEI OR ARB ASSESSED BY PLASMA RENIN ACTIVITY/PLASMA ALDOSTERONE CONCENTRATION RATIO.
    J Hypertens. 2016;34 Suppl 1:e388.
    >> Share

  554. ZENG W, Chu T, Hu M, Kong A, et al
    OS 31-02 ANTIHYPERTENSIVE RESPONSE TO BISOPROLOL WAS NOT RELATED TO POLYMORPHISMS IN ADRB1 Or CYP2D6 IN CHINESE HYPERTENSIVE PATIENTS.
    J Hypertens. 2016;34 Suppl 1:e388.
    >> Share

  555. KIM CH
    APSH PRE-1 WHAT CAN BE IMPROVED IN THE MANAGEMENT OF HYPERTENSION?
    J Hypertens. 2016;34 Suppl 1:e387.
    >> Share

  556. KANG YY, Li Y, Huang QF, Song J, et al
    APSH YI-05 CIGARETTE SMOKING AND MASKED HYPERTENSION IN CHINESE MEN.
    J Hypertens. 2016;34 Suppl 1:e386.
    >> Share

  557. LEE CJ, Oh J, Lee SH, Kang SM, et al
    APSH YI-01 EFFECTS OF DIFFERENT CLASSES OF ANTI-HYPERTENSIVE AGENTS ON SURVIVAL IN PATIENTS WITH UNCOMPLICATED HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e385.
    >> Share

  558. TOUYZ RM
    ISH PRE-2 THE VASCULAR PHENOTYPE IN HYPERTENSION - MOLECULAR MECHANISMS AND CLINICAL IMPLICATIONS.
    J Hypertens. 2016;34 Suppl 1:e384.
    >> Share

  559. SAFAR ME
    ISH PRE-1 REDUCTION OF CARDIOVASCULAR MORTALITY IN HYPERTENSIVES WITH COMORBIDITIES: BEYOND BLOOD PRESSURE LOWERING - THE ROLE OF ARTERIAL AGING.
    J Hypertens. 2016;34 Suppl 1:e384.
    >> Share

  560. POGLITSCH M
    JS ISH-ECCR-4 THE PLASMA ALDOSTERONE / ANGIOTENSIN II RATIO FOR THE SCREENING OF SECONDARY HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e382-3.
    >> Share

  561. ROSSI GP
    JS ISH-ECCR-3 A NOVEL ALGORITHM FOR THE CASE DETECTION OF THE MOST COMMON FORM OF ENDOCRINE HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e382.
    >> Share

  562. FUJITA T
    ME 03-1 ROLE OF ALDOSTERNE AND MINERALOCORTICOID RECEPTOR IN SALT-SENSITIVE HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e379.
    >> Share

  563. WHELTON P
    SP 05-1 SHOULD THE TARGET FOR BLOOD PRESSURE REDUCTION BE LOWER IN ADULTS WITH HYPERTENSION AND A HISTORY OF CARDIOVASCULAR DISEASE.
    J Hypertens. 2016;34 Suppl 1:e378.
    >> Share

  564. BAKRIS G
    DB 03-2 RENAL SYMPATHETIC DENERVATION IS STILL A VIABLE OPTION FOR TREATING RESISTANT HYPERTENSION (CON).
    J Hypertens. 2016;34 Suppl 1:e375.
    >> Share

  565. SCHLAICH M
    DB 03-1 RENAL SYMPATHETIC DENERVATION IS STILL A VIABLE OPTION FOR TREATING RESISTANT HYPERTENSION (PRO).
    J Hypertens. 2016;34 Suppl 1:e375.
    >> Share

  566. SHI L
    ED 08-4 DIAGNOSIS AND TREATMENT OF HYPERTENSIVE EMERGENCY IN CHILDREN.
    J Hypertens. 2016;34 Suppl 1:e373-4.
    >> Share

  567. AWAZU M
    ED 08-3 APPLICATION OF ABP MONITORING IN THE MANAGEMENT OF PEDIATRIC HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e373.
    >> Share

  568. DAVIES PF, Manduchi E, Stoeckert CJ, Jiang YZ, et al
    SY 15-2 ENDOTHELIAL EPIGENETICS AND ITS ROLE IN MEDIATING BIOMECHANICAL STRESS OF HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e371.
    >> Share

  569. SCHIFFRIN E
    SY 15-1 MECHANISM OF ENDOTHELIN-1 REGULATION IN HYPERTENSION: THE ROLE OF ENDOTHELIN TYPE A RECEPTORS.
    J Hypertens. 2016;34 Suppl 1:e371.
    >> Share

  570. TSIMPLOULIS A, Doumas M, Pittaras A, Faselis C, et al
    YIA 01-06 CARDIORESPIRATORY FITNESS AND MORTALITY RISK IN HYPERTENSIVE MEN >/=70 YEARS.
    J Hypertens. 2016;34 Suppl 1:e37-8.
    >> Share

  571. MORISHITA R
    SY 14-4 VACCINE THERAPY FOR RESISTANT HYPERTENSION: IS IT A DYING ISSUE?
    J Hypertens. 2016;34 Suppl 1:e369-70.
    >> Share

  572. CALHOUN D
    SY 14-3 PRIMARY ALDOSTERONISM IN RESISTANT HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e369.
    >> Share

  573. VONGPATANASIN W
    SY 14-1 THERAPEUTIC DRUG MONITORING FACILITATES BLOOD PRESSURE CONTROL IN RESISTANT HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e369.
    >> Share

  574. DANIELS SR
    SY 13-2 LONG-TERM CARDIOVASCULAR RISK REDUCTION IN PEDIATRIC HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e368.
    >> Share

  575. BURRELL L
    SY 12-1 RENIN ANGIOTENSIN PATHWAY BEYOND ACE AND ANGIOTENSIN II RECEPTORS: HOW IT RELATES TO THE PATHOPHYSIOLOGY OF HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e367.
    >> Share

  576. RYAN MJ
    SY 11-4 CONNECTIVE TISSUE DISEASE AND ITS ASSOCIATION WITH ARTERIAL HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e366.
    >> Share

  577. OPARIL S
    SY 11-3 HYPERTENSION IN WOMEN: MORE DANGEROUS THAN IN MEN?
    J Hypertens. 2016;34 Suppl 1:e366.
    >> Share

  578. KJELDSEN S
    PL 03-3 THE FUTURE DEVELOPMENT OF DRUG THERAPY FOR HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e365.
    >> Share

  579. IMAI Y
    PL 03-2 REMOTE BLOOD PRESSURE MONITORING IN HYPERTENSION CARE: PRACTICE OF HYPERTENSION BY TELETRANSMISSION OF HOME BLOOD PRESSURE.
    J Hypertens. 2016;34 Suppl 1:e364-5.
    >> Share

  580. STEINHUBL S
    PL 03-1 HYPERTENSION MANAGEMENT IN THE ERA OF DIGITAL INFORMATION AND COMMUNICATION TECHNOLOGIES.
    J Hypertens. 2016;34 Suppl 1:e364.
    >> Share

  581. KUWABARA M, Hoshide S, Hamasaki H, Shiga T, et al
    YIA 01-04 HYPOXIA-INDUCED SURGE NOCTURNAL HYPERTENSION IDENTIFIED BY OXYGEN-TRIGGERED NOCTURNAL BLOOD PRESSURE MONITORING IN SLEEP APNEA SYNDROME.
    J Hypertens. 2016;34 Suppl 1:e36-7.
    >> Share

  582. LEE HY, Park CS, Na SH, Kim KJ, et al
    ISH AHA-2 A CASE OF CHRONIC INDOLENT PHEOCHROMOCYTOMA WHICH CAUSED MEDICALLY-CONTROLLED HYPERTENSION BUT TREATMENT-RESISTANT DIABETES MELLITUS.
    J Hypertens. 2016;34 Suppl 1:e35.
    >> Share

  583. LEE CJ, Woo Y, Kim BK, Yoon KB, et al
    ISH AHA-1 A CASE OF REFRACTORY HYPERTENSION CONTROLLED BY REPEATED RENAL DENERVATION AND CELIAC PLEXUS BLOCK: A CASE OF REFRACTORY SYMPATHETIC OVERLOAD.
    J Hypertens. 2016;34 Suppl 1:e35.
    >> Share

  584. PARK JB
    POA 02-4 BLOOD PRESSURE BEHAVIORS APPROACH FOR HYPERTENSION MANAGEMENT.
    J Hypertens. 2016;34 Suppl 1:e33-4.
    >> Share

  585. TOUYZ RM
    POA 02-3 SMALL VESSEL DISEASE AND HYPERTENSION - MOLECULAR MECHANISMS AND CLINICAL IMPLICATIONS.
    J Hypertens. 2016;34 Suppl 1:e33.
    >> Share

  586. AVOLIO A
    POA 02-2 ATHEROGENIC VASCULAR STIFFNESS AND HYPERTENSION: CAUSE OR EFFECT?
    J Hypertens. 2016;34 Suppl 1:e33.
    >> Share

  587. DOMINICZAK AF
    POA 02-1 GENETIC BASIS OF BLOOD PRESSURE AND HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e33.
    >> Share

  588. LI Y
    CHL 01-3 MORNING AND NOCTURNAL HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e31.
    >> Share

  589. CHEN CH
    CHL 01-2 CENTRAL HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e31.
    >> Share

  590. STERN N
    BR 02-2 HYPERTENSION MANAGEMENT IN CANCER PATIENTS UNDERGOING CHEMOTHERAPY.
    J Hypertens. 2016;34 Suppl 1:e30.
    >> Share

  591. KIM YJ
    BR 02-1 MANAGEMENT OF HYPERTENSION IN SEVERE AORTIC STENOSIS.
    J Hypertens. 2016;34 Suppl 1:e30.
    >> Share

  592. KARIO K
    ME 01-2 ASSESSMENT AND TREATMENT OF MORNING HYPERTENSION: UPDATE.
    J Hypertens. 2016;34 Suppl 1:e29.
    >> Share

  593. SATOH F
    SP 01-2 HYPERTENSIVE TARGET ORGAN DAMAGE IN PRIMARY ALDOSTERONISM.
    J Hypertens. 2016;34 Suppl 1:e28.
    >> Share

  594. FUJITA T
    SP 01-1 ALDOSTERONE ANTAGONISTS FOR THE TREATMENT OF HYPERTENSIVE NEPHROPATHY.
    J Hypertens. 2016;34 Suppl 1:e28.
    >> Share

  595. SHIRAI K
    HW 01-4 CARDIOANKLE VASCULAR INDEX (CAVI) IN HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e27.
    >> Share

  596. LEE SC
    HW 01-3 CARDIAC AND VASCULAR MRI IN HYPERTENSION EVALUATION.
    J Hypertens. 2016;34 Suppl 1:e27.
    >> Share

  597. JAMERSON K
    DB 01-1 RACIAL AND ETHNIC DIFFERENCES EXIST IN TERMS OF EFFICACY OF DIFFERENT CLASSES OF ANTI-HYPERTENSIVE MEDICATIONS (PRO).
    J Hypertens. 2016;34 Suppl 1:e26.
    >> Share

  598. SUGIURA T, Takase H, Murai S, Yamashiya S, et al
    OS 30-04 FUTURE HYPERTENSION CAN BE PREDICTED USING ELECTROCARDIOGRAM.
    J Hypertens. 2016;34 Suppl 1:e255-6.
    >> Share

  599. GAFAROV V, Gromova E, Panov D, Gagulin I, et al
    OS 30-03 GENDER DIFFERENCES OF AN ARTERIAL HYPERTENSION RISK IN POPULATION WITH SLEEP DISTURBANCE IN RUSSIA / SIBERIA: WHO PROGRAM MONICA-PSYCHOSOCIAL.
    J Hypertens. 2016;34 Suppl 1:e255.
    >> Share

  600. DENTON K, Moritz K, Booth L, May C, et al
    OS 29-06 RESPONSE TO HEMORRHAGE FOLLOWING CATHETER-BASED RENAL DENERVATION IN SHEEP WITH HYPERTENSIVE KIDNEY DISEASE.
    J Hypertens. 2016;34 Suppl 1:e254.
    >> Share

  601. LI X, Hong M, Zhu D, Gao P, et al
    OS 29-05 RENAL DENERVATION ATTENUATES ALDOSTERONE EXPRESSION AND ASSOCIATED CARDIOVASCULAR PATHOPHYSIOLOGY IN ANGIOTENSIN II-INDUCED HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e254.
    >> Share

  602. LIM JK, Burke S, Head G
    OS 29-01 TRANS-GENERATIONAL PROGRAMMING OF OBESITY RELATED HYPERTENSION: AMPLIFICATION OF LEPTIN SIGNALLING PATHWAY.
    J Hypertens. 2016;34 Suppl 1:e253.
    >> Share

  603. YADAV R, Yadav RK, Khadgawat R, Mehta N, et al
    OS 28-06 BENEFICIAL EFFECTS OF A 12-WEEK YOGA-BASED LIFESTYLE INTERVENTION ON CARDIO-METABOLIC RISK FACTORS AND ADIPOKINES IN SUBJECTS WITH PRE-HYPERTENSION OR HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e252.
    >> Share

  604. URATA H, Devarajan S, Okamura K
    OS 28-05 ANTIHYPERTENSIVE EFFECT OF CHYMASE INHIBITORY JAPANESE WATER PEPPER INTAKE IN SALT-DEPENDENT MODERATE HYPERTENSION MOUSE MODEL AND IN HUMAN.
    J Hypertens. 2016;34 Suppl 1:e252.
    >> Share

  605. OTT C, Kistner I, Schmid A, Friedrich S, et al
    OS 28-03 SECRETORY CAPACITY OF PANCREATIC BETA CELLS IS ENHANCED 6 MONTHS AFTER RENAL DENERVATION IN TREATMENT RESISTANT HYPERTENSIVE PATIENTS.
    J Hypertens. 2016;34 Suppl 1:e251.
    >> Share

  606. SCHLAICH M, Hering D, Marusic P, Walton A, et al
    OS 28-02 RENAL DENERVATION ALTERS ADIPOKINE LEVELS IN PATIENTS WITH RESISTANT HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e251.
    >> Share

  607. ITO S
    ED 04-3 ASSESSMENT OF RENAL FUNCTION DURING FOLLOW UP OF HYPERTENSIVE SUBJECTS.
    J Hypertens. 2016;34 Suppl 1:e25.
    >> Share

  608. LI Y
    ED 04-2 ASSESSMENT OF TARGET ORGAN DAMAGE DURING ANTI-HYPERTENSIVE TREATMENT: WHAT TO USE AND HOW FREQUENTLY WE SHOULD MEASURE.
    J Hypertens. 2016;34 Suppl 1:e25.
    >> Share

  609. HRISTOVA K, Bogdanova V, Marinov R
    OS 27-04 PREDICTION OF LEFT VENTRICULAR DYSTOLIC DYSFUNCTION IN PATIENT WITH ARTERIAL HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e249-50.
    >> Share

  610. YOON HJ
    OS 27-03 IMPAIRED DIASTOLIC RECOVERY BEFORE DISCHARGE IS ASSOCIATED WITH RE-HOSPITALIZATION WITH HYPERTENSIVE HEART FAILURE.
    J Hypertens. 2016;34 Suppl 1:e249.
    >> Share

  611. KIM MN, Cho D, Shim JM, Choi JI, et al
    OS 27-01 IS HYPERTENSION A RISK FACTOR FOR RECURRENCE AFTER RADIOFREQUENCY CATHETER ABLATION IN ATRIAL FIBRILLATION?
    J Hypertens. 2016;34 Suppl 1:e249.
    >> Share

  612. SUN J, Steffen LM, Xi B
    OS 26-05 HOW TO ACCURATELY DEFINE PEDIATRIC HYPERTENSION: A SYSTEMATIC REVIEW.
    J Hypertens. 2016;34 Suppl 1:e248.
    >> Share

  613. NGUI D, Qiu MJ, Mann M
    OS 26-04 TARGETING CARE GAPS IN PATIENTS WITH HYPERTENSION: A QUALITY IMPROVEMENT PROJECT UTILIZING EMR HYPERTENSION DASHBOARDS AND A CHRONIC DISEASE COORDINATOR.
    J Hypertens. 2016;34 Suppl 1:e247-8.
    >> Share

  614. KOCHARYAN L, Baghdasaryan L
    OS 26-02 A NEW APPROACH FOR THE MANAGEMENT AND MONITORING OF ARTERIAL HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e247.
    >> Share

  615. MELIN P, Prado-Arechiga G, Pulido M, Miramontes I, et al
    OS 26-01 CLASSIFICATION OF ARTERIAL HYPERTENSION USING A COMPUTATIONAL MODEL BASED ON ARTIFICIAL MODULAR NEURAL NETWORKS.
    J Hypertens. 2016;34 Suppl 1:e247.
    >> Share

  616. CHAN J, Lo CS, Shi Y, Chenier I, et al
    OS 25-03 OVEREXPRESSION OF HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN F PREVENTS SYSTEMIC HYPERTENSION AND KIDNEY INJURY AND NORMALIZES RENAL RENIN-ANGIOTENSIN SYSTEM GENES EXPRESSION IN TYPE 2 DIABETIC DB/DB TRANSGENIC MICE.
    J Hypertens. 2016;34 Suppl 1:e245.
    >> Share

  617. LIM JK, Barzel B, Burke S
    OS 25-02 ORIGIN OF NEUROGENIC HYPERTENSION AND THE SYMPATHO-EXCITATION IN DIET INDUCED OBESITY.
    J Hypertens. 2016;34 Suppl 1:e245.
    >> Share

  618. LEE JH, Baek JS, Yu JJ, Kim YH, et al
    OS 24-06 HIGH B-TYPE NATRIURETIC PEPTIDE IS ASSOCIATED WITH LEFT VENTRICULAR HYPERTROPHY AND HEART FAILURE IN CHILDREN WITH HYPERTENSION ON PERITONEAL DIALYSIS.
    J Hypertens. 2016;34 Suppl 1:e244.
    >> Share

  619. PALL D, Katona E, Zrinyi M, Lengyel S, et al
    OS 24-01 ASSESSMENT OF TARGET-ORGAN DAMAGE IN ADOLESCENT WHITE COAT AND SUSTAINED HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e243.
    >> Share

  620. SHIN MS, Park SM, Kim MN, Kim HL, et al
    OS 23-05 LEFT VENTRICULAR HYPERTROPHY AND SIGNIFICANT CORONARY ARTERIAL STENOSIS INTERACTION IN HYPERTENSIVE WOMEN.
    J Hypertens. 2016;34 Suppl 1:e242.
    >> Share

  621. ZHAO X, Yu J
    OS 23-04 A NOVEL HORMONE THERAPY, DROSPIRENONE WITH ESTRADIOL FOR HYPERTENSIVE POSTMENOPAUSAL WOMEN: A SYSTEMIC REVIEW AND META-ANALYSIS.
    J Hypertens. 2016;34 Suppl 1:e242.
    >> Share

  622. KIM SA, Park JB
    OS 23-03 MID-TRIMESTER RISK PREDICTION OF SUPERIMPOSED PRE-ECLAMPSIA IN PREGNANT WOMEN WITH CHRONIC HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e241.
    >> Share

  623. KIM S, Lim NK, Lee JH, Park HY, et al
    OS 22-09 Population-attributable risk of hypertension in development of Stroke: using the National Sample Cohort.
    J Hypertens. 2016;34 Suppl 1:e240.
    >> Share

  624. LI N, Yao X, Zhou L, Abulikem S, et al
    OS 22-08 Prevalence of primary aldosteronism and its cardio-metabolic factors Chinese hypertensive patients in Xinjiang of China.
    J Hypertens. 2016;34 Suppl 1:e240.
    >> Share

  625. PATIL M, Durairaj M, Tauseef SM
    OS 22-06 Evaluating the Health Related Quality of Life of Hypertensive Patients.
    J Hypertens. 2016;34 Suppl 1:e239.
    >> Share

  626. ARAKAWA K, Ibaraki A, Kawamoto Y, Inoue M, et al
    OS 22-05 Variability of urinary salt excretion in treated hypertensive patients during several years.
    J Hypertens. 2016;34 Suppl 1:e239.
    >> Share

  627. LEE JW, Lim NK, Lee JH, Park HY, et al
    OS 22-03 Joint effect of pre-existing hypertension and diabetes on cardiovascular diseases and mortality in the middle-aged Koreans.
    J Hypertens. 2016;34 Suppl 1:e238-9.
    >> Share

  628. WANG HH, Wang JJ, Lawson KD, Wong SY, et al
    OS 22-02 Hypertensive patients with multimorbidity in mainland China, Scotland, and Hong Kong: a cross-country population-based study.
    J Hypertens. 2016;34 Suppl 1:e238.
    >> Share

  629. LEE CJ, Oh J, Lee SH, Kang SM, et al
    OS 22-01Treatment of Hypertension with Low Cardiovascular Risk is associated with significantly lowered mortality.
    J Hypertens. 2016;34 Suppl 1:e238.
    >> Share

  630. NISHIYAMA A, Sufiun A, Fujisawa Y, Rahman A, et al
    OS 21-09 DIPPING PATTERN OF BLOOD PRESSURE AND RENAL INJURY IN DAHL SALT-SENSITIVE HYPERTENSIVE RATS.
    J Hypertens. 2016;34 Suppl 1:e237.
    >> Share

  631. VAVRINOVA A, Behuliak M, Zicha J
    OS 21-07 EXPRESSION OF CATECHOLAMINERGIC SYSTEM GENES IN ADRENAL MEDULLA OR SYMPATHETIC GANGLIA OF SPONTANEOUSLY HYPERTENSIVE RAT.
    J Hypertens. 2016;34 Suppl 1:e236-7.
    >> Share

  632. KROTOVA V, Khomazyuk T
    OS 20-09 DIAGNOSIS AND TREATMENT OF COGNITIVE DISORDERS IN ARTERIAL HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e234.
    >> Share

  633. ISHIKAWA J, Toba A, Yamanaka Y, Watanabe S, et al
    OS 20-08 GENDER-ADJUSTMENT AND CUTOFF LEVELS OF CORNELL PRODUCT IN ELECTROCARDIOGRAM AMONG JAPANESE HYPERTENSIVE PATIENTS.
    J Hypertens. 2016;34 Suppl 1:e234.
    >> Share

  634. SECHI L, Colussi G, Novello M, Pezzutto F, et al
    OS 20-06 DAILY ALCOHOL CONSUMPTION AFFECTS LEFT VENTRICULAR DIASTOLIC FUNCTION IN HYPERTENSION: A TISSUE-DOPPLER STUDY.
    J Hypertens. 2016;34 Suppl 1:e233.
    >> Share

  635. SEUNG-WOON R, Geol CB, Hu L, Oh NJ, et al
    OS 20-05 IMPACT OF LEFT VENTRICULAR HYPERTROPHY IN HYPERTENSIVE PATIENTS UNDERWENT SUCCESSFUL PERCUTANEOUS CORONARY INTERVENTION WITH DRUG ELUTING STENTS ON LONG-TERM CLINICAL OUTCOMES.
    J Hypertens. 2016;34 Suppl 1:e233.
    >> Share

  636. CHI C, Zhang Y, Wang K, Wang L, et al
    OS 20-02 HYPERTENSIVE TARGET ORGAN DAMAGES ARE BETTER ASSOCIATED WITH CENTRAL THAN BRACHIAL BLOOD PRESSURE: THE NORTHERN SHANGHAI STUDY.
    J Hypertens. 2016;34 Suppl 1:e232.
    >> Share

  637. JUNG SM, Ryu DR, Kim CT
    OS 19-07 PRESCRIPTION PATTERN OF RAS BLOCKADE IN KOREAN HYPERTENSIVE PATIENTS WITH PROTEINURIA.
    J Hypertens. 2016;34 Suppl 1:e230.
    >> Share

  638. JEFFERS B, Zho D
    OS 19-02 RELATIONSHIP BETWEEN VISIT-TO-VISIT BLOOD PRESSURE VARIABILITY (BPV) AND KIDNEY FUNCTION IN PATIENTS WITH HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e228.
    >> Share

  639. MEENA J, Raghav P, Rustagi N
    LBOS 03-06 ANTI HYPERTENSIVE TREATMENT COMPLIANCE AND ADVERSE EFFECT PROFILE AMONG HYPERTENSION CLINIC ATTENDEES IN JODHPUR, INDIA.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e552.
    >> Share

  640. KOHLI C, Gupta K
    LBOS 03-03 ECONOMIC IMPACT OF HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e551-e552.
    >> Share

  641. KARAMAT F, Diemer F, Baldew S, Oehlers G, et al
    LBOS 03-02 PREHYPERTENSION AND HYPERTENSION IN URBAN SURINAME: THE HELISUR STUDY.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e551.
    >> Share

  642. YUSUFALI A, Khatib R, Islam S, AlHabib K, et al
    LBOS 03-01 PREVALENCE, AWARENESS, TREATMENT, AND CONTROL OF HYPERTENSION IN THE MIDDLE EAST: RESULTS FROM THE PROSPECTIVE URBAN RURAL EPIDEMIOLOGY (PURE) STUDY.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e551.
    >> Share

  643. DEY SK, Prabhakar P, Saini M, Joseph T, et al
    LBOS 02-05 INHIBITORS OF DOPAMINE-beta-HYDROXYLASE OBTAINED BY STRUCTURE BASED METHODS EXHIBITED ANTI-HYPERTENSIVE EFFECT IN L-NAME INDUCED HYPERTENSIVE RATS.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e550.
    >> Share

  644. LIU D
    LBOS 02-02 TELMISARTAN REDUCING MONOCYTE MITOCHONDRIA RESPIRATORY FUNCTION IS ASSOCIATED WITH INHIBITION OF TRANSIENT RECEPTOR POTENTIAL CHANNEL CANONICAL TYPE 3 CHANNELS IN HYPERTENSIVE RATS.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e549.
    >> Share

  645. TAO J
    LBOS 02-01 HYPERTENSION, ALDOSTERONE AND EPC-MEDIATED ENDOTHALIAL INJURY REPAIR.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e549.
    >> Share

  646. VILLEVALDE S, Kobalava Z
    LBOS 01-06 INTEGRATED APPROACH IMPROVED BLOOD PRESSURE CONTROL IN NON ADHERENT MOTIVATED HYPERTENSIVE PATIENTS: PRISMA STUDY.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e548.
    >> Share

  647. CHO EJ, Lee HY, Sung KC, Park S, et al
    LBOS 01-05 24-HOUR CENTRAL BLOOD PRESSURE REDUCTION EFFICACY OF CALCIUM CHANNEL BLOCKER COMBINATION IS SUPERIOR TO DIURETICS COMBINATION WITH ANGIOTENSIN II RECEPTOR BLOCKER ESPECIALLY IN MALE HYPERTENSIVE PATIENTS.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e548.
    >> Share

  648. SEVER P, Gupta A, Thompson D, Whitehouse A, et al
    LBOS 01-04 THE TRUE INCIDENCE OF STATIN -RELATED ADVERSE EVENTS IN HYPERTENSIVE PATIENTS REVEALED BY COMPARISON OF BLINDED AND UN-BLINDED USE OF STATIN IN THE ANGLO-SCANDINAVIAN CARDIAC OUTCOMES TRIAL (ASCOT).
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e547-e548.
    >> Share

  649. VILLEVALDE S, Kovbalava Z
    LBOS 01-03 MICROALBUMINURIA IS THE MOST INTEGRATED SIGN OF SUBCLINICAL ORGAN DAMAGE IN UNCOMPLICATED HYPERTENSIVE PATIENTS.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e547.
    >> Share

  650. MARCUS Y, Haran A, Shefer G, Stern N, et al
    LBOS 01-02 CLUSTERING OF SILENT HYPOTENSIVE EPISODES IN THE MORNING/LATE-MORNING HOURS IN SUBJECTS TREATED FOR HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e547.
    >> Share

  651. POULTER N, Anjum A, Cross M, Falaschetti E, et al
    LBOS 01-01A COMPARISON OF THE IMPACT OF MORNING OR NIGHT DELIVERY OF ANTIHYPERTENSIVE AGENTS ON 24 HOUR ABPM LEVELS: A RANDOMISED CROSS-OVER TRIAL (HARMONY).
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e547.
    >> Share

  652. MUTHUSAMY VV
    BR 08-3 MANAGEMENT OF DYSLIPIDEMIA IN HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e545.
    >> Share

  653. PARK J
    BR 08-2 CARDIOVASCULAR RISK ASSESSMENT IN HYPERTENSIVES WITH CKD.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e544-e545.
    >> Share

  654. ZHU Z
    BR 08-1 HIGH SODIUM INTAKE REDUCTION IN DIABETES WITH HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e544.
    >> Share

  655. PARK JB
    ME 04-2 AORTIC PWV FOR RISK STRATIFICATION IN HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e541.
    >> Share

  656. KIM SH
    HW 03-2 EFFECT OF CPAP ON THE TREATMENT OF RESISTANT HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e538.
    >> Share

  657. KIM BK
    HW 03-1 RENAL SYMPATHETIC DENERVATION FOR RESISTANT HYPERTENSION UNDER OPTIMAL DRUG THERAPY.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e538.
    >> Share

  658. RAIZADA M
    SY 17-4 NEURO-IMMUNE COMMUNICATION IN HYPERTENSION: A NEW THERAPEUTIC ANGLE?
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e535.
    >> Share

  659. HARRISON D
    SY 17-2 INFLAMMATION, IMMUNITY AND HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e535.
    >> Share

  660. VAN BALLEGOOIJEN A
    SY 16-4 VITAMIN D WITH OR WITHOUT CALCIUM SUPPLEMENTATION IN RELATION TO HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e534.
    >> Share

  661. XU T, Sun J, Lee AP, Yang Y, et al
    OS 37-09 LAYER-SPECIFIC QUANTIFICATION OF MYOCARDIAL DEFORMATION MAY DISCLOSE THE SUBCLINICAL SYSTOLIC DYSFUNCTION AND THE MECHANISM OF RESERVED EJECTION FRACTION IN PATIENTS WITH HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e407.
    >> Share

  662. KIM D, Shim CY, Hong GR, Cho IJ, et al
    OS 37-08 ASSOCIATION OF CENTRAL HEMODYNAMICS AND NEUROHORMONAL FACTORS TO MECHANICAL ADAPTATION OF LEFT VENTRICLE IN HYPERTENSION: A STUDY WITH TWO DIMENSIONAL LAYER SPECIFIC SPECKLE TRACKING STRAIN IMAGING.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e407.
    >> Share

  663. LIM HM, Chia YC, Ching SM
    OS 37-05 LONG-TERM VISIT-TO-VISIT VARIABILITY OF SYSTOLIC BLOOD PRESSURE AND DECLINE IN RENAL FUNCTION IN HYPERTENSIVE PATIENTS OVER 15 YEARS.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e406.
    >> Share

  664. CHO KI, Cho EA, Heo JH, Kim HS, et al
    OS 37-04 EFFECTS OF WHITE COAT HYPERTENSION ON HEART RATE RECOVERY AND BLOOD PRESSURE RESPONSE DURING EXERCISE TESTING.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e406.
    >> Share

  665. LEE JY, Sung KC
    OS 37-03 IMPACT OF CHANGE IN EXERCISE DOSE ON RISK OF NEWLY DEVELOPED HYPERTENSION AND DIABETES MELLITUS IN KOREAN MEN.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e405-e406.
    >> Share

  666. AMUSA G, Awokola B, Isiguzo G, Onuh J, et al
    OS 37-02 HYPERTENSION IN HIV-INFECTED ADULTS IN NORTH-CENTRAL NIGERIA: PREVALENCE, ASSOCIATED RISK FACTORS AND ASSESSMENT OF RISK USING THE FRAMINGHAM RISK SCORE.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e405.
    >> Share

  667. KONG L, Ruan C, Gao P
    OS 36-08 A2A RECEPTOR-MEDIATED ACTIVATION OF REGULATORY T CELLS ATTENUATES HYPERTENSION-INDUCED CARDIOVASCULAR INJURY.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e404.
    >> Share

  668. ZHONG JC, Zhang ZZ, Xu R, Chen LJ, et al
    OS 36-07 TREATMENT WITH APELIN-13 PREVENTS PRESSURE OVERLOAD-INDUCED AORTIC ADVENTITIAL REMODELING AND FIBROSIS IN HYPERTENSIVE RATS WITH TAC.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e403-e404.
    >> Share

  669. ZUO C
    OS 36-06 OSTEOGLYCIN INHIBITS HYPERTENSIVE CARDIAC FIBROSIS THOUGH SUPPRESSION OF EGFR SIGNALING.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e403.
    >> Share

  670. WANG Q, Chang P, Xu H, Bai F, et al
    OS 36-05 TETRAHYDROBIOPTERIN REVERSE LEFT VENTRICULAR HYPERTROPHY AND DIASTOLIC DYSFUNCTION THROUGH THE PI3K/p-Akt PATHWAY IN SPONTANEOUSLY HYPERTENSIVE RATS.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e403.
    >> Share

  671. WANG Q, Xie A, Xu H, Yu J, et al
    OS 36-02 ASTRAGALOSIDE IV AMELIORATED MITOCHONDRIAL OXIDATIVE STRESS IN HYPERTENSIVE MICE WITH CARDIOMYOPATHY BY REGULATING MITOCHONDRIAL Ca2+ FLUX.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e402.
    >> Share

  672. MAIOLINO G, Flego A, Rossi GP
    OS 35-09 LONG-TERM OUTCOME OF SURGICALLY- AND MEDICALLY-TREATED PATIENTS OF THE PRIMARY ALDOSTERONISM PREVALENCE IN HYPERTENSIVES (PAPY) STUDY.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e401.
    >> Share

  673. XU J, Ge Q, Zhang J, Zhu L, et al
    OS 35-06 COMPARISON OF N-TERMINAL PRO-B-TYPE NATRIURETIC PEPTIDE LEVEL IN PRIMARY ALDOSTERONISM AND ESSENTIAL HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e401.
    >> Share

  674. POGLITSCH M, Ahmed AH, Resl M, Stoller A, et al
    OS 35-04 THE AA2-RATIO: TOWARDS IMPROVED SCREENING FOR PRIMARY ALDOSTERONISM IN HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e400.
    >> Share

  675. RYUNO H, Kamide K, Gondo Y, Kabayama M, et al
    OS 34-01 ASSOCIATION OF COMBINATION OF HYPERTENSION AND DIABETES WITH COGNITIVE FUNCTION AMONG THE 70-YEARS-OLD JAPANESE GENERAL POPULATION FROM LONGITUDINAL OBSERVATION IN THE SONIC STUDY.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e396.
    >> Share

  676. WANG H, Chen H
    OS 33-09 ASSOCIATION OF CLOCK GENE POLYMORPHISM WITH INSULIN RESISTANCE IN HYPERTENSION: A CASE-CONTROL STUDY.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e395.
    >> Share

  677. CAI A, Wang L, Zhou Y, Chen J, et al
    OS 33-08 OBSTRUCTIVE SLEEP APNEA PROMOTES CARDIOVASCULAR RISK IN HYPERTENSIVE POPULATIONS: A CROSS-SECTIONAL STUDY.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e395.
    >> Share

  678. TANAKA M, Nishimura T, Sekioka R, Kawai T, et al
    OS 33-07 LOW SERUM ALBUMIN CONCENTRATION IN HYPERTENSIVE PATIENTS COMPLICATED BY TYPE 2 DIABETES IS ASSOCIATED WITH MICROVASCULAR COMPLICATIONS.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e394-e395.
    >> Share

  679. OGOLA E
    OS 33-05 HIGH PREVALENCE AND POOR CONTROL OF HYPERTENSION AND ASSOCIATED CARDIOVASCULAR RISK FACORS IN DIABETIC PATIENTS IN A RURAL HOSPITAL IN KENYA.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e394.
    >> Share

  680. OPARIL S, Calhoun DA, Ghazi L, Dudenbostel T, et al
    OS 33-02 IN PATIENTS WITH RESISTANT HYPERTENSION INCREASED 24-H URINARY CORTISOL LEVEL PREDICT INCREASED BODY MASS INDEX.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e393.
    >> Share

  681. PENG L, Xia K, Zhao Z, Li D, et al
    OS 32-09 THE BENEFICIAL EFFECT OF LOSARTAN ON PLATELET AGGREGATION RESULTS FROM THE REDUCTION OF ENDOGENOUS ASYMMETRIC DIMETHYL ARGININE IN SPONTANEOUSLY HYPERTENSIVE RATS.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e391-e392.
    >> Share

  682. YANG Z, Ruixin M, Jing Y
    OS 32-02 EFFECTS OF RENIN-ANGIOTENSIN SYSTEM INHIBITORS ON VAGINA AND CARDIAC EXPRESSION OF RAAS COMPONENTS IN FEMALE SPONTANEOUSLY HYPERTENSIVE RATS.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e390.
    >> Share

  683. CHEN X, Wang S, Li J, Zhou X, et al
    OS 31-06 COMPARISON BETWEEN THE EFFECTS OF HYDROCHLOROTHIAZIDE AND INDAPAMIDE ON THE KIDNEY IN HYPERTENSIVE PATIENTS INADEQUATELY CONTROLLED WITH LOSARTAN.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e389.
    >> Share

  684. SEUNG-WOON R, Geol CB, Hu L, Oh NJ, et al
    OS 31-04 COMPARISON OF CALCIUM CHANNEL BLOCKERS VERSUS CALCIUM CHANNEL BLOCKERS WITH RENIN ANGIOTENSIN SYSTEM BLOCKERS ON THE DEVELOPMENT OF NEW-ONSET DIABETES MELLITUS IN HYPERTENSIVE PATIENTS.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e388-e389.
    >> Share

  685. GIULIETTI F, Spannella F, Borioni E, Lombardi FE, et al
    OS 31-03 CLINICAL EFFECTIVENESS OF ANTI-HYPERTENSIVE THERAPY WITH ACEI OR ARB ASSESSED BY PLASMA RENIN ACTIVITY/PLASMA ALDOSTERONE CONCENTRATION RATIO.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e388.
    >> Share

  686. ZENG W, Chu T, Hu M, Kong A, et al
    OS 31-02 ANTIHYPERTENSIVE RESPONSE TO BISOPROLOL WAS NOT RELATED TO POLYMORPHISMS IN ADRB1 Or CYP2D6 IN CHINESE HYPERTENSIVE PATIENTS.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e388.
    >> Share

  687. KIM CH
    APSH PRE-1 WHAT CAN BE IMPROVED IN THE MANAGEMENT OF HYPERTENSION?
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e387.
    >> Share

  688. KANG YY, Li Y, Huang QF, Song J, et al
    APSH YI-05 CIGARETTE SMOKING AND MASKED HYPERTENSION IN CHINESE MEN.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e386.
    >> Share

  689. LEE CJ, Oh J, Lee SH, Kang SM, et al
    APSH YI-01 EFFECTS OF DIFFERENT CLASSES OF ANTI-HYPERTENSIVE AGENTS ON SURVIVAL IN PATIENTS WITH UNCOMPLICATED HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e385.
    >> Share

  690. TOUYZ RM
    ISH PRE-2 THE VASCULAR PHENOTYPE IN HYPERTENSION - MOLECULAR MECHANISMS AND CLINICAL IMPLICATIONS.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e384.
    >> Share

  691. SAFAR ME
    ISH PRE-1 REDUCTION OF CARDIOVASCULAR MORTALITY IN HYPERTENSIVES WITH COMORBIDITIES: BEYOND BLOOD PRESSURE LOWERING - THE ROLE OF ARTERIAL AGING.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e384.
    >> Share

  692. POGLITSCH M
    JS ISH-ECCR-4 THE PLASMA ALDOSTERONE / ANGIOTENSIN II RATIO FOR THE SCREENING OF SECONDARY HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e382-e383.
    >> Share

  693. ROSSI GP
    JS ISH-ECCR-3 A NOVEL ALGORITHM FOR THE CASE DETECTION OF THE MOST COMMON FORM OF ENDOCRINE HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e382.
    >> Share

  694. FUJITA T
    ME 03-1 ROLE OF ALDOSTERNE AND MINERALOCORTICOID RECEPTOR IN SALT-SENSITIVE HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e379.
    >> Share

  695. WHELTON P
    SP 05-1 SHOULD THE TARGET FOR BLOOD PRESSURE REDUCTION BE LOWER IN ADULTS WITH HYPERTENSION AND A HISTORY OF CARDIOVASCULAR DISEASE.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e378.
    >> Share

  696. BAKRIS G
    DB 03-2 RENAL SYMPATHETIC DENERVATION IS STILL A VIABLE OPTION FOR TREATING RESISTANT HYPERTENSION (CON).
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e375.
    >> Share

  697. SCHLAICH M
    DB 03-1 RENAL SYMPATHETIC DENERVATION IS STILL A VIABLE OPTION FOR TREATING RESISTANT HYPERTENSION (PRO).
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e375.
    >> Share

  698. SHI L
    ED 08-4 DIAGNOSIS AND TREATMENT OF HYPERTENSIVE EMERGENCY IN CHILDREN.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e373-e374.
    >> Share

  699. AWAZU M
    ED 08-3 APPLICATION OF ABP MONITORING IN THE MANAGEMENT OF PEDIATRIC HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e373.
    >> Share

  700. DAVIES PF, Manduchi E, Stoeckert CJ, Jiang YZ, et al
    SY 15-2 ENDOTHELIAL EPIGENETICS AND ITS ROLE IN MEDIATING BIOMECHANICAL STRESS OF HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e371.
    >> Share

  701. SCHIFFRIN E
    SY 15-1 MECHANISM OF ENDOTHELIN-1 REGULATION IN HYPERTENSION: THE ROLE OF ENDOTHELIN TYPE A RECEPTORS.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e371.
    >> Share

  702. MORISHITA R
    SY 14-4 VACCINE THERAPY FOR RESISTANT HYPERTENSION: IS IT A DYING ISSUE?
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e369-e370.
    >> Share

  703. CALHOUN D
    SY 14-3 PRIMARY ALDOSTERONISM IN RESISTANT HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e369.
    >> Share

  704. VONGPATANASIN W
    SY 14-1 THERAPEUTIC DRUG MONITORING FACILITATES BLOOD PRESSURE CONTROL IN RESISTANT HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e369.
    >> Share

  705. DANIELS SR
    SY 13-2 LONG-TERM CARDIOVASCULAR RISK REDUCTION IN PEDIATRIC HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e368.
    >> Share

  706. BURRELL L
    SY 12-1 RENIN ANGIOTENSIN PATHWAY BEYOND ACE AND ANGIOTENSIN II RECEPTORS: HOW IT RELATES TO THE PATHOPHYSIOLOGY OF HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e367.
    >> Share

  707. RYAN MJ
    SY 11-4 CONNECTIVE TISSUE DISEASE AND ITS ASSOCIATION WITH ARTERIAL HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e366.
    >> Share

  708. OPARIL S
    SY 11-3 HYPERTENSION IN WOMEN: MORE DANGEROUS THAN IN MEN?
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e366.
    >> Share

  709. KJELDSEN S
    PL 03-3 THE FUTURE DEVELOPMENT OF DRUG THERAPY FOR HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e365.
    >> Share

  710. IMAI Y
    PL 03-2 REMOTE BLOOD PRESSURE MONITORING IN HYPERTENSION CARE: PRACTICE OF HYPERTENSION BY TELETRANSMISSION OF HOME BLOOD PRESSURE.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e364-e365.
    >> Share

  711. STEINHUBL S
    PL 03-1 HYPERTENSION MANAGEMENT IN THE ERA OF DIGITAL INFORMATION AND COMMUNICATION TECHNOLOGIES.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e364.
    >> Share

  712. SUGIURA T, Takase H, Murai S, Yamashiya S, et al
    OS 30-04 FUTURE HYPERTENSION CAN BE PREDICTED USING ELECTROCARDIOGRAM.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e255-e256.
    >> Share

  713. GAFAROV V, Gromova E, Panov D, Gagulin I, et al
    OS 30-03 GENDER DIFFERENCES OF AN ARTERIAL HYPERTENSION RISK IN POPULATION WITH SLEEP DISTURBANCE IN RUSSIA / SIBERIA: WHO PROGRAM MONICA-PSYCHOSOCIAL.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e255.
    >> Share

  714. DENTON K, Moritz K, Booth L, May C, et al
    OS 29-06 RESPONSE TO HEMORRHAGE FOLLOWING CATHETER-BASED RENAL DENERVATION IN SHEEP WITH HYPERTENSIVE KIDNEY DISEASE.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e254.
    >> Share

  715. LI X, Hong M, Zhu D, Gao P, et al
    OS 29-05 RENAL DENERVATION ATTENUATES ALDOSTERONE EXPRESSION AND ASSOCIATED CARDIOVASCULAR PATHOPHYSIOLOGY IN ANGIOTENSIN II-INDUCED HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e254.
    >> Share

  716. LIM JK, Burke S, Head G
    OS 29-01 TRANS-GENERATIONAL PROGRAMMING OF OBESITY RELATED HYPERTENSION: AMPLIFICATION OF LEPTIN SIGNALLING PATHWAY.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e253.
    >> Share

  717. YADAV R, Yadav RK, Khadgawat R, Mehta N, et al
    OS 28-06 BENEFICIAL EFFECTS OF A 12-WEEK YOGA-BASED LIFESTYLE INTERVENTION ON CARDIO-METABOLIC RISK FACTORS AND ADIPOKINES IN SUBJECTS WITH PRE-HYPERTENSION OR HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e252.
    >> Share

  718. URATA H, Devarajan S, Okamura K
    OS 28-05 ANTIHYPERTENSIVE EFFECT OF CHYMASE INHIBITORY JAPANESE WATER PEPPER INTAKE IN SALT-DEPENDENT MODERATE HYPERTENSION MOUSE MODEL AND IN HUMAN.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e252.
    >> Share

  719. OTT C, Kistner I, Schmid A, Friedrich S, et al
    OS 28-03 SECRETORY CAPACITY OF PANCREATIC BETA CELLS IS ENHANCED 6 MONTHS AFTER RENAL DENERVATION IN TREATMENT RESISTANT HYPERTENSIVE PATIENTS.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e251.
    >> Share

  720. SCHLAICH M, Hering D, Marusic P, Walton A, et al
    OS 28-02 RENAL DENERVATION ALTERS ADIPOKINE LEVELS IN PATIENTS WITH RESISTANT HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e251.
    >> Share

  721. HRISTOVA K, Bogdanova V, Marinov R
    OS 27-04 PREDICTION OF LEFT VENTRICULAR DYSTOLIC DYSFUNCTION IN PATIENT WITH ARTERIAL HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e249-e250.
    >> Share

  722. YOON HJ
    OS 27-03 IMPAIRED DIASTOLIC RECOVERY BEFORE DISCHARGE IS ASSOCIATED WITH RE-HOSPITALIZATION WITH HYPERTENSIVE HEART FAILURE.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e249.
    >> Share

  723. KIM MN, Cho D, Shim JM, Choi JI, et al
    OS 27-01 IS HYPERTENSION A RISK FACTOR FOR RECURRENCE AFTER RADIOFREQUENCY CATHETER ABLATION IN ATRIAL FIBRILLATION?
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e249.
    >> Share

  724. SUN J, Steffen LM, Xi B
    OS 26-05 HOW TO ACCURATELY DEFINE PEDIATRIC HYPERTENSION: A SYSTEMATIC REVIEW.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e248.
    >> Share

  725. NGUI D, Qiu MJ, Mann M
    OS 26-04 TARGETING CARE GAPS IN PATIENTS WITH HYPERTENSION: A QUALITY IMPROVEMENT PROJECT UTILIZING EMR HYPERTENSION DASHBOARDS AND A CHRONIC DISEASE COORDINATOR.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e247-e248.
    >> Share

  726. KOCHARYAN L, Baghdasaryan L
    OS 26-02 A NEW APPROACH FOR THE MANAGEMENT AND MONITORING OF ARTERIAL HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e247.
    >> Share

  727. MELIN P, Prado-Arechiga G, Pulido M, Miramontes I, et al
    OS 26-01 CLASSIFICATION OF ARTERIAL HYPERTENSION USING A COMPUTATIONAL MODEL BASED ON ARTIFICIAL MODULAR NEURAL NETWORKS.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e247.
    >> Share

  728. CHAN J, Lo CS, Shi Y, Chenier I, et al
    OS 25-03 OVEREXPRESSION OF HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN F PREVENTS SYSTEMIC HYPERTENSION AND KIDNEY INJURY AND NORMALIZES RENAL RENIN-ANGIOTENSIN SYSTEM GENES EXPRESSION IN TYPE 2 DIABETIC DB/DB TRANSGENIC MICE.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e245.
    >> Share

  729. LIM JK, Barzel B, Burke S
    OS 25-02 ORIGIN OF NEUROGENIC HYPERTENSION AND THE SYMPATHO-EXCITATION IN DIET INDUCED OBESITY.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e245.
    >> Share

  730. LEE JH, Baek JS, Yu JJ, Kim YH, et al
    OS 24-06 HIGH B-TYPE NATRIURETIC PEPTIDE IS ASSOCIATED WITH LEFT VENTRICULAR HYPERTROPHY AND HEART FAILURE IN CHILDREN WITH HYPERTENSION ON PERITONEAL DIALYSIS.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e244.
    >> Share

  731. PALL D, Katona E, Zrinyi M, Lengyel S, et al
    OS 24-01 ASSESSMENT OF TARGET-ORGAN DAMAGE IN ADOLESCENT WHITE COAT AND SUSTAINED HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e243.
    >> Share

  732. SHIN MS, Park SM, Kim MN, Kim HL, et al
    OS 23-05 LEFT VENTRICULAR HYPERTROPHY AND SIGNIFICANT CORONARY ARTERIAL STENOSIS INTERACTION IN HYPERTENSIVE WOMEN.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e242.
    >> Share

  733. ZHAO X, Yu J
    OS 23-04 A NOVEL HORMONE THERAPY, DROSPIRENONE WITH ESTRADIOL FOR HYPERTENSIVE POSTMENOPAUSAL WOMEN: A SYSTEMIC REVIEW AND META-ANALYSIS.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e242.
    >> Share

  734. KIM SA, Park JB
    OS 23-03 MID-TRIMESTER RISK PREDICTION OF SUPERIMPOSED PRE-ECLAMPSIA IN PREGNANT WOMEN WITH CHRONIC HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e241.
    >> Share

  735. KIM S, Lim NK, Lee JH, Park HY, et al
    OS 22-09 Population-attributable risk of hypertension in development of Stroke: using the National Sample Cohort.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e240.
    >> Share

  736. LI N, Yao X, Zhou L, Abulikem S, et al
    OS 22-08 Prevalence of primary aldosteronism and its cardio-metabolic factors Chinese hypertensive patients in Xinjiang of China.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e240.
    >> Share

  737. PATIL M, Durairaj M, Tauseef SM
    OS 22-06 Evaluating the Health Related Quality of Life of Hypertensive Patients.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e239.
    >> Share

  738. ARAKAWA K, Ibaraki A, Kawamoto Y, Inoue M, et al
    OS 22-05 Variability of urinary salt excretion in treated hypertensive patients during several years.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e239.
    >> Share

  739. LEE JW, Lim NK, Lee JH, Park HY, et al
    OS 22-03 Joint effect of pre-existing hypertension and diabetes on cardiovascular diseases and mortality in the middle-aged Koreans.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e238-e239.
    >> Share

  740. WANG HH, Wang JJ, Lawson KD, Wong SY, et al
    OS 22-02 Hypertensive patients with multimorbidity in mainland China, Scotland, and Hong Kong: a cross-country population-based study.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e238.
    >> Share

  741. LEE CJ, Oh J, Lee SH, Kang SM, et al
    OS 22-01Treatment of Hypertension with Low Cardiovascular Risk is associated with significantly lowered mortality.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e238.
    >> Share

  742. NISHIYAMA A, Sufiun A, Fujisawa Y, Rahman A, et al
    OS 21-09 DIPPING PATTERN OF BLOOD PRESSURE AND RENAL INJURY IN DAHL SALT-SENSITIVE HYPERTENSIVE RATS.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e237.
    >> Share

  743. VAVRINOVA A, Behuliak M, Zicha J
    OS 21-07 EXPRESSION OF CATECHOLAMINERGIC SYSTEM GENES IN ADRENAL MEDULLA OR SYMPATHETIC GANGLIA OF SPONTANEOUSLY HYPERTENSIVE RAT.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e236-e237.
    >> Share

  744. KROTOVA V, Khomazyuk T
    OS 20-09 DIAGNOSIS AND TREATMENT OF COGNITIVE DISORDERS IN ARTERIAL HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e234.
    >> Share

  745. ISHIKAWA J, Toba A, Yamanaka Y, Watanabe S, et al
    OS 20-08 GENDER-ADJUSTMENT AND CUTOFF LEVELS OF CORNELL PRODUCT IN ELECTROCARDIOGRAM AMONG JAPANESE HYPERTENSIVE PATIENTS.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e234.
    >> Share

  746. SECHI L, Colussi G, Novello M, Pezzutto F, et al
    OS 20-06 DAILY ALCOHOL CONSUMPTION AFFECTS LEFT VENTRICULAR DIASTOLIC FUNCTION IN HYPERTENSION: A TISSUE-DOPPLER STUDY.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e233.
    >> Share

  747. SEUNG-WOON R, Geol CB, Hu L, Oh NJ, et al
    OS 20-05 IMPACT OF LEFT VENTRICULAR HYPERTROPHY IN HYPERTENSIVE PATIENTS UNDERWENT SUCCESSFUL PERCUTANEOUS CORONARY INTERVENTION WITH DRUG ELUTING STENTS ON LONG-TERM CLINICAL OUTCOMES.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e233.
    >> Share

  748. CHI C, Zhang Y, Wang K, Wang L, et al
    OS 20-02 HYPERTENSIVE TARGET ORGAN DAMAGES ARE BETTER ASSOCIATED WITH CENTRAL THAN BRACHIAL BLOOD PRESSURE: THE NORTHERN SHANGHAI STUDY.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e232.
    >> Share

  749. JUNG SM, Ryu DR, Kim CT
    OS 19-07 PRESCRIPTION PATTERN OF RAS BLOCKADE IN KOREAN HYPERTENSIVE PATIENTS WITH PROTEINURIA.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e230.
    >> Share

  750. JEFFERS B, Zho D
    OS 19-02 RELATIONSHIP BETWEEN VISIT-TO-VISIT BLOOD PRESSURE VARIABILITY (BPV) AND KIDNEY FUNCTION IN PATIENTS WITH HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e228.
    >> Share

  751. ZHANG Y, Lu Y, Bai B, Yu S, et al
    OS 18-09 COMPARISON OF CAROTID-FEMORAL AND BRACHIAL-ANKLE PULSE WAVE VELOCITY IN THE ASSOCIATION WITH HYPERTENSIVE TARGET ORGAN DAMAGES IN THE COMMUNITY-DWELLING ELDERLY: THE NORTHERN SHANGHAI STUDY.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e226-e227.
    >> Share

  752. UCHIWA H, Kai H, Iwamoto Y, Anegawa T, et al
    OS 18-07 SAFETY AND EFFICACY OF ARB/HCTZ COMBINATION THERAPY IN CONTROLLING MORNING HYPERTENSION IN VERY ELDERLY PATIENTS.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e226.
    >> Share

  753. TRIAM-ANURUCK U, Vathesatogkit P, Yingchoncharoen T, Katekao W, et al
    OS 18-04 HYPERTENSION AS A PREDICTOR OF PATTERN OF LV HYPERTROPHY AND GEOMETRIC REMODELING IN ELDERLY: HAPPY MODEL STUDY.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e225.
    >> Share

  754. BOHLENDER J, Nussberger J, Bohlender B
    OS 18-02 ANTIHYPERTENSIVE TREATMENT AND RISK OF BRAIN ISCHEMIA DUE TO CAROTID STENOSIS IN A SURVEY OF HOSPITALISED PATIENTS AGED 90 YEARS AND OLDER.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e224.
    >> Share

  755. DE LA COLINA AN, Wu R, Desjardins-Crepeau L, Larochelle P, et al
    OS 18-01 CORRELATION BETWEEN COGNITIVE DECLINE AND BLOOD PRESSURE IN ELDERLY PATIENTS WITH CONTROLLED HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e224.
    >> Share

  756. WANG Z, Chen Z, Wang X, Hao G, et al
    OS 16-07 COST-EFFECTIVENESS OF NITRENDIPINE PLUS HYDROCHLOROTHIAZIDE OR METOPROLOL TO TREAT HYPERTENSION IN RURAL COMMUNITY HEALTH CENTERS IN CHINA.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e220.
    >> Share

  757. REYNOLDS K, Shimbo D, Bowling CB, Deng L, et al
    OS 16-06 RISK FACTORS FOR SERIOUS FALL INJURIES FOLLOWING INITIATION OF ANTIHYPERTENSIVE MEDICATION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e219-e220.
    >> Share

  758. KAUSER M, Sr V, Rc K, Afreen A, et al
    OS 16-05 STUDY OF DETERMINANTS OF NONADHERENCE TO ANTI-HYPERTENSIVE MEDICATIONS IN ESSENTIAL HYPERTENSION AT A TEACHING HOSPITAL IN SOUTHERN INDIA.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e219.
    >> Share

  759. CHANG C, Zeng Q, Ji Y, Sun X, et al
    OS 16-04 EFFECTS OF HEALTH LITERACY ON BLOOD PRESSURE CONTROL AMONG HYPERTENSIVE: A MEDIATING EFFECT ANALYSIS.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e219.
    >> Share

  760. YU Q, Liu B, Na R
    OS 16-01 THE EPIDEMIOLOGY SURVEY OF THE PREVALENCE AND RISK FACTORS OF HYPERTENSION AMONG RESIDENTS IN COUNTRY OF DALIAN ZHUANGHE.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e218.
    >> Share

  761. HOOD KY, Yusuf H, Findlay JE, Santos RA, et al
    OS 15-08 Ang(1-7) INFLUENCES ET-1 SIGNALING THROUGH MAS: ETBR INTERACTIONS: IMPLICATIONS IN PULMONARY HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e216.
    >> Share

  762. KIM YG, Lee S, Moon JY, Kim SY, et al
    OS 15-06 SEQUENTIAL ACTIVATION OF INTRARENAL ACE/ACE2 AS THE PROGRESSION OF HYPERTENSIVE NEPHROPATHY IN 2-KIDNEY 10CLIP (2K1C) GOLDBLATT RATS.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e216.
    >> Share

  763. SEO M, Sung KC
    OS 14-05 THE EFFECT OF URINARY ALBUMIN AND HYPERTENSION IN ALL-CAUSE AND CVD MORTALITY IN EAST ASIAN.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e213.
    >> Share

  764. SALVETTI M, Paini A, Rosei CA, Stassaldi D, et al
    OS 14-02 ON TREATMENT BLOOD PRESSURE VALUES AND CARDIAC ORGAN DAMAGE IN HYPERTENSIVE PATIENTS.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e212.
    >> Share

  765. ZHANG X, Zhang Y, Liu L, Zanchetti A, et al
    OS 14-01 AN ESTIMATED OPTIMAL HYPERTENSION LEVEL OF GOALS ON DRUG THERAPY FROM THE FEVER TRIAL.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e212.
    >> Share

  766. ZHANG Y, Chi C, Yu S, Argyris A, et al
    OS 13-08 ASSOCIATION OF CARDIAC STRUCTURE AND FUNCTION WITH CENTRAL AND BRACHIAL BLOOD PRESSURE VARIABILITY IN HYPERTENSIVE PATIENTS: THE SAFAR STUDY.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e210.
    >> Share

  767. CHENG YB, Xu TY, Yang Y, Guo QH, et al
    OS 13-05 PREVALENCE OF CENTRAL HYPERTENSION AND ITS ASSOCIATION WITH TARGET ORGAN DAMAGE IN UNTREATED CHINESE PATIENTS.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e209.
    >> Share

  768. SALADINI F, Benetti E, Fania C, Mos L, et al
    OS 13-02 ASSOCIATION BETWEEN URIC ACID, METABOLIC VARIABLES AND ARTERIAL STIFFNESS IN THE EARLY PHASE OF HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e208.
    >> Share

  769. PANDEY D, Tori D, Nomura Y, Berkowitz D, et al
    YIA 03-10 ENDOTHELIAL KRUPPEL-LIKE FACTOR 15: A NOVEL TARGET FOR THE TREATMENT OF PULMONARY HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e206-e207.
    >> Share

  770. RAMADHIANI R, Rohman MS, Widodo N, Putri VY, et al
    YIA 03-05 BLOOD PRESSURE REDUCTION AND DIFFERENT C/EBPalpha-DNA BINDING PATTERN IN TELMISARTAN-TREATED ANGIOTENSINOGEN G-217A POLYMORPHISM HYPERTENSIVE PATIENTS.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e205.
    >> Share

  771. BEHULIAK M, Bencze M, Vavrinova A, Vaneckova I, et al
    YIA 03-03 EFFECT OF GABAPENTIN, LIGAND OF ALPHA 2 DELTA SUBUNIT OF VOLTAGE-DEPENDENT CALCIUM CHANNELS, ON BLOOD PRESSURE AND BAROREFLEX SENSITIVITY IN SPONTANEOUSLY HYPERTENSIVE RATS: THE INFLUENCE OF GUANETHIDINE-INDUCED SYMPATHECTOMY.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e204.
    >> Share

  772. RUAN CC, Li Y, Ma Y, Zhu DL, et al
    YIA 03-02 ADIPONECTIN-MEDIATED EPITHELIAL AUTOPHAGY ATTENUATES HYPERTENSIVE RENAL FIBROSIS.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e204.
    >> Share

  773. PERI-OKONNY P, Ayers C, Maalouf N, Das S, et al
    YIA 02-04 RELATIONSHIP BETWEEN LEPTIN AND INCIDENT HYPERTENSION; OBSERVATIONS FROM THE DALLAS HEART STUDY.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e203.
    >> Share

  774. SUNG KC
    JS KSH-JSH-CHL 01-2 HYPERTENSION, ADDITIONAL MAKERS AND MORTALITY IN SUBJECTS WITH METABOLIC SYNDROME: BIG DATA ANALYSIS.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e200.
    >> Share

  775. ITOH H
    JS KSH-JSH-CHL 01-1 CARDIO-METABOLIC RISKS IN HYPERTENSION: ARE WE DIFFERENT FROM WESTERN SOCIETIES?
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e200.
    >> Share

  776. YIM DS
    BR 04-2 CONCENTRATION-RESPONSE MODELING OF ANTIHYPERTENSIVE DRUGS - IMPLICATION IN CLINICAL DEVELOPMENT.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e198.
    >> Share

  777. WEBB DJ
    BR 04-1MANAGEMENT OF TREATMENT-RESISTANT HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e198.
    >> Share

  778. CARLBERG B
    ME 02-1 IS LOWER REALLY BETTER? ISSUE OF THE J CURVE HYPOTHESIS IN HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e196.
    >> Share

  779. TOMASZEWSKI M
    SP 03-2 ASSESSMENT OF ADHERENCE TO ANTIHYPERTENSIVE TREATMENT BY HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY (HP LC-MS/MS) URINE ANALYSIS.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e195.
    >> Share

  780. SCHIFFRIN E
    SP 02-5 DO WE NEED A NEW DEFINITION OF HYPERTENSION?
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e194.
    >> Share

  781. CUSHMAN WC
    JS ISH-ESH-4 WHAT DO CLINICAL TRIALS TEACH US ABOUT SELECTION OF ANTIHYPERTENSIVE DRUGS.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e193.
    >> Share

  782. DECHEND R
    JS ISH-ESH-3 RESISTANT HYPERTENSION - A GROWING CHALLENGE.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e193.
    >> Share

  783. ROSEI EA
    JS ISH-ESH-2 UPDATE ON THE DETECTION AND FOLLOW-UP OF EARLY HYPERTENSIVE HEART DISEASE.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e192-e193.
    >> Share

  784. BAKRIS G
    JS ISH-ISN-2 ROLE OF THE KIDNEY IN RESISTANT HYPERTENSION: WHY SO RESISTANT TO BP CONTROL IN CKD PATIENTS?
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e191.
    >> Share

  785. WILCOX C
    JS ISH-ISN-1 OXIDATIVE STRESS, THE KIDNEY AND HYPERTENSION CLINICAL IMPLICATIONS.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e191.
    >> Share

  786. APPEL L
    DB 02-3 STRICT CONTROL OF HYPERTENSION IN THE ELDERLY WITH DIABETES AND CHRONIC KIDNEY DISEASE (PRO).
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e190.
    >> Share

  787. RAKUGI H
    DB 02-2 STRICT CONTROL OF HYPERTENSION IN THE FRAIL ELDERLY: IS IT BENEFICIAL? (CON).
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e190.
    >> Share

  788. KIM KI
    DB 02-1 STRICT CONTROL OF HYPERTENSION IN THE FRAIL ELDERLY: IS IT BENEFICIAL? (PRO).
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e190.
    >> Share

  789. SHARMAN J
    ED 07-4 IS EXERCISE-INDUCED HYPERTENSION ASSOCIATED WITH ADVERSE CARDIOVASCULAR OUTCOMES?
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e189.
    >> Share

  790. KOKKINOS P
    ED 07-2 TO LIFT, WALK OR RUN: WHAT IS THE OPTIMAL MODE OF EXERCISE TO REDUCE HYPERTENSION AND PREVENT CARDIOVASCULAR DISEASE?
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e189.
    >> Share

  791. JAE SY
    ED 07-1 CONTRIBUTION OF CARDIOPULMONARY FITNESS IN OBESITY PHENOTYPES AND INCIDENT HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e189.
    >> Share

  792. SARZANI R
    ED 05-4 NATRIURETIC PEPTIDES, METABOLIC SYNDROME AND HYPERTENSION: AN INTEGRATED VIEW.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e187.
    >> Share

  793. MERTENS P
    SY 10-3 SGLT2 INHIBITORS AS POTENTIAL ANTIHYPERTENSIVE AND RENOPROTECTIVE AGENTS.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e186.
    >> Share

  794. NISHIYAMA A
    SY 09-3 ROLE OF INTRARENAL RAS IN THE PATHOGENESIS OF SALT-DEPENDENT HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e184-e185.
    >> Share

  795. SHIMADA K
    SY 08-2 HYPERTENSION MANAGEMENT FOR SECONDARY PREVENTION OF STROKE.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e183.
    >> Share

  796. WEBER M
    PL 02-3 MANAGEMENT OF ELDERLY HYPERTENSION: WHOM TO TREAT AND HOW LOW TO GO.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e182.
    >> Share

  797. KOKUBO Y
    PL 02-2 PERSPECTIVE ON ELDERLY HYPERTENSION IN ASIA.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e182.
    >> Share

  798. WANG W, Ma L, Sui H, Liu L, et al
    OS 12-05 THE EFFECT OF INTENSIVE LIFESTYLE INTERVENTION ON BLOOD PRESSURE IN PATIENTS WITH HYPERTENSION, SUB-ANALYSIS FROM CHIEF.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e77.
    >> Share

  799. KARIO K, Hoshide S
    OS 12-01 ARB AND CCB LONGEST COMBINATION TREATMENT ON AMBULATORY AND HOME BP IN HYPERTENSION WITH ATRIAL FIBRILLATION - MULTICENTER STUDY ON TIME OF DOSING (ACROBAT).
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e76.
    >> Share

  800. SOKOLOVIC S, Mehmedagic S
    OS 11-06 The effect of vagus nerve stimulation on arterial hypertension using active implantable device.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e75.
    >> Share

  801. WALAS D, Von Roloff E, Paton J
    OS 11-05 Superior cervical ganglionectomy (SCGx) reduces sympathetic innervation of vertebrobasilar arteries but does not affect cerebrovascular remodelling in the adult spontaneously hypertensive rat (SHR).
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e75.
    >> Share

  802. NISHIYAMA A, Hitomi H, Nakano D, Fujisawa Y, et al
    OS 11-03 Role of renal nervous activity in the development of renovascular hypertension in rats.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e74-e75.
    >> Share

  803. KIM MN, Kim YB, Park SM, Kim YI, et al
    OS 11-02 Effect of estrogen on the change of GABA function in the vasopressin neurons of salt-dependent hypertension model rats.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e74.
    >> Share

  804. WAINFORD R, Carmichael C, Walsh K
    OS 11-01 Afferent renal nerve modulation of sodium homeostasis and blood pressure: A sodium sensitive PVN Galphai2 protein dependent mechanism countering the development of salt-sensitive hypertension?
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e74.
    >> Share

  805. PAULETTO P, Puato M, Rattazzi M, Buso R, et al
    OS 10-06 THE IMPACT OF WELL CONTROLLED BLOOD PRESSURE LEVELS ON ARTERIAL PROPERTIES IN ESSENTIAL HYPERTENSIVES.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e73.
    >> Share

  806. LIU Z, Zhao Y, Dong Y, Lu B, et al
    OS 10-02 EFFECTS OF HELICOBACTER PYLORI INFECTION ON ATHEROSCLEROSIS WITH HYPERTENSION AND TYPE 2 DIABETES MELLITUS IN AGED POPULATION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e72.
    >> Share

  807. BURSZTYN M, Ben-Dov IZ
    OS 09-03 EXTREME DIPPING IS NOT ASSOCIATED WITH INCREASED MORTALITY IN BOTH TREATED AND UNTREATED HYPERTENSIVES.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e70.
    >> Share

    August 2016
  808. ZANCHETTI A
    Genetic and environmental factors in development of hypertension.
    J Hypertens. 2016.
    >> Share

  809. MUSICHA C, Crampin AC, Kayuni N, Koole O, et al
    Accessing clinical services and retention in care following screening for hypertension and diabetes among Malawian adults: an urban/rural comparison.
    J Hypertens. 2016.
    >> Share

  810. ANTIKAINEN RL, Peters R, Beckett NS, Fagard RH, et al
    Left ventricular hypertrophy is a predictor of cardiovascular events in elderly hypertensive patients: Hypertension in the Very Elderly Trial.
    J Hypertens. 2016.
    >> Share

  811. KARAMAT FA, Oudman I, Haan YC, van Kuilenburg AB, et al
    Creatine kinase inhibition lowers systemic arterial blood pressure in spontaneously hypertensive rats: a randomized controlled trial.
    J Hypertens. 2016.
    >> Share

  812. LEHMANN N, Erbel R, Mahabadi AA, Kalsch H, et al
    Accelerated progression of coronary artery calcification in hypertension but also prehypertension.
    J Hypertens. 2016.
    >> Share

  813. KIM GR, Cho SN, Kim HS, Yu SY, et al
    Histone deacetylase and GATA-binding factor 6 regulate arterial remodeling in angiotensin II-induced hypertension.
    J Hypertens. 2016.
    >> Share

  814. WOHLFAHRT P, Cifkova R, Movsisyan N, Kunzova S, et al
    Threshold for diagnosing hypertension by automated office blood pressure using random sample population data.
    J Hypertens. 2016.
    >> Share

  815. CHUANG SY, Chiu TH, Lee CY, Liu TT, et al
    Vegetarian diet reduces the risk of hypertension independent of abdominal obesity and inflammation: a prospective study.
    J Hypertens. 2016.
    >> Share

  816. OMBONI S, Aristizabal D, De la Sierra A, Dolan E, et al
    Hypertension types defined by clinic and ambulatory blood pressure in 14 143 patients referred to hypertension clinics worldwide. Data from the ARTEMIS study.
    J Hypertens. 2016.
    >> Share

  817. SALAZAR MR, Espeche WG, Leiva Sisnieguez BC, Balbin E, et al
    Significance of masked and nocturnal hypertension in normotensive women coursing a high-risk pregnancy.
    J Hypertens. 2016.
    >> Share

  818. MUNTNER P, Booth JN 3rd, Shimbo D, Schwartz JE, et al
    Is white-coat hypertension associated with increased cardiovascular and mortality risk?
    J Hypertens. 2016;34:1655-8.
    >> Share

  819. SCHLAICH MP, Schultz C, Shetty S
    Renal denervation for resistant hypertension: closing in on potential confounders.
    J Hypertens. 2016;34:1505-6.
    >> Share

  820. JORDAN J, Grassi G, Tank J
    Device-based treatments in hypertension: think physiology.
    J Hypertens. 2016;34:1502-4.
    >> Share

  821. TADDEI S, Bruno RM
    Endothelial dysfunction in hypertension: achievements and open questions.
    J Hypertens. 2016;34:1492-3.
    >> Share

  822. KJELDSEN SE, Os I, Redon J
    Treatment of hypertension and the price to pay; adverse events and discontinuation from randomized treatment in clinical trials.
    J Hypertens. 2016;34:1489-91.
    >> Share

  823. ZANCHETTI A
    Challenges of antihypertensive treatment.
    J Hypertens. 2016;34:1449-50.
    >> Share

    July 2016
  824. ZANCHETTI A
    The approach to hypertension: from childhood to old age.
    J Hypertens. 2016.
    >> Share

  825. ONWUBERE B, Coca A, Damasceno A, Kadiri S, et al
    Report of the International Society of Hypertension Teaching Seminar organized by the International Society of Hypertension Africa Regional Advisory Group: Maputo, Mozambique, 2016.
    J Hypertens. 2016.
    >> Share

  826. LURBE E, Agabiti-Rosei E, Cruickshank JK, Dominiczak A, et al
    2016 European Society of Hypertension guidelines for the management of high blood pressure in children and adolescents.
    J Hypertens. 2016.
    >> Share

  827. THOMOPOULOS C, Parati G, Zanchetti A
    Effects of blood-pressure-lowering treatment in hypertension: 9. Discontinuations for adverse events attributed to different classes of antihypertensive drugs: meta-analyses of randomized trials.
    J Hypertens. 2016.
    >> Share

  828. DE COSMO S, Viazzi F, Piscitelli P, Giorda C, et al
    Blood pressure status and the incidence of diabetic kidney disease in patients with hypertension and type 2 diabetes.
    J Hypertens. 2016.
    >> Share

  829. BURSZTYN M, Jacobs JM, Hammerman-Rozenberg A, Stessman J, et al
    Prevalence of orthostatic hypertension in the very elderly and its relationship to all-cause mortality.
    J Hypertens. 2016.
    >> Share

  830. TENTORI S, Messaggio E, Brioni E, Casamassima N, et al
    Endogenous ouabain and aldosterone are coelevated in the circulation of patients with essential hypertension.
    J Hypertens. 2016.
    >> Share

  831. HERRERA NA, Jesus I, Shinohara AL, Dionisio TJ, et al
    Exercise training attenuates dexamethasone-induced hypertension by improving autonomic balance to the heart, sympathetic vascular modulation and skeletal muscle microcirculation.
    J Hypertens. 2016.
    >> Share

  832. JICHOVA S, Kopkan L, Huskova Z, Dolezelova S, et al
    Epoxyeicosatrienoic acid analog attenuates the development of malignant hypertension, but does not reverse it once established: a study in Cyp1a1-Ren-2 transgenic rats.
    J Hypertens. 2016.
    >> Share

  833. IMPRIALOS K, Boutari C, Stavropoulos K, Doumas M, et al
    Depression in hypertensive patients: the role of comorbidities.
    J Hypertens. 2016;34:1441.
    >> Share

  834. ZANCHETTI A
    From pregnancy to childhood and adulthood: the trajectory of hypertension.
    J Hypertens. 2016;34:1235-1236.
    >> Share

  835. NIEMIRSKA A, Litwin M, Trojanek J, Gackowska L, et al
    Altered matrix metalloproteinase 9 and tissue inhibitor of metalloproteinases 1 levels in children with primary hypertension.
    J Hypertens. 2016.
    >> Share

  836. HAMER M, Kivimaki M, Batty GD
    Pulse rate reactivity in childhood as a risk factor for adult hypertension: the 1970 British cohort study.
    J Hypertens. 2016.
    >> Share

  837. MAHFOUD F, Moon LB, Pipenhagen CA, Jensen JA, et al
    Catheter-based radio-frequency renal nerve denervation lowers blood pressure in obese hypertensive swine model.
    J Hypertens. 2016.
    >> Share

    June 2016
  838. SANTOS LP, Moraes RS, Vieira PJ, Ash GI, et al
    Effects of aerobic exercise intensity on ambulatory blood pressure and vascular responses in resistant hypertension: a crossover trial.
    J Hypertens. 2016.
    >> Share

  839. DE SIMONE G, Izzo R, Losi MA, Stabile E, et al
    Depressed myocardial energetic efficiency is associated with increased cardiovascular risk in hypertensive left ventricular hypertrophy.
    J Hypertens. 2016.
    >> Share

  840. BOMBELLI M, Maloberti A, Raina L, Facchetti R, et al
    Prognostic relevance of electrocardiographic Tpeak-Tend interval in the general and in the hypertensive population: data from the Pressioni Arteriose Monitorate E Loro Associazioni study.
    J Hypertens. 2016.
    >> Share

  841. MAATOUK I, Herzog W, Bohlen F, Quinzler R, et al
    Association of hypertension with depression and generalized anxiety symptoms in a large population-based sample of older adults.
    J Hypertens. 2016.
    >> Share

  842. OLIVERAS A, Armario P, Clara A, Sans-Atxer L, et al
    Spironolactone versus sympathetic renal denervation to treat true resistant hypertension: results from the DENERVHTA study - a randomized controlled trial.
    J Hypertens. 2016.